研究者情報

マスター

アカウント（マスター）

• 氏名

  比能　洋(ヒノウ　ヒロシ), ヒノウ　ヒロシ

所属（マスター）

• 先端生命科学研究院　先端融合科学研究部門　新薬探索研究分野

所属（マスター）

• 先端生命科学研究院　先端融合科学研究部門　新薬探索研究分野

独自項目

syllabus

• 2021, 生体高分子学実験Ⅲ, Laboratory Work on Bio-macromolecular Science III, 学士課程, 理学部, 物理学実験，化学分析実験，有機合成実験，生化学実験, 分子生物学実験, 細胞生物学実験，生物物理学実験
• 2021, 高分子機能学卒業研究, Research Work in Bio-macromolecular Science, 学士課程, 理学部, 実験研究
• 2021, 高分子機能学文献講読, Seminar in Bio-macromolecular Science, 学士課程, 理学部, 物理学実験，化学分析実験，有機合成実験，生化学実験, 分子生物学実験, 細胞生物学実験，生物物理学実験
• 2021, 生物系のための有機化学, Organic Chemistry for Life Science, 学士課程, 理学部, 生命科学と有機化学、分子軌道、物理的性質、酸と塩基、命名法、立体化学、配座、配位、熱力学と速度論、アルケンの反応
• 2021, 科学・技術の世界, The World of Science and Technology, 学士課程, 全学教育, 生命科学　細胞　分子　生物　化学　物理　体　病気　薬　医療
• 2021, 生体高分子学実験Ⅱ, Laboratory Work on Bio-macromolecular Science II, 学士課程, 理学部, 物理学実験，化学分析実験，有機合成実験，生化学実験, 分子生物学実験，細胞生物学実験, 生物物理学実験
• 2021, 実験生物科学, Experimental Biological Science, 学士課程, 理学部, 高分子機能学，実験技術，生命科学，物質科学，情報科学，融合科学
• 2021, 科学英語講読, Exercise on Scientic English, 学士課程, 理学部, 科学英語, 英文論文の作製, 英文読解
• 2021, 基礎化学英語, Chemistry and English for Life Science, 学士課程, 理学部, ケミカルバイオロジ― 生命科学 英語と化学
• 2021, 生体高分子学実験Ⅰ, Laboratory Work on Bio-macromolecular Science I, 学士課程, 理学部, 物理学実験，化学分析実験，有機合成実験，生化学実験, 分子生物学実験，細胞生物学実験, 生物物理学実験
• 2021, 高分子機能学基礎実験, Fundamental Laboratory Work on Bio-macromolecular Science, 学士課程, 理学部, 基礎実験手法，物理学実験，化学分析実験，有機合成実験，生化学実験，安全教育，法令

researchmap

プロフィール情報

学位

• 博士（工学）（埼玉大学）

プロフィール情報

• 姓

  比能, ヒノウ

• 名

  洋, ヒロシ

• ID各種

  A-4395-2012, 200901028518191110

対象リソース

https://sites.google.com/eis.hokudai.ac.jp/hinou/home

業績リスト

研究キーワード

• 有機化学   生物有機化学   糖鎖工学   質量分析   分析化学   表面化学   創薬化学   環境制御化学   環状化合物   

研究分野

• ナノテク・材料 / ケミカルバイオロジー
• ライフサイエンス / 生物有機化学
• ナノテク・材料 / 有機合成化学
• ナノテク・材料 / 分析化学
• ライフサイエンス / 薬系化学、創薬科学
• ライフサイエンス / 細菌学
• ナノテク・材料 / 生体化学
• ものづくり技術（機械・電気電子・化学工学） / バイオ機能応用、バイオプロセス工学
• ナノテク・材料 / ナノバイオサイエンス
• ナノテク・材料 / グリーンサステイナブルケミストリー、環境化学
• 環境・農学 / 化学物質影響

経歴

• 2019年04月 - 現在 北海道大学 先端生命科学研究院 次世代物質生命科学研究センター副センタ―長
• 2019年01月 - 現在 北海道大学 先端生命科学研究院 教授
• 2013年04月 - 2018年12月 北海道大学 先端生命科学研究院 准教授
• 2007年10月 - 2013年03月 北海道大学 先端生命科学研究院 助教
• 2010年02月 - 2010年09月 Institute for Research in Biomedicine (IRB barcelona) 客員研究員
• 2006年 - 2009年 産業技術総合研究所創薬シーズ探索研究ラボ 大学等非常勤研究員
• 2005年 - 2007年 北海道大学理学研究科 助手
• 2005年 - 2006年 産業技術総合研究所糖鎖工学研究センター 大学等非常勤研究員
• 2003年 - 2005年 産業技術総合研究所糖鎖工学研究センター糖鎖自動合成チーム 研究員
• 2002年 - 2003年 理化学研究所細胞制御化学研究室 共同研究員
• 2002年 - 2003年 日本大学薬学部化学研究室 助手
• 2000年 - 2002年 東京理科大学理学部化学科 非常勤講師
• 2000年 - 2002年 理化学研究所細胞制御化学研究室 協力研究員
• 1999年 - 2000年 理化学研究所有機合成化学研究室 Junior Research Associate

学歴

• 1997年04月 - 2000年03月   埼玉大学   大学院理工学研究科   生物環境科学専攻
• 1995年04月 - 1997年03月   埼玉大学   大学院理工学研究科   応用化学専攻
•         - 1995年   埼玉大学   工学部   応用化学・環境化学工学科

委員歴

• 2021年04月 - 現在   日本質量分析学会   日本質量分析学会北海道談話会・研究会 世話人
• 2021年04月 - 現在   高分子学会   代議員
• 2020年04月 - 現在   日本化学会   北海道支部幹事
• 2019年07月 - 現在   日本糖質学会   評議員
• 2014年 - 2023年   GFRG   GFRGシンポジウム運営委員
• 2022年09月 - 2022年09月   高分子学会   高分子学会高分子討論会実行委員
• 2018年09月 - 2018年09月   高分子学会   高分子討論会会場責任者
• 2012年 - 2014年   高分子学会   「高分子」編集委員会、若手連携委員
• 2012年08月   高分子学会   高分子若手会・サマーユニバーシティ運営委員
• 2011年08月   高分子学会   高分子若手会・サマーユニバーシティ運営委員   高分子学会
• 2007年07月 - 2007年07月   高分子学会   第５３回 高分子夏季大学実行委員   高分子学会
• 2007年02月   高分子学会   第41回北海道支部研究発表会実行委員   高分子学会
• 2007年   高分子学会   第42回北海道支部研究発表会実行委員   高分子学会
• 2006年09月 - 2006年09月   繊維学会   第３７回繊維学会夏季セミナー実行委員

受賞

• 2023年03月 John Wiley & Sons, Inc. Top Downloaded Article
   Top Downloaded Article 

  受賞者: Shogo Urakami;Hiroshi HINOU
• 2022年03月 Analysis & Sensing. Most accessed 03/2022
  
• 2011年 Best Poster Award
  
• 2011年 Very Important Paper (VIP)
  
• 2007年 高分子研究奨励賞
  
• 2007年 Poster Presentation Award
  

論文

• Integration of MALDI glycotyping and NMR analysis to uncover an O-antigen substructure from pathogenic Escherichia coli O111.

  June Chelyn Lee, Shogo Urakami, Hiroshi Hinou

  International journal of biological macromolecules 137178 - 137178 2024年11月04日 [査読有り]
   

  Escherichia coli O111 serotype is a critical pathogenic E. coli strain that causes severe, potentially fatal complications. Despite its reported variation, only one structure of the O-antigen polysaccharide from E. coli O111 has been reported. Here, a substructure of the O-antigen from E. coli O111 was characterized using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry and NMR analysis. MALDI glycotyping revealed differing O-antigen repeating unit masses of Δm/z 787 and 828 in the E. coli strains and lipopolysaccharides from the O111 serogroup. This variation was caused by the replacement of the hexose residue with hexosamine in the repeating units, which was further confirmed by LIFT-TOF/TOF analysis. Structural elucidation of the O111 substructure by NMR analysis further demonstrated replacement of the hydroxyl group with an N-acetyl group on the terminal glucose residue of the O-antigen pentasaccharide repeating unit. To our knowledge, this study is the first to provide a detailed structural analysis of a new O-antigen substructure from the E. coli O111 serogroup.
• MALDI glycotyping of O-antigens from a single colony of gram-negative bacteria.

  Shogo Urakami, Hiroshi Hinou

  Scientific reports 14 1 12719 - 12719 2024年06月03日 [査読有り][通常論文]
   

  Polypeptide-targeted MALDI-TOF MS for microbial species identification has revolutionized microbiology. However, no practical MALDI-TOF MS identification method for O-antigen polysaccharides, a major indicator for epidemiological classification within a species of gram-negative bacteria, is available. We describe a simple MALDI glycotyping method for O-antigens that simultaneously identifies the molecular mass of the repeating units and the monosaccharide composition of the O-antigen. We analyzed the Escherichia coli O1, O6, and O157-type strains. Conventional species identification based on polypeptide patterns and O-antigen polysaccharide typing can be performed in parallel from a single colony using our MALDI-TOF MS workflow. Moreover, subtyping within the same O-antigen and parallel colony-specific O-antigen determination from mixed strains, including the simultaneous identification of multiple strains-derived O-antigens within selected colony, were performed. In MALDI glycotyping of two Enterobacteriaceae strains, a Citrobacter freundii strain serologically cross-reactive with E. coli O157 gave a MALDI spectral pattern identical to E. coli O157. On the other hand, an Edwardsiella tarda strain with no reported O-antigen cross-reactivity gave a MALDI spectral pattern of unknown O-antigen repeating units. The method described in this study allows the parallel and rapid identification of microbial genera, species, and serotypes of surface polysaccharides using a single MALDI-TOF MS instrument.
• Sulfated N-glycans Upregulation in Sera Predicts Early-Stage Breast Cancer in Patients

  Dereje G. Feleke, Bryan M. Montalban, Solomon T. Gizaw, Hiroshi Hinou

  2024年03月28日
• Glycoblotting-Based Ovo-Sulphoglycomics Reveals Phosphorylated N-Glycans as a Possible Host Factor of AIV Prevalence in Waterfowls

  Bryan M. Montalban, Hiroshi Hinou

  ACS Infectious Diseases 2024年02月09日 [査読有り][通常論文]
  
• Sodium-Doped 3-Amino-4-hydroxybenzoic Acid: Rediscovered Matrix for Direct MALDI Glycotyping of O-Linked Glycopeptides and Intact Mucins

  Shogo Urakami, Hiroshi Hinou

  International Journal of Molecular Sciences 2023年11月28日 [査読有り][招待有り]
  
• DHB Matrix with Additives for Direct MALDI Mass Spectrometry of Carbohydrates and Glycoconjugates

  Hiroshi Hinou

  Trends in Glycoscience and Glycotechnology 35 204 E19 - E22 2023年03月25日 [査読有り][招待有り]
  
• Altering the Modular Architecture of Galectins Affects its Binding with Synthetic α‐Dystroglycan O‐Mannosylated Core M1 Glycoconjugates In situ

  Lareno L. Villones, Anna-Kristin Ludwig, Seiya Kikuchi, Rika Ochi, Shin-Ichiro Nishimura, Hans-Joachim Gabius, Herbert Kaltner, Hiroshi Hinou

  ChemBioChem 2023年03月09日 [査読有り]
  
• Glycoblotting enables seamless and straightforward workflow for MALDI-TOF/MS-based sulphoglycomics of N- and O-glycans

  Bryan M. Montalban, Hiroshi Hinou

  Proteomics 2023年 [査読有り][通常論文]
   

  Sulfated N- and O-glycans exist in trace levels which are challenging to detect, especially when abundant neutral and sialylated glycans are present. Current matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS)-based sulfoglycomics approaches effectively utilize permethylation to discriminate sulfated glycans from sialyl-glycans. And a charge-based separation to isolate the sulfated glycans from the rest of the permethylated neutral and sialyl-glycans. However, these approaches suffer from concomitant sample losses during cleanup steps. Herein, we describe Glycoblotting as a straightforward complementary method with seamless glycan purification, enrichment, methylation, and labeling on a single platform to address sulfated glycan enrichment, sialic acid methylation, and sample loss. Glycoblottings’ on-bead chemoselective ligation of reducing sugars with hydrazide showed excellent recovery of sulfated glycans, allowing the detection of more sulfated glycan species. On-bead methyl esterification of sialic acid using 3-methyl-1-p-tolyltriazene (MTT) effectively discriminates sulfated glycans from sialyl-glycans. Furthermore, we have shown that using MTT as a methylating agent allowed us to simultaneously detect and differentiate sulfate from phosphate groups in isobaric N-glycan species. We believe that Glycoblotting will contribute significantly to the MALDI-TOF MS-based Sulphoglycomics workflow.
• Structural and molecular insight into antibody recognition of dynamic neoepitopes in membrane tethered MUC1 of pancreatic cancer cells and secreted exosomes

  Hajime Wakui, Yasuhiro Yokoi, Chieko Horidome, Toyoyuki Ose, Min Yao, Yoshikazu Tanaka, Hiroshi Hinou, Shin-Ichiro Nishimura

  RSC Chemical Biology 2023年 [査読有り][通常論文]
   

  We unveil for the first time that pancreatic cancer cells (PANC-1) and secreted exosomes express MUC1 bearing cancer-relevant dynamic epitopes recognized specifically by an anti-MUC1 antibody (SN-131).
• Direct MALDI Glycotyping of Glycoproteins toward Practical Subtyping of Biological Samples

  Shogo Urakami, Hiroshi Hinou

  ACS Omega 7 43 39280 - 39286 2022年11月01日 [査読有り]
  
• Exploring the In situ pairing of human galectins toward synthetic O-mannosylated core M1 glycopeptides of α-dystroglycan

  Lareno L. Villones, Anna-Kristin Ludwig, Hiroyuki Kumeta, Seiya Kikuchi, Rika Ochi, Tomoyasu Aizawa, Shin-Ichiro Nishimura, Hans-Joachim Gabius, Hiroshi Hinou

  Scientific Reports 12 1 2022年10月23日 [査読有り][通常論文]
   

  Abstract Dystroglycan (DG), which constitutes a part of the dystrophin–glycoprotein complex, connects the extracellular matrix to the cytoskeleton. The matriglycans presented by the extracellular α-DG serve as a contact point with extracellular matrix proteins (ECM) containing laminin G-like domains, providing cellular stability. However, it remains unknown whether core M1 (GlcNAcβ1-2Man) structures can serve as ligands among the various O-Mannosylated glycans. Therefore, based on the presence of N-acetylLactosamine (LacNAc) in this glycan following the core extension, the binding interactions with adhesion/growth-regulatory galectins were explored. To elucidate this process, the interaction between galectin (Gal)-1, -3, -4 and -9 with α-DG fragment ³⁷²TRGAIIQTPTLGPIQPTRV³⁹⁰ core M1-based glycopeptide library were profiled, using glycan microarray and nuclear magnetic resonance studies. The binding of galectins was revealed irrespective of its modular architecture, adding galectins to the list of possible binding partners of α-DG core M1 glycoconjugates by cis-binding (via peptide- and carbohydrate-protein interactions), which can be abrogated by α2,3-sialylation of the LacNAc units. The LacNAc-terminated α-DG glycopeptide interact simultaneously with both the S- and F-faces of Gal-1, thereby inducing oligomerization. Furthermore, Gal-1 can trans-bridge α-DG core M1 structures and laminins, which proposed a possible mechanism by which Gal-1 ameliorates muscular dystrophies; however, this proposal warrants further investigation.
• BOA/DHB/Na: An Efficient UV-MALDI Matrix for High-Sensitivity and Auto-Tagging Glycomics

  Erina Barada, Hiroshi Hinou

  International Journal of Molecular Sciences 23 20 12510  2022年10月22日 [査読有り][招待有り]
  
• Generation 6 polyamidoamine dendrimer provides an ideal nanoparticular platform for enzyme-assisted synthesis of glycopeptides having bulky and complex glycans

  Takahiko Matsushita, Hiroshi Hinou, Shin-Ichiro Nishimura

  Chemistry Letters 51 1044 - 1048 2022年09月16日 [査読有り]
  
• Selective reaction monitoring approach using structure-defined synthetic glycopeptides for validating glycopeptide biomarkers pre-determined by bottom-up glycoproteomics.

  Kouta Shiratori, Yasuhiro Yokoi, Hajime Wakui, Nozomi Hirane, Michiru Otaki, Hiroshi Hinou, Tohru Yoneyama, Shingo Hatakeyama, Satoshi Kimura, Chikara Ohyama, Shin-Ichiro Nishimura

  RSC advances 12 33 21385 - 21393 2022年07月21日 [査読有り]
   

  Clusterin is a heavily glycosylated protein that is upregulated in various cancer and neurological diseases. The findings by the Hancock and Iliopoulos group that levels of the tryptic glycopeptide derived from plasma clusterin, 372Leu-Ala-Asn-Leu-Thr-Gln-Gly-Glu-Asp-Gln-Tyr-Tyr-Leu-Arg385 with a biantennary disialyl N-glycan (A2G2S2 or FA2G2S2) at Asn374 differed significantly prior to and after curative nephrectomy for clear cell renal cell carcinoma (RCC) patients motivated us to verify the feasibility of this glycopeptide as a novel biomarker of RCC. To determine the precise N-glycan structure attached to Asn374, whether A2G2S2 is composed of the Neu5Acα2,3Gal or/and the Neu5Acα2,6Gal moiety, we synthesized key glycopeptides having one of the two putative isomers. Selective reaction monitoring assay using synthetic glycopeptides as calibration standards allowed "top-down glycopeptidomics" for the absolute quantitation of targeted label-free glycopeptides in a range from 313.3 to 697.5 nM in the complex tryptic digests derived from serum samples of RCC patients and healthy controls. Our results provided evidence that the Asn374 residue of human clusterin is modified dominantly with the Neu5Acα2,6Gal structure and the levels of clusterin bearing an A2G2S2 with homo Neu5Acα2,6Gal terminals at Asn374 decrease significantly in RCC patients as compared with healthy controls. The present study elicits that a new strategy integrating the bottom-up glycoproteomics with top-down glycopeptidomics using structure-defined synthetic glycopeptides enables the confident identification and quantitation of the glycopeptide targets pre-determined by the existing methods for intact glycopeptide profiling.
• Glycan‐Selective MALDI In‐Source Decay Analysis of Intact Glycoproteins

  Shogo Urakami, Hiroshi Hinou

  Analysis & Sensing 2 2 e20210004  2022年03月 [査読有り]
  
• Click Synthesis of Size- and Shape-Tunable Star Polymers with Functional Macrocyclic Cores for Synergistic DNA Complexation and Delivery.

  Ana I Carbajo-Gordillo, José L Jiménez Blanco, Juan M Benito, Hugo Lana, Gema Marcelo, Christophe Di Giorgio, Cédric Przybylski, Hiroshi Hinou, Valentín Ceña, Carmen Ortiz Mellet, Francisco Mendicuti, Conchita Tros de Ilarduya, José M García Fernández

  Biomacromolecules 21 12 5173 - 5188 2020年12月14日 [査読有り]
   

  The architectural perfection and multivalency of dendrimers have made them useful for biodelivery via peripheral functionalization and the adjustment of dendrimer generations. Modulation of the core-forming and internal matrix-forming structures offers virtually unlimited opportunities for further optimization, but only in a few cases this has been made compatible with strict diastereomeric purity over molecularly diverse series, low toxicity, and limited synthetic effort. Fully regular star polymers built on biocompatible macrocyclic platforms, such as hyperbranched cyclodextrins, offer advantages in terms of facile synthesis and flexible compositions, but core elaboration in terms of shape and function becomes problematic. Here we report the synthesis and characterization of star polymers consisting of functional trehalose-based macrocyclic cores (cyclotrehalans, CTs) and aminothiourea dendron arms, which can be efficiently synthesized from sequential click reactions of orthogonal monomers, display no cytotoxicity, and efficiently complex and deliver plasmid DNA in vitro and in vivo. When compared with some commercial cationic dendrimers or polymers, the new CT-scaffolded star polymers show better transfection efficiencies in several cell lines and structure-dependent cell selectivity patterns. Notably, the CT core could be predefined to exert Zn(II) complexing or molecular inclusion capabilities, which has been exploited to synergistically boost cell transfection by orders of magnitude and modulate the organ tropism in vivo.
• A straightforward approach to antibodies recognising cancer specific glycopeptidic neoepitopes (vol 11, pg 4999, 2020)

  Hajime Wakui, Yoshikazu Tanaka, Toyoyuki Ose, Isamu Matsumoto, Koji Kato, Yao Min, Taro Tachibana, Masaharu Sato, Kentaro Naruchi, Fayna Garcia Martin, Hiroshi Hinou, Shin-Ichiro Nishimura

  CHEMICAL SCIENCE 11 46 12588 - 12589 2020年12月 [査読有り]
   

  Correction for 'A straightforward approach to antibodies recognising cancer specific glycopeptidic neoepitopes' by Hajime Wakui et al., Chem. Sci., 2020, 11, 4999-5006, DOI: ; 10.1039/D0SC00317D.
• Amplified Detection of Breast Cancer Autoantibodies Using MUC1-Based Tn Antigen Mimics.

  Pablo A Guillen-Poza, Elena M Sánchez-Fernández, Gerard Artigas, José Manuel García Fernández, Hiroshi Hinou, Carmen Ortiz Mellet, Shin-Ichiro Nishimura, Fayna Garcia-Martin

  Journal of medicinal chemistry 63 15 8524 - 8533 2020年08月13日 [査読有り]
   

  In many human carcinomas, mucin-1 (MUC1) is overexpressed and aberrantly glycosylated, resulting in the exposure of previously hidden antigens. This generates new patient antibody profiles that can be used in cancer diagnosis. In the present study, we focused on the MUC1-associated Tn antigen (α-O-GalNAc-Ser/Thr) and substituted the GalNAc monosaccharide by a glycomimic to identify MUC1-based glycopeptides with increased antigenicity. Two different glycopeptide libraries presenting the natural Tn antigen or the sp2-iminosugar analogue were synthesized and evaluated with anti-MUC1 monoclonal antibodies in a microarray platform. The most promising candidates were tested with healthy and breast cancer sera aiming for potential autoantibody-based biomarkers. The suitability of sp2-iminosugar glycopeptides to detect anti-MUC1 antibodies was demonstrated, and serological experiments showed stage I breast cancer autoantibodies binding with a specific unnatural glycopeptide with almost no healthy serum interaction. These results will promote further studies on their capabilities as early cancer biomarkers.
• A straightforward approach to antibodies recognising cancer specific glycopeptidic neoepitopes

  Hajime Wakui, Yoshikazu Tanaka, Toyoyuki Ose, Isamu Matsumoto, Koji Kato, Yao Min, Taro Tachibana, Masaharu Sato, Kentaro Naruchi, Fayna Garcia Martin, Hiroshi Hinou, Shin-Ichiro Nishimura

  CHEMICAL SCIENCE 11 19 4999 - 5006 2020年05月 [査読有り][通常論文]
   

  Aberrantly truncated immature O-glycosylation in proteins occurs in essentially all types of epithelial cancer cells, which was demonstrated to be a common feature of most adenocarcinomas and strongly associated with cancer proliferation and metastasis. Although extensive efforts have been made toward the development of anticancer antibodies targeting MUC1, one of the most studied mucins having cancer-relevant immature O-glycans, no anti-MUC1 antibody recognises carbohydrates and the proximal MUC1 peptide region, concurrently. Here we present a general strategy that allows for the creation of antibodies interacting specifically with glycopeptidic neoepitopes by using homogeneous synthetic MUC1 glycopeptides designed for the streamlined process of immunization, antibody screening, three-dimensional structure analysis, epitope mapping and biochemical analysis. The X-ray crystal structure of the anti-MUC1 monoclonal antibody SN-101 complexed with the antigenic glycopeptide provides for the first time evidence that SN-101 recognises specifically the essential epitope by forming multiple hydrogen bonds both with the proximal peptide and GalNAc linked to the threonine residue, concurrently. Remarkably, the structure of the MUC1 glycopeptide in complex with SN-101 is identical to its solution NMR structure, an extended conformation induced by site-specific glycosylation. We demonstrate that this method accelerates dramatically the development of a new class of designated antibodies targeting a variety of "dynamic neoepitopes" elaborated by disease-specific O-glycosylation in the immunodominant mucin domains and mucin-like sequences found in intrinsically disordered regions of many proteins.
• Impaired O-Glycosylation at Consecutive Threonine TTX Motifs in Mucins Generates Conformationally Restricted Cancer Neoepitopes.

  Shun Hayakawa, Takahiko Matsushita, Yasuhiro Yokoi, Hajime Wakui, Fayna Garcia-Martin, Hiroshi Hinou, Koji Matsuoka, Kazuhiro Nouso, Toshiya Kamiyama, Akinobu Taketomi, Shin-Ichiro Nishimura

  Biochemistry 59 12 1221 - 1241 2020年03月31日 [査読有り][通常論文]
   

  Autoantibody signatures of circulating mucin fragments stem from cancer tissues, and microenvironments are promising biomarkers for cancer diagnosis and therapy. This study highlights dynamic epitopes generated by aberrantly truncated immature O-glycosylation at consecutive threonine motifs (TTX) found in mucins and intrinsically disordered proteins (IDPs). NMR analysis of synthetic mucin models having glycosylated TTX motifs and colonic MUC2 tandem repeats (TRs) containing TTP and TTL moieties unveils a general principle that O-glycosylation at TTX motifs generates a highly extended and rigid conformation in IDPs. We demonstrate that the specific conformation of glycosylated TTX motifs in MUC2 TRs is rationally rearranged by concerted motions of multiple dihedral angles and noncovalent interactions between the carbohydrate and peptide region. Importantly, this canonical conformation of glycosylated TTX motifs minimizes steric crowding of glycans attached to threonine residues, in which O-glycans possess restricted orientations permitting further sugar extension. An antiadhesive microarray displaying synthetic MUC2 derivatives elicited the presence of natural autoantibodies to MUC2 with impaired O-glycosylation at TTX motifs in sera of healthy volunteers and patients diagnosed with early stage colorectal cancer (CRC). Interestingly, autoantibody levels in sera of the late stage CRC patients were distinctly lower than those of early stage CRC and normal individuals, indicating that the anti-MUC2 humoral response to MUC2 neoepitopes correlates inversely with the CRC stage of patients. Our results uncovered the structural basis of the creation of dynamic epitopes by immature O-glycosylation at TTX motifs in mucins that facilitates the identification of high-potential targets for cancer diagnosis and therapy.
• Synthesis, conformational analysis and in vivo assays of an anti-cancer vaccine that features an unnatural antigen based on an sp2-iminosugar fragment

  Iris A. Bermejo, Claudio D. Navo, Jorge Castro-López, Ana Guerreiro, Ester Jiménez-Moreno, Elena M. Sánchez Fernández, Fayna García-Martín, Hiroshi Hinou, Shin-Ichiro Nishimura, José M. García Fernández, Carmen Ortiz Mellet, Alberto Avenoza, Jesús H. Busto, Gonçalo J. L. Bernardes, Ramón Hurtado-Guerrero, Jesús M. Peregrina, Francisco Corzana

  Chemical Science 11 15 3996 - 4006 2020年 [査読有り]
   

  An anti-cancer vaccine based on an unnatural antigen with an sp²-iminosugar fragment.

• Aniline derivative/DHB/alkali metal matrices for reflectron mode MALDI-TOF and TOF/TOF MS analysis of unmodified sialylated oligosaccharides and glycopeptides

  Hiroshi Hinou

  International Journal of Mass Spectrometry 2019年09月 [査読有り][通常論文]
  
• Glycan-immobilized dual-channel field effect transistor biosensor for the rapid identification of pandemic influenza viral particles.

  Hideshima S, Hayashi H, Hinou H, Nambuya S, Kuroiwa S, Nakanishi T, Momma T, Nishimura SI, Sakoda Y, Osaka T

  Scientific reports 9 1 11616 - 11616 2019年08月12日 [査読有り][通常論文]
   

  Pandemic influenza, triggered by the mutation of a highly pathogenic avian influenza virus (IFV), has caused considerable damage to public health. In order to identify such pandemic IFVs, antibodies that specifically recognize viral surface proteins have been widely used. However, since the analysis of a newly discovered virus is time consuming, this delays the availability of suitable detection antibodies, making this approach unsuitable for the early identification of pandemic IFVs. Here we propose a label-free semiconductor-based biosensor functionalized with sialic-acid-containing glycans for the rapid identification of the pandemic IFVs present in biological fluids. Specific glycans are able to recognize wild-type human and avian IFVs, suggesting that they are useful in discovering pandemic IFVs at the early stages of an outbreak. We successfully demonstrated that a dual-channel integrated FET biosensing system, which were modified with 6'-sialyllactose and 3'-sialyllactose for each gate area, can directly and specifically detect human H1N1 and avian H5N1 IFV particles, respectively, present in nasal mucus. Furthermore, to examine the possibility of identifying pandemic IFVs, the signal attributed to the detection of Newcastle disease virus (NDV) particles, which was selected as a prime model of a pandemic IFV, was clearly observed from both sensing gates. Our findings suggest that the proposed glycan-immobilized sensing system could be useful in identifying new pandemic IFVs at the source of an outbreak.
• Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.

  Hiroshi Hinou

  BMC cancer 19 1 588  2019年06月17日 [査読有り][通常論文]
   

  BACKGROUND:Alterations in protein glycosylation patterns have potentially been targeted for biomarker discovery in a wide range of diseases including cancer. Although there have been improvements in patient diagnosis and survival for breast cancer (BC), there is no clinically validated serum biomarker for its early diagnosis. Here, we profiled whole serum and purified Immunoglobulin G (IgG) fraction N-glycome towards identification of non-invasive glycan markers of BC. METHODS:We employed a comprehensive glycomics approach by integrating glycoblotting-based glycan purification with MALDI-TOF/MS based quantitative analysis. Sera of BC patients belonging to stages I-IV and normal controls (NC) were collected from Ethiopian women during 2015-2016. IgG was purified by affinity chromatography using protein G spin plate and further subjected to glycoblotting for glycan release. Mass spectral data were further processed and evaluated rigorously, using various bioinformatics and statistical tools. RESULTS:Out of 35 N-glycans that were significantly up-regulated in the sera of all BC patients compared to the NC, 17 complex type N-glycans showed profound expression abundance and diagnostic potential (AUC = 0.8-1) for the early stage (I and II) BC patients. Most of these glycans were core-fucosylated, multiply branched and sialylated structures, whose abundance has been strongly associated with greater invasive and metastatic potential of cancer. N-glycans quantified form IgG confirmed their abundance in BC patients, of which two core-fucosylated and agalactosylated glycans (m/z 1591, 1794) could specifically distinguish (AUC = 0.944 and 0.921, p ≤ 0.001) stage II patients from NC. Abundance of such structural features in IgG is associated with a decrease in its immunosuppressive potential towards tumor cells, which in part may correlate with the aggressive nature of BC commonly noticed in black population. CONCLUSIONS:Our comprehensive study has addressed for the first time both whole serum and IgG N-glycosylation signatures of native black women suffering from BC and revealed novel glyco-biomarkers with marked overexpression and distinguishing ability at early stage patients. Further studies on direct identification of the intact glycoproteins using a glycoprteomics approach will provide a deeper understanding of specific biomarkers towards their clinical utility.
• Synthetic glycopeptides reveal specific binding pattern and conformational change at O-mannosylated position of α-dystroglycan by POMGnT1 catalyzed GlcNAc modification.

  Hiroshi Hinou

  Bioorganic & medicinal chemistry 27 13 2822 - 2831 2019年05月06日 [査読有り][通常論文]
   

  Structural and functional effects of core M1 type glycan modification catalyzed by protein O-linked mannose β1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) were investigated using a core M1 glycoform focused library of an α-dystroglycan fragment, 372TRGAIIQTPTLGPIQPTRV390. Evanescent-field fluorescence-assisted microarray system illuminated the specific binding pattern of plant lectins that can discriminate the glycan structure of core M1 glycan of the library. The comparative NMR analysis of synthetic glycopeptide having different length of the O-mannosylated glycans revealed a conformational change of the peptide backbone along with core M1 disaccharide formation. No long-range NOE signals of glycan-amino acid nor inter amino acid indicate the conformational change is induced by steric hindrance of core M1, the sole 1,2-O-modified form among protein binding sugar residue found in mammals.
• Novel matrix system for reflectron mode MALDI-TOF and TOF/TOF MS analysis of unmodified sialylated oligosaccharides and glycopeptides

  Hiroshi Hinou

  Abstracts of Papers of the American Chemical Society 2019年
• Glycoblotting of Egg White Reveals Diverse N-Glycan Expression in Quail Species

  Jurgen T. Sanes, Hiroshi Hinou, Yuan Chuan Lee, Shin-Ichiro Nishimura

  JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 67 1 531 - 540 2019年01月 [査読有り][通常論文]
   

  The glycan part of glycoproteins is known to be involved in the structure and modulatory functions of glycoproteins, serving as ligands for cell-to-cell interactions, and as specific ligands for cell-to-microbe interactions. It is believed that intraspecies and interspecies variations in glycosylation exist. As an approach to better understand glycan diversity, egg whites (EW) from four different quail species are studied by the well-established glycoblotting procedure, a glycan enrichment and analysis method. N-Glycans were classified and the profiles were established for quail egg white samples which showed 21 relevant glycan peaks; 18 peaks were expressed significantly, and 10 glycan peaks are found to be abundant in certain species. The result establishes glycan profiles for Blue Scaled, Bobwhite, Japanese, and Mountain Quail egg whites and shows a unique difference among glycan expressions, particularly, high mannose in Japanese Quail and tetra-antennary glycan structure for other quail species.
• Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.

  Hiroshi Hinou

  PloS one 13 12 e0209515  2018年12月28日 [査読有り][通常論文]
   

  BACKGROUND:Most glycomics studies have focused on understanding disease mechanisms and proposing serum markers for various diseases, yet the influence of ethnic variation on the identified glyco-biomarker remains poorly addressed. This study aimed to investigate the inter-ethnic serum N-glycan variation among US origin control, Japanese, Indian, and Ethiopian healthy volunteers. METHODS:Human serum from 54 healthy subjects of various ethnicity and 11 Japanese hepatocellular carcinoma (HCC) patients were included in the study. We employed a comprehensive glycoblotting-assisted MALDI-TOF/MS-based quantitative analysis of serum N-glycome and fluorescence HPLC-based quantification of sialic acid species. Data representing serum N-glycan or sialic acid levels were compared among the ethnic groups using SPSS software. RESULTS:Total of 51 N-glycans released from whole serum glycoproteins could be reproducibly quantified within which 33 glycoforms were detected in all ethnicities. The remaining N-glycans were detected weakly but exclusively either in the Ethiopians (13 glycans) or in all the other ethnic groups (5 glycans). Highest abundance (p < 0.001) of high mannose, core-fucosylated, hyperbranched/hypersialylated N-glycans was demonstrated in Ethiopians. In contrast, only one glycan (m/z 2118) significantly differed among all ethnicities being highest in Indians and lowest in Ethiopians. Glycan abundance trend in Ethiopians was generally close to that of Japanese HCC patients. Glycotyping analysis further revealed ethnic-based disparities mainly in the branched and sialylated structures. Surprisingly, some of the glycoforms greatly elevated in the Ethiopian subjects have been identified as serum biomarkers of various cancers. Sialic acid level was significantly increased primarily in Ethiopians, compared to the other ethnicities. CONCLUSION:The study revealed ethnic-specific differences in healthy human serum N-glycome with highest abundance of most glycoforms in the Ethiopian ethnicity. The results strongly emphasized the need to consider ethnicity matching for accurate glyco-biomarker identification. Further large-scale study employing various ethnic compositions is needed to verify the current result.
• Synthetic Glycopeptides Allow for the Quantitation of Scarce Nonfucosylated IgG Fc N-Glycans of Therapeutic Antibody

  Hiroshi Hinou

  ACS Medicinal Chemistry Letters 9 9 889 - 894 2018年09月 [査読有り][通常論文]
  
• Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers

  K. Yogesh, Toshiya Kamiyama, Chikara Ohyama, Tohru Yoneyama, Kazuhiro Nouso, Satoshi Kimura, Hiroshi Hinou, Shin-Ichiro Nishimura

  MEDCHEMCOMM 9 8 1351 - 1358 2018年08月 [査読有り][通常論文]
   

  Previous studies on the large-scale glycomics of more than 3500 human serum samples revealed that the serum glycoproteins of cancer patients often have more dominant and specific glycoforms, namely, branched tri- and tetra-antennary N-glycans, most cancer patient groups than normal control groups. We herein established an efficient synthetic protocol of glycopeptides having highly complicated N-glycan structures that may be generated by direct tryptic digestion of serum glycoproteins. A preliminary selected reaction monitoring (SRM) assay using the synthetic model glycopeptide 1, (40)Ser-Val-Gln-Glu-Ile-Gln-Ala-Thr-Phe-Phe-Tyr-Phe-Thr-Pro-Asn-Lys-Thr-Glu-Asp-Thr-Ile-Phe-Leu-Arg(63) having an asialo tri-antennary N-glycan at the Asn54 residue as a designated calibration standard allowed for the rapid and absolute quantitation of the tryptic fragment derived from the serum alpha 1-acid glycoprotein carrying a focused N-glycoform of cancer patients and healthy controls in a range between 200 and 1600 fmole mu L-1 without any enrichment process for the target glycoprotein.
• Further applications of classical amide coupling reagents: Microwave-assisted esterification on solid phase

  Risa Takayama, Shun Hayakawa, Hiroshi Hinou, Fernando Albericio, Fayna Garcia-Martin

  JOURNAL OF PEPTIDE SCIENCE 24 8-9 e3111  2018年08月 [査読有り][通常論文]
   

  Ester linkage (s) is a key chemical connector in organic chemistry, including natural products, peptides, and synthetic polymers. We herein describe a straightforward method for the efficient formation of ester linkage (s) on solid-phase. This method simply involves the use of amide coupling reagents under microwave irradiation. The robustness of this method relies on the use of classical solid-phase coupling reagents, heating by microwave irradiation, and a short time period, which results in high yields and the minimization of racemization.
• The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

  Victor J. Somovilla, Iris A. Bermejo, Ines S. Albuquerque, Nuria Martinez-Saez, Jorge Castro-Lopez, Fayna Garcia-Martin, Ismael Companon, Hiroshi Hinou, Shin-Ichiro Nishimura, Jesus Jimenez-Barbero, Juan L. Asensio, Alberto Avenoza, Jesus H. Busto, Ramon Hurtado-Guerrero, Jesus M. Peregrina, Goncalo J. L. Bernardes, Francisco Corzana

  JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 139 50 18255 - 18261 2017年12月 [査読有り][通常論文]
   

  A structure-based design of a new generation of tumor-associated glycopeptides with improved affinity against two anti-MUC1 antibodies is described. These unique antigens feature a fluorinated proline residue, such as a (4S)-4-fluoro-L-proline or 4,4-difluoro-L-proline, at the most immunogenic domain. Binding assays using biolayer interferometry reveal 3-fold to 10-fold affinity improvement with respect to the natural (glyco)peptides. According to X-ray crystallography and MD simulations, the fluorinated residues' stabilize the antigen-antibody complex by enhancing key CH/pi interactions. Interestingly, a notable improvement in detection of cancer-associated anti-MUC1 antibodies from serum of patients with prostate cancer is achieved with the non-natural antigens, which proves that these derivatives can be considered better diagnostic tools than the natural antigen for prostate cancer.
• Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs

  Gerard Artigas, Joao T. Monteiro, Hiroshi Hinou, Shin-Ichiro Nishimura, Bernd Lepenies, Fayna Garcia-Martin

  JOURNAL OF MEDICINAL CHEMISTRY 60 21 9012 - 9021 2017年11月 [査読有り][通常論文]
   

  The macrophage galactose-type lectin (MGL) recognizes glycan moieties exposed by pathogens. and malignant cells. Particularly, mucin-1 (MUC1) glycoprotein presents an altered glycosylation in several cancers. To estimate the ability of distinct MGL orthologs to recognize aberrant glycan cores in mucins, we applied evanescent-field detection to a versatile MUC1-like glycopeptide microarray platform. Here, as binding was sequence-dependent, we demonstrated that not only sugars but also peptide region impact the recognition of murine MGL1 (raMGL1). In addition, we observed for all three MGL orthologs that divalent glycan presentation increased the binding. To assess the utility of the glycopeptide binders of the MGL orthologs for MGL targeting, we performed uptake assays with fluorescein-MUC1 using murine dendritic cells. A diglycosylated MUC1 peptide was preferentially internalized in an MGL-dependent fashion, thus showing the utility for divalent MGL targeting. These findings may be relevant to a rational design of antitumor vaccines targeting dendritic cells via MGL.
• An Efficient Glycoblotting-Based Analysis of Oxidized Lipids in Liposomes and a Lipoprotein

  Takayuki Furukawa, Hiroshi Hinou, Seiji Takeda, Hitoshi Chiba, Shin-Ichiro Nishimura, Shu-Ping Hui

  CHEMBIOCHEM 18 19 1903 - 1909 2017年10月 [査読有り][通常論文]
   

  Although widely occurring lipid oxidation, which is triggered by reactive oxygen species (ROS), produces a variety of oxidized lipids, practical methods to efficiently analyze oxidized lipids remain elusive. Herein, it is shown that the glycoblotting platform can be used to analyze oxidized lipids. Analysis is based on the principle that lipid aldehydes, one of the oxidized lipid species, can be captured selectively, enriched, and detected. Moreover, 3-methyl-1-p-tolyltriazene (MTT) methylates phosphoric and carboxylic acids, and this MTT-mediated methylation is, in combination with conventional tandem mass spectrometry (MS/MS) analysis, an effective method for the structural analysis of oxidized lipids. By using three classes of standards, liposomes, and a lipoprotein, it is demonstrated that glycoblotting represents a powerful approach for focused lipidomics, even in complex macromolecules.
• Chemical Synthesis Demonstrates That Dynamic O-Glycosylation Regulates the Folding and Functional Conformation of a Pivotal EGF12 Domain of the Human NOTCH1 Receptor

  Shun Hayakawa, Yasuhiro Yokoi, Hiroshi Hinou, Shin-Ichiro Nishimura

  BIOCHEMISTRY 56 33 4379 - 4391 2017年08月 [査読有り][通常論文]
   

  The interaction of the human NOTCH1 receptor and its ligands is a crucial step in initiating the intracellular signal transductions, in which O-glycosylation of the extracellular EGF-like domain strongly affects multiple aspects of cell differentiation, development, and, cancer biology. However, consequences of biosynthetic O-glycosylation processes in the endoplasmic reticulum: (ER) and Golgi I on the folding of EGF domains remain unclear. Synthetic I human NOTCH1 EGF12 modules allow for new insight into, the crucial roles of O-glycosylation in the folding and conformation of this pivotal domain. Here, we show - for the, first time that predominant O-glucosylation at Ser458 facilitates proper folding of the EGF12 domain in the presence of calcium. ion, while the nonglycosylated linear EGF12 peptide affords large amounts of misfolded products (>50%) during in vitro oxidative folding. Strikingly, O-fucosylation at Thr466 prior to O-glucosylation at Ser458 totally impedes folding of EGF12 independent of calcium ion, whereas modification of the Fucal -> moiety with beta-linked GlcNAC dramatically. enhances folding effitiency. In addition,. we elicit that extension of the Glc beta 1 -> moiety with xyloses is a negative-regrilation mechanism in the folding of EGF12 when synthesis, of a. trisaccharide (Xylal -> 3Xyla1- 3G1c beta 1 ->) dominates over the posttrarislational modification at Thr466. Comprehensive nuclear magnetic resonance studies of correctly folded EGF12 modules demonstrate that noncovalently bonded bridges, between sugars and, peptide moieties, namely sugar bridges, contribute independently to the stabilization of the antiparallel beta-sheet in the ligand-binding region. Our results provide evidence that the dynamic O-glycosylation status of the EGF12 domain elaborated in the ER and Golgi strongly affects folding and trafficking of the human. NOTCH1 receptor.
• Synthetic Mucin-Like Glycopeptides as Versatile Tools to Measure Effects of Glycan Structure/Density/Position on the Interaction with Adhesion/Growth-Regulatory Galectins in Arrays

  Gerard Artigas, Hiroshi Hinou, Fayna Garcia-Martin, Hans-Joachim Gabius, Shin-Ichiro Nishimura

  CHEMISTRY-AN ASIAN JOURNAL 12 1 159 - 167 2017年01月 [査読有り][通常論文]
   

  Functional pairing of cellular glycoconjugates with tissue lectins is a highly selective process, whose determinative factors have not yet been fully delineated. Glycan structure and modes of presentation, that is, its position and density, can contribute to binding, as different members of a lectin family can regulate degrees of responsiveness to these factors. Using a peptide repeat sequence motif of the glycoprotein mucin-1, the principle of introducing synthetic (glyco) peptides with distinct variations in these three parameters to an array-based screening of tissue lectins is illustrated. Interaction profiles of seven adhesion/growth-regulatory galectins cover the range from intense signals with core 2 pentasaccharides and core 1 binding for galectins-3 and -5 to a lack of binding for galectin-1 and also the galectin-related protein, which was included as a negative control. Remarkably, the two tandem-repeat-type galectins-4 and -8 were distinguished by core 1 sialylation, as the two separated domains were. These results encourage further synthetic elaboration of the glycopeptide library and testing of the network of natural galectins and rationally engineered variants of the lectins.
• Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery

  Solomon T. Gizaw, Tetsu Ohashi, Masakazu Tanaka, Hiroshi Hinou, Shin-Ichiro Nishimura

  BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 1860 8 1716 - 1727 2016年08月 [査読有り][通常論文]
   

  Background: Understanding of the significance of posttranslational glycosylation in Alzheimer's disease (AD) is of growing importance for the investigation of the pathogenesis of AD as well as discovery research of the disease specific serum biomarkers. Methods: We designed a standard protocol for the glycoblotting combined with MALDI-TOFMS to perform rapid and quantitative profiling of the glycan parts of glycoproteins (N-glycans) and glycosphingolipids (GSLs) using human AD's post-mortem samples such as brain tissues (dissected cerebral cortices such as frontal, parietal, occipital, and temporal domains), serum and cerebrospinal fluid (CSF). Results: The structural profiles of the major N-glycans released from glycoproteins and the total expression levels of the glycans were found to be mostly similar between the brain tissues of the AD patients and those of the normal control group. In contrast, the expression levels of the serum and CSF protein N-glycans such as bisect-type and multiply branched glycoforms were increased significantly in AD patient group. In addition, the levels of some gangliosides such as GM1, GM2 and GM3 appeared to alter in the AD patient brain and serum samples when compared with the normal control groups. Conclusion: Alteration of the expression levels of major N- and GSL-glycans in human brain tissues, serum and CSF of AD patients can be monitored quantitatively by means of the glycoblotting-based standard protocols. General significance: The changes in the expression levels of the glycans derived from the human post-mortem samples uncovered by the standardized glycoblotting method provides potential serum biomarkers in central nervous system disorders and can contribute to the insight into the molecular mechanisms in the pathogenesis of neurodegenerative diseases and future drug discovery. Most importantly, the present preliminary trials using human post-mortem samples of AD patients suggest that large-scale serum glycomics cohort by means of various-types of human AD patients as well as the normal control sera can facilitate the discovery research of highly sensitive and reliable serum biomarkers for an early diagnosis of AD.. This article is part of a Special Issue entitled "Glycans in personalised medicine" Guest Editor: Professor Gordan Lauc. (C) 2016 Elsevier B.V. All rights reserved.
• Convergent Solid-Phase Synthesis of Macromolecular MUC1 Models Truly Mimicking Serum Glycoprotein Biomarkers of Interstitial Lung Diseases

  Naoki Ohyabu, Kiyoshi Kakiya, Yasuhiro Yokoi, Hiroshi Hinou, Shin-Ichiro Nishimura

  JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 138 27 8392 - 8395 2016年07月 [査読有り][通常論文]
   

  Synthetic macromolecular MUC1 glycopeptides have been used to unravel molecular mechanisms in antibody recognition of disease-specific epitopes. We have established a novel synthetic strategy for MUC1 tandem repeats having complex O-glycosylation states at each repeating unit based on convergent solid-phase fragment condensation under microwave irradiation. We have accomplished the synthesis of 77 amino acid MUC1 glycopeptides (MW = 12 759) having three major antigenic O-glycoforms [Tn, core 1 (T), and core 2 structures] at 10 designated positions out of 19 potential O-glycosylation sites. We demonstrate that the macro molecular MUC1 glycopeptide displaying the essential glycopeptidic neoepitope Pro-Asp-Thr(sialyl-T)-Arg-Pro-Ala-Pro at two different tandem repeats is an excellent serum MUC1 model showing ideal stoichiometric binding with anti-KL6/MUC1 antibody in the sandwich ELISA to quantify human serum KL6/MUC1 levels as a critical biomarker of interstitial lung diseases.
• Solid-phase synthesis of C-mannosylated glycopeptide on WSXWS motif of human erythropoietin receptor

  Hiroshi Hinou, Yuya Abe, Shun Hayakawa, Kentaro Naruchi, Naoki Fujitani, Shin-Ichiro Nishimura

  TETRAHEDRON LETTERS 57 7 791 - 795 2016年02月 [査読有り][通常論文]
   

  Protein C-mannosylation is a widely conserved posttranslational modification in multicellular organisms although the function of this modification is yet to be clarified. To evaluate the effect of this modification, a C-mannosyltryptophan containing glycopeptide of human erythropoietin receptor (EPOR), which includes WSXWS motif conserved in cytokine receptor superfamily, was synthesized by microwave assisted solid-phase synthesis using per-O-benzyl protected amino acids and C-mannosyltryptophan on Sieber amide resin. Comparative NMR analysis of the C-mannosyl glycopeptide and a corresponding naked peptide revealed that the C-mannosylation enhances the NOE signal between the peptide main chain and the aromatic side chain to suggest enhancement of conformational stability of the WSXWS motif and its surrounding regions. (C) 2016 Elsevier Ltd. All rights reserved.
• Synthetic Human NOTCH1 EGF Modules Unraveled Molecular Mechanisms for the Structural and Functional Roles of Calcium Ions and O-Glycans in the Ligand-Binding Region

  Shun Hayakawa, Ryosuke Koide, Hiroshi Hinou, Shin-Ichiro Nishimura

  BIOCHEMISTRY 55 5 776 - 787 2016年02月 [査読有り][通常論文]
   

  The Notch signaling pathway is an evolutionarily highly conserved mechanism that operates across multicellular organisms and is critical for cell-fate decisions during development and homeostasis in most tissues. Notch signaling is modified by posttranslational glycosylations of the Notch extracellular EGF-like domain. To evaluate the structural and functional roles of various glycoforms at multiple EGF domains in the human Notch transmembrane receptor, we established a universal method for the construction of NOTCH1 EGF modules displaying the desired O-glycans at the designated glycosylation sites. The versatility of this strategy was demonstrated by the rapid and highly efficient synthesis of NOTCH1 EGF12 concurrently having a beta-D-glucopyranose-initiated glycan (Xyl alpha 1 -> 3Xyl alpha 1 -> 3Glc beta 1 ->) at Ser458 and alpha-L-fucopyranose-initiated glycan (Neu5Ac alpha 2 -> 3Gal beta 1 -> 4GlcNA beta 1 -> 3Fuc alpha 1 ->) at Thr466. The efficiency of the proper folding of the glycosylated EGF12 was markedly enhanced in the presence of 5 mM CaCl2. A nuclear magnetic resonance study revealed the existence of strong nuclear Overhauser effects between key sugar moieties and neighboring amino acid residues, indicating that both O-glycans contribute independently to the intramolecular stabilization of the antiparallel beta-sheet structure in the ligand-binding region of EGF12. A preliminary test using synthetic human NOTCH1 EGF modules showed significant inhibitory effects on the proliferation and adhesiveness of human breast cancer cell line MCF-7 and lung adenocarcinoma epithelial cell line A549, demonstrating for the first time evidence that exogenously applied synthetic EGF modules have the ability to interact with intrinsic Notch ligands on the surface of cancer cells.
• Novel β-galactosynthase-β-mannosynthase dual activity of β-galactosidase from: Aspergillus oryzae uncovered using monomer sugar substrates

  R. S. Tan, R. S. Tan, H. Hinou, H. Hinou, S. I. Nishimura, S. I. Nishimura

  RSC Advances 6 56 50833 - 50836 2016年 [査読有り][通常論文]
   

  © 2016 The Royal Society of Chemistry.A novel β-galactosynthase-β-mannosynthase dual-activity of β-galactosidase from Aspergillus oryzae was uncovered, for the first time, using free monosaccharide substrates. The enzyme successfully converted galactose and mannose monomer sugars efficiently into Gal-β(1-6)-Gal and Man-β(1-6)-Man, respectively. The discovery could potentially revolutionize chemoenzymatic glycan and non-digestible oligosaccharide (NDO) syntheses.
• Effects of the multiple O-glycosylation states on antibody recognition of the immunodominant motif in MUC1 extracellular tandem repeats

  Shobith Rangappa, Gerard Artigas, Risho Miyoshi, Yasuhiro Yokoi, Shun Hayakawa, Fayna Garcia-Martin, Hiroshi Hinou, Shin-Ichiro Nishimura

  MEDCHEMCOMM 7 6 1102 - 1122 2016年 [査読有り][通常論文]
   

  Antibodies that react with human epithelial cell membrane MUC1 glycoprotein with aberrant glycoforms are promising diagnostic and therapeutic reagents in various cancers and interstitial lung diseases. However, the precise epitopes for anti-MUC1 antibodies have remained unclear. Although the MUC1 extracellular domain has multiple O-glycosylation sites within the tandem repeats, there have been few systematic approaches to determine the effects of the multiple O-glycosylation states, in the context of the disease-relevant epitope regions, on antibody recognition. In this study, we established a comprehensive approach for the characterization of anti-MUC1 antibodies by combining microarray-based epitope profiling and NMR-based conformational analysis of synthetic MUC1 glycopeptides. Epitope mapping analysis using a microarray that displayed 23 synthetic MUC1 glycopeptides revealed that anti-KL6/MUC1 monoclonal antibody (anti-KL6 mAb) has absolute binding specificity with an essential epitope, Pro-Asp-Thr[Neu5Ac alpha(2 -> 3)Gal beta(1 -> 3)GalNAc alpha 1 ->]-Arg-Pro-Ala-Pro, in an ultimately glycoform-specific manner when compared with the other well-studied anti-MUC1 mAbs DF3 and SM3, which are directed against the same Pro-Asp-Thr-Arg (PDTR) motif in the tandem repeats. Multiple O-glycosylations at the neighbouring Ser/Thr residues did not disturb this specific recognition by anti-KL6 mAb, even when modified by sterically hindered core 2-type pentasaccharide moieties (SC2). To our surprise, both DF3 and SM3 exhibited a drastic decrease in binding ability with putative MUC1 fragments with an immunodominant PDTR motif when other glycosylation sites were occupied by Tn antigen (GalNAc alpha 1 ->) or T antigen [Gal beta(1 -> 3)GalNAc alpha 1 ->]. However, modification at the two adjacent Ser residues by O-glycans that contained ST antigen [Neu5Ac alpha(2 -> 3)Gal beta( 1 -> 3)GalNAc alpha 1 ->] resulted, exceptionally, in a substantial enhancement of the affinity of DF3 for the PDTR region. These results demonstrated for the first time that the O-glycosylation states around the immunodominant PDTR motif strongly influence the binding potency and profile of DF3 and SM3. NMR studies of the synthetic MUC1 fragments discovered the molecular mechanisms by which multiple O-glycosylations at the adjacent Ser/Thr residues induce significant conformational alterations in the PDTR motif in a glycoform-dependent manner. Anti-KL6 mAb was proved to be the only anti-MUC1 mAb that can recognise a unique glycopeptidic neo-epitope generated via site-specific posttranslational modification by ST antigen independently from O-glycosylation states at the adjacent Ser/Thr residues within the MUC1 tandem repeats.
• Large-Scale Glycomics of Livestock: Discovery of Highly Sensitive Serum Biomarkers Indicating an Environmental Stress Affecting Immune Responses and Productivity of Holstein Dairy Cows

  Ibrahim F. Rehan, Koichiro Ueda, Tomohiro Mitani, Maho Amano, Hiroshi Hinou, Tetsu Ohashi, Seiji Kondo, Shin-Ichiro Nishimura

  JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 63 48 10578 - 10590 2015年12月 [査読有り][通常論文]
   

  Because various stresses strongly influence the food productivity of livestock, biomarkers to indicate unmeasurable environmental stress in domestic animals are of increasing importance. Thermal comfort is one of the basic principles of dairy cow welfare that enhances productivity. To discover sensitive biomarkers that monitor such environmental stresses in dairy cows, we herein performed, for the first time, large-scale glycomics on 336 lactating Holstein cow serum samples over 9 months between February and October. Glycoblotting combined with MALDI-TOF/MS and DMB/HPLC allowed for comprehensive glycomics of whole serum glycoproteins. The results obtained revealed seasonal alterations in serum N-glycan levels and their structural characteristics, such as an increase in high-mannose type N-glycans in spring, the occurrence of di/triantennary complex type N-glycans terminating with two or three Neu5Gc residues in summer and autumn, and N-glycans in winter dominantly displaying Neu5Ac. A multivariate analysis revealed a correlation between the serum expression levels of these season-specific glycoforms and productivity.
• The Quest for Anticancer Vaccines: Deciphering the Fine-Epitope Specificity of Cancer-Related Monoclonal Antibodies by Combining Microarray Screening and Saturation Transfer Difference NMR

  Helena Coelho, Talcahiko Matsushita, Gerard Artigas, Hiroshi Hinou, F. Javier Canada, Richard Lo-Man, Claude Leclerc, Eurico J. Cabrita, Jesus Jimenez-Barbero, Shin-Ichiro Nishimura, Fayna Garcia-Martin, Filipa Marcelo

  JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 137 39 12438 - 12441 2015年10月 [査読有り][通常論文]
   

  The identification of MUC1 tumor-associated Tn antigen (alpha GalpNAc1-O-Ser/Thr) has boosted the development of anticancer vaccines. Combining microarrays and saturation transfer difference NMR, we have characterized the fine-epitope mapping of a MUC1 chemical library (naked and Tn-glycosylated) toward two families of cancer-related monoclonal antibodies (anti-MUC1 and anti-Tn mAbs). Anti-MUC1 mAbs clone VU-3C6 and VU-11E2 recognize naked MUC1-derived peptides and bind GalNAc in a peptide-sequence-dependent manner. In contrast, anti-Tn mAbs clone 8D4 and 14D6 mostly recognize the GalNAc and do not bind naked MUC1-derived peptides. These anti-Tn mAbs show a clear preference for glycopeptides containing the Tn-Ser antigen rather than the Tn-Thr analogue, stressing the role of the underlying amino acid (serine or threonine) in the binding process. The reported strategy can be employed, in general, to unveil the key minimal structural features that modulate antigen-antibody recognition, with particular relevance for the development of Tn-MUC1-based anticancer vaccines.
• A comprehensive glycome profiling of Huntington's disease transgenic mice

  Solomon T. Gizaw, Toshiaki Koda, Maho Amano, Keiko Kamimura, Tetsu Ohashi, Hiroshi Hinou, Shin-Ichiro Nishimura

  BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 1850 9 1704 - 1718 2015年09月 [査読有り][通常論文]
   

  Background: Huntington's disease (HD) is an autosomal, dominantly inherited and progressive neurodegenerative disease, nosologically classified as the presence of intranuclear inclusion bodies and the loss of GABA-containing neurons in the neostriatum and subsequently in the cerebellar cortex. Abnormal processing of neuronal proteins can result in the misfolding of proteins and altered post-translational modification of newly synthesized proteins. Total glycomics, namely, N-glycomics, O-glycomics, and glycosphingolipidomics (GSL-omics) of HD transgenic mice would be a hallmark for central nervous system disorders in order to discover disease specific biomarkers. Methods: Glycoblotting method, a high throughput glycomic protocol, and matrix-assisted laser desorption ionization-time of flight/mass spectrometry (MALDI-TOF/MS) were used to study the total glycome expression levels in the brain tissue (3 mice of each sex) and sera (5 mice of each sex) of HD transgenic and control mice. All experiments were performed twice and differences in the expression levels of major glycoforms were compared between HD transgenic and control mice. Results: We estimated the structure and expression levels of 87 and 58 N-glycans in brain tissue and sera, respectively, of HD transgenic and control mice. The present results clearly indicated that the brain glycome and their expression levels are significantly gender specific when compared with those of other tissues and serum. Core-fucosylated and bisecting-GlcNAc types of N-glycans were found in increased levels in the brain tissue HD transgenic mice. Accordingly, core-fucosylated and sialic acid (particularly N-glycolylneuraminic acid, NeuGc) for biantennary type glycans were found in increased amounts in the sera of HD transgenic mice compared to that of control mice. Core 3 type O-glycans were found in increased levels in male and in decreased levels in both the striatum and cortexes of female HD transgenic mice. Furthermore, serum levels of core 1 type O-glycans decreased and were undetected for core 2 type O-glycans for HD transgenic mice. In glycosphingolipids, GD1a in brain tissue and GM2-NeuGc serum levels were found to have increased and decreased, respectively, in HD transgenic mice compared to those of the control group mice. Conclusion: Total glycome expression levels are significantly different between HD transgenic and control group mice. General significance: Glycoblotting combined with MALDI-TOF/MS total glycomics warrants a comprehensive, effective, novel and versatile technique for qualitative and quantitative analysis of total glycome expression levels. Furthermore, glycome-focused studies of both environmentally and genetically rooted neurodegenerative diseases are promising candidates for the discovery of potential disease glyco-biomarkers in the post-genome era. (C) 2015 Elsevier B.V. All rights reserved.
• Rapid Endolysosomal Escape and Controlled Intracellular Trafficking of Cell Surface Mimetic Quantum-Dots-Anchored Peptides and Glycopeptides

  Roger S. Tan, Kentaro Naruchi, Maho Amano, Hiroshi Hinou, Shin-Ichiro Nishimura

  ACS CHEMICAL BIOLOGY 10 9 2073 - 2086 2015年09月 [査読有り][通常論文]
   

  A novel strategy for the development of a high performance nanoparticules platform was established by means of cell surface mimetic quantum-dots (QDs)-anchored peptides/glycopeptides, which was developed as a model system for nanopartide-based drug delivery (NDD) vehicles with defined functions helping the specific intracellular trafficking after initial endocytosis. In this paper, we proposed a standardized protocol for the preparation of multifunctional QDs that allows for efficient cellular uptake and rapid escaping from the endolysosomal system and subsequent cytoplasmic molecular delivery to the target cellular compartment. Chemoselective ligation of the ketone-functionalized hexahistidine derivative facilitated both efficient endocytic entry and rapid endolysosomal escape of the aminooxy/phosphorylcholine self-assembled monolayer-coated QDs (AO/PCSAM-QDs) to the cytosol in various cell lines such as human normal and cancer cells, while modifications of these QDs with cell-penetrating arginine-rich peptides showed poor cellular uptake and induced self-aggregation of AO/PCSAM-QDs. Combined use of hexahistidylated AO/PCSAM-QDs with serglycine-like glycopeptides, namely synthetic proteoglycan initiators (PGIs), elicited the entry and controlled intracellular trafficking, Golgi localization, and also excretion of these nanoparticles, which suggested that the present approach would provide an ideal platform for the design of high performance NDD systems.
• A comprehensive glycome profiling of Huntington's disease transgenic mice.

  Gizaw ST, Koda T, Amano M, Kamimura K, Ohashi T, Hinou H, Nishimura SI

  Biochimica et biophysica acta 1850 9 1704 - 1718 2015年04月 [査読有り][通常論文]
  
• Fast Epitope Mapping for the Anti-MUC1 Monoclonal Antibody by Combining a One-Bead-One-Glycopeptide Library and a Microarray Platform

  Fayna Garcia-Martin, Takahiko Matsushita, Hiroshi Hinou, Shin-Ichiro Nishimura

  CHEMISTRY-A EUROPEAN JOURNAL 20 48 15891 - 15902 2014年11月 [査読有り][通常論文]
   

  Anti-MUC1 monoclonal antibodies (mAbs) are powerful tools that can be used to recognize cancer-related MUC1 molecules, the O-glycosylation status of which is believed to affect binding affinity. We demonstrate the feasibility of using a rapid screening methodology to elucidate those effects. The approach involves i) " one-bead-one-compound"- based preparation of bilayer resins carrying glycopeptides on the shell and mass-tag tripeptides coding Oglycan patterns in the core, ii) on-resin screening with an anti-MUC1 mAb, iii) separating positive resins by utilizing secondary antibody conjugation with magnetic beads, and (iv) decoding the mass-tag that is detached from the positive resins pool by using mass spectrometric analysis. We tested a small library consisting of 27 MUC1 glycopeptides with different O-glycosylations against anti-MUC1 mAb clone VU-3C6. Qualitative mass-tag analysis showed that increasing the number of glycans leads to an increase in the binding affinity. Six glycopeptides selected from the library were validated by using a microarray-based assay. Our screening provides valuable information on O-glycosylations of epitopes leading to high affinity with mAb.
• A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.

  Matsushita T, Takada W, Igarashi K, Naruchi K, Miyoshi R, Garcia-Martin F, Amano M, Hinou H, Nishimura S

  Biochimica et biophysica acta 1840 3 1105 - 1116 3 2014年03月 [査読有り][通常論文]
  
• A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides

  Takahiko Matsushita, Wataru Takada, Kota Igarashi, Kentaro Naruchi, Risho Miyoshi, Fayna Garcia-Martin, Maho Amano, Hiroshi Hinou, Shin-Ichiro Nishimura

  BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 1840 3 1105 - 1116 2014年03月 [査読有り][通常論文]
   

  Background: Human serum MUC1 peptide fragments bearing aberrant O-glycans are secreted from columnar epithelial cell surfaces and known as clinically important serum biomarkers for the epithelial carcinoma when a specific monoclonal antibody can probe disease-relevant epitopes. Despite the growing importance of MUC1 glycopeptides as biomarkers, the precise epitopes of most anti-MUC1 monoclonal antibodies remains unclear. Methods: A novel protocol for the fabrication of versatile microarray displaying peptide/glycopeptide library was investigated for the construction of highly sensitive and accurate epitope mapping assay of various anti-MUC1 antibodies. Results: Selective imine-coupling between aminooxy-functionalized methaciylic copolymer with phosphorylcholine unit and synthetic MUC1 glycopeptides-capped by a ketone linker at N-terminus provided a facile and seamless protocol for the preparation of glycopeptides microarray platform. It was demonstrated that anti-KL-6 monoclonal antibody shows an extremely specific and strong binding affinity toward MUC1 fragments carrying sialyl T antigen (Neu5Ac alpha 2,3Gal beta 1,3GalNAc alpha 1 ->) at Pro-Asp-Thr-Arg motif when compared with other seven anti-MUD monoclonal antibodies such as VU-3D, VU-12E1, VU-11E2, Ma552, VU-3C6, SM3, and DF3. The present microarray also uncovered the occurrence of IgG autoantibodies in healthy human sera that bind specifically with sialyl T antigen attached at five potential O-glycosylation sites of MUD tandem repeats. Conclusion: We established a straightforward strategy toward the standardized microarray platform allowing highly sensitive and accurate epitope mapping analysis by reducing the background noise due to nonspecific protein adsorption. General significance: The present approach would greatly accelerate the discovery research of new class autoantibodies as well as the development of therapeutic mAbs reacting specifically with disease-relevant epitopes. (C) 2013 Elsevier B.V. All rights reserved.
• Synthesis of neoglycosphingolipid from methoxyamino-functionalized ceramide

  Junya Ishida, Hiroshi Hinou, Kentaro Naruchi, Shin-Ichiro Nishimura

  BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 24 4 1197 - 1200 2014年02月 [査読有り][通常論文]
   

  An efficient approach for the synthesis of a methoxyamino- functionalized ceramide was established from phytosphingosine using specific Nb -> Na acyl migration of the octadecanoyl group during the removal of Na-Fmoc protective group. One step glycoblotting reaction of the ceramide mimic with lactose afforded a neoglycosphingolipid showing potent inhibitory activity against recombinant endoglycoceramidase II from Rhodococcus sp. (C) 2014 Elsevier Ltd. All rights reserved.
• Potential usage for in vivo lectin screening in live animals utilizing cell surface mimetic glyco-nanoparticles, phosphorylcholine-coated quantum dots (PC-QDs)

  Maho Amano, Hiroshi Hinou, Risho Miyoshi, Shin-Ichiro Nishimura

  Methods in Molecular Biology 1200 361 - 369 2014年 [査読有り][招待有り]
   

  Utilizing glycosylated derivatives as a tag, we are able to explore novel counter-receptor of endogenous lectins or lectin-like molecules in vivo. We have established the standardized methodology including preparation of glycosylated derivatives and construction of a platform for tracing the molecules in vivo at first. Combined use of an aminooxy-terminated thiol derivative and a phosphorylcholine (PC) derivative provides quantum dots (QDs) with novel functions for the chemical ligation of ketone-functionalized compounds and the prevention of nonspecific protein adsorption concurrently. In order to track the derivatives in vivo, near-infrared (NIR) fluorescence imaging of QDs displaying various simple sugars (glyco-PC-QDs) after administration into the tail vein of the mouse can be performed. It has revealed that distinct long-term delocalization over 2 h can be observed depending on the species of glycans ligated to PC-QDs at least in the liver. Until today we have performed live animal imaging utilizing various kinds of sialyl glyco-PC-QDs. They are still retained stably in whole body after 2 h while they showed significantly different in vivo dynamics in the tissue distribution, suggesting that structure/sequence of the neighboring sugar residues in the individual sialyl oligosaccharides might influence the final organ-specific distribution, which should be equivalent to the distribution of sialic acid-recognizing lectins. Here we describe a standardized protocol using ligand-displayed PC-QDs for live cell/animal imaging by versatile NIR fluorescence photometry without influence of size-dependent accumulation/excretion pathway for nanoparticles (e.g., viruses)∈> ∈10 nm in hydrodynamic diameter by the liver. © 2014 Springer Science+Business Media New York.
• 糖タンパク質の糖鎖を付け替える 均一な糖鎖構造をもつ糖タンパク質の効率的合成

  比能洋, 西村紳一郎

  化学 69 1 74 - 75 2014年 [査読無し][招待有り]
  
• A New Approach for the Synthesis of Hyperbranched N-Glycan Core Structures from Locust Bean Gum

  Ravi H. Kumar, Kentaro Naruchi, Risho Miyoshi, Hiroshi Hinou, Shin-Ichiro Nishimura

  ORGANIC LETTERS 15 24 6278 - 6281 2013年12月 [査読有り][通常論文]
   

  A novel protocol for the synthesis of general N-glycan core structures was established by means of Man beta(1 -> 4)Man peracetate derived from a naturally abundant locust bean gum as a key starting material. Phenyl (2-O-benzy1-4,6-O-benzylidine-beta-D-mannopyranosyl)-(1 -> 4)-3,6-di-O-benzyl-2-azido-2-deoxy-1-thio-beta-D-glucopyranoside facilitated the synthesis of key intermediates leading to hyperbranched N-glycan core structures.
• A novel approach for the parallel synthesis of glycopeptides by combining solid-phase peptide synthesis and dendrimer-supported enzymatic modifications

  Takahiko Matsushita, Seiji Handa, Kentaro Naruchi, Fayna Garcia-Martin, Hiroshi Hinou, Shin-Ichiro Nishimura

  Polymer Journal 45 8 854 - 862 2013年08月 [査読無し][招待有り]
   

  Functionalized, high-generation (G7) polyamidoamine (PAMAM) dendrimers are a convenient scaffold for the fully automated enzymatic synthesis of oligosaccharides such as biologically important sialyl Lewis X tetrasaccharide derivatives. In this study, we expanded this strategy to the synthesis of more complicated glycopeptides by assessing the feasibility of G7 PAMAM dendrimer-based polymer supports for attaching glycopeptide intermediates during the subsequent enzymatic modification steps. A monosaccharide-attached glycopeptide containing an N-terminal heterobifunctional linker was prepared by microwave-assisted solid-phase synthesis and was coupled with an aminooxy-functionalized G7 PAMAM dendrimer through oxime bond formation. This reaction proceeded smoothly at pH 4 and afforded the conjugates in 98% yield when 0.2 equivalents of the glycopeptide were combined with 1 equivalent of the aminooxy group of dendrimer. Although modifications using recombinant human β1,4-galactosyltransferase/uridine-5'-diphospho-α-D-galactose disodium salt and recombinant rat α2,3-sialyltransferase/cytidine-5'- monophospho-β-D-N-acetylneuraminic acid disodium salt gave the trisaccharide Neu5Acα2,3Galβ1,4GlcNAc in quantitative yields, treatment with recombinant human α1,3-fucosyltransferase in the presence of excess guanosine 5'-diphospho-β-L-fucose disodium salt did not convert this trisaccharide into the tetrasaccharide sialyl Lewis X tetrasaccharide on the dendrimer. Further optimization studies are required to improve the efficiency of branched-type sugar elongations and product release from polymers by selective peptidases for constructing a high-throughput glycopeptide synthetic system. © 2013 The Society of Polymer Science, Japan (SPSJ) All rights reserved.
• Attomolar Detection of Influenza A Virus Hemagglutinin Human H1 and Avian H5 Using Glycan-Blotted Field Effect Transistor Biosensor

  Sho Hideshima, Hiroshi Hinou, Daisuke Ebihara, Ryosuke Sato, Shigeki Kuroiwa, Takuya Nakanishi, Shin-Ichiro Nishimura, Tetsuya Osaka

  ANALYTICAL CHEMISTRY 85 12 5641 - 5644 2013年06月 [査読有り][通常論文]
   

  Influenza virus, through cell invasion and propagation with the interaction between hemagglutinin (HA) present on its surface and glycans on the host cell, causes a rapidly spreading infection throughout the world. In the present investigation, we succeeded for the first time in the attomolar-level sensing and discrimination of influenza A viral HA molecules H1 and H5 by using a glycan-immobilized field effect transistor (FET) biosensor. The small ligand glycans immobilized on the FET device, which make effective use of the charge-detectable region for FET-based detection in terms of Debye length, gave an advantage in the highly sensitive detection of the proteins. Two kinds of trisaccharides receptors terminating in sialic acid-alpha 2,6-galactose (6'-sialyllactose) and in sialic acid-alpha 2,3-galactose (3'-sialyllactose) were conjugated directly with the SiO2 surface of FET devices by a simple glycoblotting method using the self-assembled monolayer (SAM) of aminooxy terminated silane-coupling reagent, 3-aminooxypropyltriethoxysilane. Furthermore, it was demonstrated that the FETs with densely immobilized glycans, which possess the high capture ability by achieving the glycoside cluster effect, clearly distinguish HA molecules between their subtypes H1 (human) and H5 (avian) at the attomolar level, while the conventional method based on HA antibodies achieves only picomolar-level detection. Our findings indicate that the glycan-immobilized FET is a promising device to detect various pathogenic bacteria and viruses through glycan-protein interaction found ubiquitously in many infectious diseases.
• Microwave-Assisted Solid-Phase Synthesis of Antifreeze Glycopeptides

  Ryukou Izumi, Takahiko Matsushita, Naoki Fujitani, Kentaro Naruchi, Hiroki Shimizu, Sakae Tsuda, Hiroshi Hinou, Shin-Ichiro Nishimura

  CHEMISTRY-A EUROPEAN JOURNAL 19 12 3913 - 3920 2013年03月 [査読有り][通常論文]
   

  Microwave-assisted solid-phase synthesis allows for the rapid and large-scale preparation and structureactivity characterization of tandem repeating glycopeptides, namely monodispersed synthetic antifreeze glycopeptides (syAFGPs, H-[Ala-Thr(Gal1,3GalNAc1)-Ala]n-OH, n=26). By employing novel AFGP analogues, we have demonstrated that of the monodispersed syAFGPn (n=26, degree of polymerization, DP=26, Mw=12573690Da), syAFGP5 (DP=5, Mw=3082Da) and syAFGP6 (DP=6, Mw=3690Da) exhibit the ability to form typical hexagonal bipyramidal ice crystals and satisfactory thermal hysteresis activity. Structural characterization by NMR and CD spectroscopy revealed that syAFGP6 forms a typical poly-L-proline typeII helix-like structure in aqueous solution whereas enzymatic modification by sialic acid of the residues at the C-3 positions of the nonreducing Gal residues disturbs this conformation and eliminates the antifreeze activity.
• Glycoblotting-based high throughput protocol for the structural characterization of hyaluronan degradation products during enzymatic fragmentation

  Takayuki Furukawa, Misaki Arai, Fayna Garcia-Martin, Maho Amano, Hiroshi Hinou, Shin-Ichiro Nishimura

  GLYCOCONJUGATE JOURNAL 30 2 171 - 182 2013年02月 [査読有り][通常論文]
   

  Increasing interests have been focused on the functional roles of hyaluronan degradation products, namely hyaluronan oligosaccharides, as signal molecules regulating cell growth, differentiation, malignancy, and inflammatory responses. It is clear that molecular size of hyaluronan oligosaccharides might be crucial for defining possible and dynamic roles in supporting and suppressing homeostatic cellular processes. The present paper communicates a facile and efficient approach based on glycoblotting method for the characterization of hyaluronan fragments liberated from three different sources of hyaluronan (rooster comb, bovine vitreous humor, and Streptococcus) by in vitro degradation using two typical hyaluronidases of bovine testicular (EC 3.2.1.35) and Streptomyces hyalurolyticus (EC 4.2.2.1). It was demonstrated that glycoblotting method allows for high throughput and quantitative analysis of hyaluronan fragments within a wide dynamic range (1 similar to 1,000 pmole) when 5 mu g of hyaluronan digests were applied for this enrichment protocol. Molecular size and distribution of hyaluronan fragments were proved to be influenced strongly by conditions and hyaluronidases employed while source of hyaluronan did not affect the degradation profiles. Strikingly, the present method uncovered the existence of the smallest and unusual hyaluronan degradation fragments such as a disaccharide GlcA beta 1-3GlcNAc during the digestion by bovine hyaluronidase and a trisaccharide GlcA beta 1-3GlcNAc beta 1-4GlcA derivative by Streptomyces hyaluronidase. Bovine testis hyaluronidases afforded hyaluronan tetra- and hexasaccharides as major products. On the other hand, it was demonstrated that Streptomyces hyaluronidase can produce odd number fragments from three to nine sugar residues while even number fragments from four to fourteen sugar residues were major products.
• Macrocyclic Mechanism-Based Inhibitor for Neuraminidases

  Hirokazu Kai, Hiroshi Hinou, Kentaro Naruchi, Takahiko Matsushita, Shin-Ichiro Nishimura

  CHEMISTRY-A EUROPEAN JOURNAL 19 4 1364 - 1372 2013年01月 [査読有り][通常論文]
   

  A macrocyclic mechanism-based inhibitor for neuraminidases (NAs) bearing a 2-difluoromethylphenyl aglycone and a linker between the aglycone and C-9 positions of sialic acid was synthesized and evaluated. The macrocyclic structure was designed to keep the aglycone moiety in the active site of the neuraminidase after cleavage of the glycoside bond. When Vibrio chorelae neuraminidase (VCNA) was treated with a similar acyclic derivative in the presence of detergent, the irreversible inhibition property was disabled. In contrast, this macrocyclic compound acted as an irreversible inhibitor for VCNA in the presence of detergent. Inhibition assay for various NAs using this macrocyclic compound revealed that the irreversible inhibition property depends on the kcat of the neuraminidase treated. NAs having small kcat values, such as Influenza viruses, Clostridium, Trypanosoma cruzi, and Human, were also inhibited irreversibly. However, Salmonella typhimurium NA, which has an extremely high kcat, was not affected irreversibly by the inhibitor. Interestingly, in contrast to common kcat inhibitors, the irreversibility of inhibition by this macrocyclic compound is inversely proportional to the kcat of the target neuraminidase.
• Site-Specific Conformational Alteration Induced by Sialylation of MUC1 Tandem Repeating Glycopeptides at an Epitope Region for the Anti-KL-6 Monoclonal Antibody

  Takahiko Matsushita, Naoki Ohyabu, Naoki Fujitani, Kentaro Naruchi, Hiroki Shimizu, Hiroshi Hinou, Shin-Ichiro Nishimura

  BIOCHEMISTRY 52 2 402 - 414 2013年01月 [査読有り][通常論文]
   

  Protein O-glycosylation is an essential step for controlling structure and biological functions of glycoproteins involving differentiation, cell adhesion, immune response, inflammation, and tumorigenesis and metastasis. This study provides evidence of site-specific structural alteration induced during multiple sialylation at Ser/Thr residues of the tandem repeats in human MUC1 glycoprotein. Systematic nuclear magnetic resonance (NMR) study revealed that sialylation of the MUC1 tandem repeating glycopeptide, Pro-Pro-Ala-His-Gly-Val-Thr-Ser-Ala-Pro-Asp-Thr-Arg-Pro-Ala-Pro-Gly-Ser-Thr-Ala with core 2-type O-glycans at five potential glycosylation sites, afforded a specific conformational change at one of the most important cancer-relevant epitopes (Pro-Asp-Thr-Arg). This result indicates that disease-relevant epitope structures of human epithelial cell surface mucins can be altered both by the introduction of an inner GalNAc residue and by the distal sialylation in a peptide sequence-dependent manner. These data demonstrate the feasibility of NMR-based structural characterization of glycopeptides synthesized in a chemical and enzymatic manner in examining the conformational impact of the distal glycosylation at multiple O-glycosylation sites of mucin-like domains.
• Molecular shuttle between extracellular and cytoplasmic space allows for monitoring of GAG biosynthesis in human articular chondrocytes

  Hiroshi Hinou

  Biochimica et Biophysica Acta (BBA) - General Subjects 1820 9 1391 - 1398 2012年09月 [査読有り][通常論文]
  
• Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases

  Hirokazu Kai, Hiroshi Hinou, Shin-Ichiro Nishimura

  BIOORGANIC & MEDICINAL CHEMISTRY 20 8 2739 - 2746 2012年04月 [査読有り][通常論文]
   

  A selective and potent inhibitor of neuraminidases, a hydrolase that is responsible for processing sialylated glycoconjugates, is a promising drug candidate for various infective diseases. The current study demonstrates that the use of an aglycone-focused library of 2-difluoromethylphenyl alpha-sialosides is an effective technique to find potent and selective mechanism-based labeling reagents for neuraminidases. The focused library was constructed from a 4-azide-2-difluoromethylphenyl sialoside (2) and an alkyne-terminated compound library by a click reaction. The focused library showed different inhibition patterns for two neuraminidases, Vibrio cholerae neuraminidase (VCNA) and human neuraminidase 2 (hNeu2), and the most potent inhibitors for each neuraminidase were selected. A kinetic analysis of the selected inhibitors demonstrated that the modification of the aglycone moiety improved the K-I value with little change in the t(1/2) value of the enzyme activity relative to the basic skeleton (2). (C) 2012 Elsevier Ltd. All rights reserved.
• Strict stereocontrol by 2,4-O-di-tert-butylsilylene group on β-glucuronylations.

  Furukawa T, Hinou H, Nishimura S

  Organic letters 14 8 2102 - 2105 8 2012年04月 [査読有り][通常論文]
   

  Furukawa, T, Hinou, H &amp; Nishimura, S, 2012, 'Strict Stereocontrol by 2,4-O-Di-tert-butylsilylene Group on β-Glucuronylations', vol. 14, no. 8, pp. 2102-2105.
• An efficient protocol for the solid-phase synthesis of glycopeptides under microwave irradiation

  Fayna Garcia-Martin, Hiroshi Hinou, Takahiko Matsushita, Shun Hayakawa, Shin-Ichiro Nishimura

  ORGANIC & BIOMOLECULAR CHEMISTRY 10 8 1612 - 1617 2012年 [査読有り][通常論文]
   

  A standardized and smooth protocol for solid-phase glycopeptides synthesis under microwave irradiation was developed. Double activation system was proved to allow for highly efficient coupling of Tn-Ser/Thr and bulky core 2-Ser/Thr derivatives. Versatility and robustness of the present strategy was demonstrated by constructing a Mucine-1 (MUC1) fragment and glycosylated fragments of tau protein. The success of this approach relies on the combination of microwave energy, a resin consisting totally of polyethylene glycol, a low excess of sugar amino acid and the "double activation" method.
• H-bonding promotion of peptide solubility and cyclization by fluorinated alcohols

  Hiroshi Hinou, Kei Hyugaji, Fayna Garcia-Martin, Shin-Ichiro Nishimura, Fernando Albericio

  RSC ADVANCES 2 7 2729 - 2731 2012年 [査読有り][通常論文]
   

  A promotion effect for peptide cyclization by strong H-bonding of fluorinated alcohols was revealed via a synthetic study of a cyclic AFGP skeleton. Combination of fluorinated alcohol-DCM solvent system and DIC-additive system afforded the cyclic hexapeptide skeleton in more than 80% yield. The ratio of intra- vs. inter-peptide condensation depended upon the H-bonding donor strength. This effect was quenched by H-bond acceptor solvents.
• A potential glucuronate glycosyl donor with 2-O-acyl-6,3-lactone structure: efficient synthesis of glycosaminoglycan disaccharides

  Takayuki Furukawa, Hiroshi Hinou, Ken Shimawaki, Shin-Ichiro Nishimura

  TETRAHEDRON LETTERS 52 43 5567 - 5570 2011年10月 [査読有り][通常論文]
   

  Development of beta-selective glucuronylation reaction using phenyl 2,4-di-O-acetyl-1-thio-beta-D-glucopyranosidurono-6,3-lactone was described. Glycosylations of this glycosyl donor with hexosamine derivatives proceeded with excellent yield and beta-stereoselectivity to afford glycosaminoglycan-type disaccharides. (C) 2011 Elsevier Ltd. All rights reserved.
• Importance of Sialic Acid Residues Illuminated by Live Animal Imaging Using Phosphorylcholine Self-Assembled Monolayer-Coated Quantum Dots

  Tatsuya Ohyanagi, Noriko Nagahori, Ken Shimawaki, Hiroshi Hinou, Tadashi Yamashita, Akira Sasaki, Takashi Jin, Toshihiko Iwanaga, Masataka Kinjo, Shin-Ichiro Nishimura

  JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 133 32 12507 - 12517 2011年08月 [査読有り][通常論文]
   

  Glycans are expected to be one of the potential signal molecules for controlling drug targeting/delivery or long-term circulation of biopharmaceuticals. However, the effect of the carbohydrates of artificially glycosylated derivatives on in vivo dynamic distribution profiles after intravenous injection of model animals remains unclear due to the lack of standardized methodology and a suitable platform. We report herein an efficient and versatile method for the preparation of multifunctional quantum dots (QDs) displaying common synthetic glycosides with excellent solubility and long-term stability in aqueous solution without loss of quantum yields. Combined use of an aminooxy-terminated thiol derivative, 11,11'-dithio bis[undec-11-yl 12-(aminooxyacetyl)amino hexa(ethyleneglycol)], and a phosphorylcholine derivative, 11-mercaptoundecylphosphorylcholine, provided QDs with novel functions for the chemical ligation of ketone-functionalized compounds and the prevention of nonspecific protein adsorption concurrently. In vivo near-infrared (NIR) fluorescence imaging of phosphorylcholine self-assembled monolayer (SAM)-coated QDs displaying various simple sugars (glyco-PC-QDs) after administration into the tail vein of the mouse revealed that distinct long-term delocalization over 2 h can be achieved in cases of QDs modified with alpha-sialic acid residue (Neu5Ac-PC-QDs) and control PC-QDs, while QDs bearing other common sugars, such as alpha-glucose (Glc-PC-QDs), alpha-mannose (Man-PC-QDs), alpha-fucose (Fuc-PC-QDs), lactose (Lac-PC-QDs), beta-glucuronic acid (GlcA-PC-QDs), N-acetyl-beta-D-glucosamine (GlcNAc-PC-QDs), and N-acetyl-beta-D-galactosamine (GalNAc-PC-QDs) residues, accumulated rapidly (5-10 min) in the liver. Sequential enzymatic modifications of GlcNAc-PC-QDs gave Gal beta 1,4GlcNAc-PC-QDs (LacNAc-PC-QDs), Gal beta 1,4(Fuc alpha 1,3)GlcNAc-PC-QDs (Le(x)-PC-QDs), Neu5Ac alpha 2,3Gal beta 1,4GlcNAc-PC-QDs (sialyl LacNAc-PC-QDs), and Neu5Ac alpha 2,3Gal beta 1,4(Fuc alpha 1,3)GlcNAc-PC-QDs (sialyl Le(x)-PC-QDs) in quantitative yield as monitored by direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry analyses. Live animal imaging uncovered for the first time that Le(x)-PC-QDs also distributed rapidly in the liver after intravenous injection and almost quenched over 1 h in similar profiles to those of LacNAc-PC-QDs and Lac-PC-QDs. On the other hand, sialyl LacNAc-PC-QDs and sialyl Le(x)-PC-QDs were still retained stably in the whole body after 2 h, while they showed significantly different in vivo dynamics in the tissue distribution, suggesting that structure/sequence of the neighboring sugar residues in the individual sialyl oligosaccharides might influence the final organ-specific distribution. The present results clearly visualize the evidence of an essential role of the terminal sialic acid residue(s) for achieving prolonged in vivo lifetime and biodistribution of various glyco-PC-QDs as a novel class of functional platforms for nanomaterial-based drug targeting/delivery. A standardized protocol using multifunctional PC-QDs should facilitate live animal imaging of ligand-displayed QDs using versatile NIR fluorescence photometry without influence of size-dependent accumulation/excretion pathway for nanoparticles (e.g., viruses) >10 nm in hydrodynamic diameter by the liver.
• A Strategy for Neuraminidase Inhibitors Using Mechanism-Based Labeling Information

  Hiroshi Hinou, Risho Miyoshi, Yasuaki Takasu, Hirokazu Kai, Masaki Kurogochi, Shingo Arioka, Xiao-Dong Gao, Nobuaki Miura, Naoki Fujitani, Shinya Omoto, Tomokazu Yoshinaga, Tamio Fujiwara, Takeshi Noshi, Hiroko Togame, Hiroshi Takemoto, Shin-Ichiro Nishimura

  CHEMISTRY-AN ASIAN JOURNAL 6 4 1048 - 1056 2011年04月 [査読有り][通常論文]
   

  A potent inhibitor for Vibrio cholerae neuraminidase (VCNA) was developed by using a novel two-step strategy, a target amino acid validation using mechanism-based labeling information, and a potent inhibitor search using a focused library. The labeling information suggested the hidden dynamics of a loop structure of VCNA, which can be a potential target of the novel inhibitor. A focused library composed of 187 compounds was prepared from a 9-azide derivative of 2,3-dehydro-N-acetylneuraminic acid (DANA) to interrupt the function of the loop of the labeled residues. Inhibitor 3c showed potent inhibition properties and was the strongest inhibitor with FANA, a N-trifluoroacetyl derivative of DANA. Validation studies of the inhibitor with a detergent and a Lineweaver-Burk plot suggested that the 9-substitution group would interact hydrophobically with the target loop moiety, adding a noncompetitive inhibition property to the DANA skeleton. This information enabled us to design compound 4 having the combined structure of 3c and FANA. Compound 4 showed the most potent inhibition (K-i = 73 nm, mixed inhibition) of VCNA with high selectivity among the tested viral, bacterial, and mammal neuraminidases.
• An Efficient Approach for the Characterization of Mucin-Type Glycopeptides: The Effect of O-Glycosylation on the Conformation of Synthetic Mucin Peptides

  Ryo Hashimoto, Naoki Fujitani, Yasuhiro Takegawa, Masaki Kurogochi, Takahiko Matsushita, Kentaro Naruchi, Naoki Ohyabu, Hiroshi Hinou, Xiao Dong Gao, Naomi Manri, Hiroyuki Satake, Akihito Kaneko, Takeshi Sakamoto, Shin-Ichiro Nishimura

  CHEMISTRY-A EUROPEAN JOURNAL 17 8 2393 - 2404 2011年02月 [査読有り][通常論文]
   

  Despite the growing importance of mucin core O-glycosylation in many biological processes including the protection of epithelial cell surfaces, the immune response, cell adhesion, inflammation, and tumorigenesis/metastasis, the regulation mechanism and conformational significance of the multiple introduction of alpha-GalNAc residues by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases (ppGalNAcTs) remains unclear. Here we report an efficient approach by combining MS and NMR spectroscopy that allows for the identification of O-glycosylation site(s) and the effect of O-glycosylation on the peptide backbone structures during enzymatic mucin domain assembly by using an isoform UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase-T2 (ppGalNAcT2) in vitro. An electron-capture dissociation device in a linear radio-frequency quadrupole ion trap (RFQ-ECD) combined with a time-of-flight (TOF) mass spectrometer was employed for the identification of Thr/Ser residues occupied by alpha-GalNAc branching among multiple and potential O-glycosylation sites in the tandem repeats of human mucin glycoproteins MUC4 (Thr-Ser-Ser-Ala-Ser-Thr-Gly-His-Ala-Thr-Pro-Leu-Pro-Val-Thr-Asp) and MUC5AC (Pro-Thr-Thr-Val-Gly-Ser-Thr-Thr-Val-Gly). In the present study, O-glycosylation was initiated specifically at Thr10 in naked MUC4 peptide and additional introduction of alpha-GalNAc proceeded preferentially but randomly at three other Thr residues to afford densely glycosylated MUC4 containing six alpha-GalNAc residues at Thr1, Ser2, Ser5, Thr6, Thr10, and Thr15. On the contrary, O-glycosylation of naked MUC5AC peptide occurred predominantly at consecutive Thr residues and led to MUC5AC with four alpha-GalNAc residues at Thr2, Thr3, Thr7, and Thr8. The solution structures determined by NMR spectroscopic studies elicited that the preferential introduction of alpha-GalNAc at Thr10 of MUC4 stabilizes specifically a beta-like extended backbone structure at this area, whereas other synthetic models with a single alpha-GalNAc residue at Thr1, Thr6, or Thr15 did not exhibit any converged three-dimensional structure at the proximal peptide moiety. Such conformational impact on the underlying peptides was proved to be remarkable in the glycosylation at the consecutive Thr residues of MUC5AC.
• Toward Green and Sustainable Chemical Glycosylation: Enhanced Lewis Acidity of Recyclable Solid Super Acid Catalyst, SO4/ZrO2 by CaCl2 Doping

  Hiroshi Hinou, Naohiro Saito, Takahiro Maeda, Masao Matsuda, Yuichi Kamiya, Shin-Ichiro Nishimura

  JOURNAL OF CARBOHYDRATE CHEMISTRY 30 7-9 575 - 586 2011年 [査読有り][通常論文]
   

  The simple doping of calcium chloride allowed highly improved yields in the glycosylation promoted by sulfated zirconia (SZ) without calcination. It was revealed by means of per-O-benzylated galactose trichloroacetimidate as a model glycosyl donor that this effect depends greatly on the cationic ion radius of used metal chlorides. Temperature-programmed desorption of ammonia (NH3 TPD) and the pyridine IR method showed clearly that coordination of calcium ion provides the SZ surface with newly formed Lewis acidic sites while the Bronsted acid site disappeared, indicating that the enhanced catalytic potency of SZ is due to the increased Lewis acid sites by doping the optimal calcium ions. The present findings might give insight into the relationship between a catalytic mechanism and superacidity of SZ, which is crucial for the design of novel superacid-based catalysts and environmentally benign glycosylation processes.
• Glycoblotting-Assisted O-Glycomics: Ammonium Carbamate Allows for Highly Efficient O-Glycan Release from Glycoproteins

  Yoshiaki Miura, Kentaro Kato, Yasuhiro Takegawa, Masaki Kurogochi, Jun-ichi Furukawa, Yasuro Shinohara, Noriko Nagahori, Maho Amano, Hiroshi Hinou, Shin-Ichiro Nishimura

  ANALYTICAL CHEMISTRY 82 24 10021 - 10029 2010年12月 [査読有り][通常論文]
   

  Glycoblotting, high throughput method for N-glycan enrichment analysis based on the specific chemical ligation between aminooxy/hyclrazide-polymers/solids and reducing N-glycans released from whole serum and cellular glycoproteins, was proved to be feasible for selective enrichment analysis of O-glycans of common (mucin) glycoproteins. We established a standard protocol of glycoblotting-based O-glycomics in combination with nonenzymatic chemical treatment to release reducing O-glycans predominantly from various glycoprotein samples. It was demonstrated that the nonreductive condition employing a simple ammonium salt, ammonium carbamate, made glycoblotting-based enrichment analysis of O-glycans possible without significant loss or unfavorable side reactions. A general workflow of glycoblotting using a hydrazide bead (BlotGlyco H), on-bead chemical manipulations, and subsequent mass spectrometry allowed for rapid O-glycomics of human milk osteopontin (OPN) and urinary MUC1 glycoproteins purified from healthy donors in a quantitative manner. It was revealed that structures of O-glycans in human milk OPN were varied with habitual fucosylation and N-acetyllactosamine units. It was also suggested that purified human urinary MUC1 was modified preferentially by sialylated O-glycans (94% of total) with 7:3 ratio of core 1 to core 2 type O-glycans. Versatility of the present strategy is evident because this method was proved to be suited for the enrichment analysis of general biological and clinical samples such as human serum and urine, cultured human cancer cells, and formalin-fixed paraffin-embedded tissue sections. It is our belief that the present protocols would greatly accelerate discovery of disease-relevant O-glycans as potential biomarkers.
• Artificial Golgi Apparatus: Globular Protein-like Dendrimer Facilitates Fully Automated Enzymatic Glycan Synthesis

  Takahiko Matsushita, Izuru Nagashima, Masataka Fumoto, Takashi Ohta, Kuriko Yamada, Hiroki Shimizu, Hiroshi Hinou, Kentaro Naruchi, Takaomi Ito, Hirosato Kondo, Shin-Ichiro Nishimura

  JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 132 46 16651 - 16656 2010年11月 [査読有り][通常論文]
   

  Despite the growing importance of synthetic glycans as tools for biological studies and drug discovery, a lack of common methods for the routine synthesis remains a major obstacle. We have developed a new method for automated glycan synthesis that employs the enzymatic approach and a dendrimer as an ideal support within the chemical process. Recovery tests using a hollow fiber ultrafiltration module have revealed that monodisperse G6 (MW = 58 kDa) and G7 (MW = 116 kDa) poly(amidoamine) dendrimers exhibit a similar profile to BSA (MW = 66 kDa). Characteristics of the globular protein-like G7 dendrimer with high solubility and low viscosity in water greatly enhanced throughput and efficiency in automated synthesis while random polyacrylamide-based supports entail significant loss during the repetitive reaction/separation step. The present protocol allowed for the fully automated enzymatic synthesis of sialyl Lewis X tetrasaccharide derivatives over a period of 4 days in 16% overall yield from a simple N-acetyl-D-glucosamine linked to an aminooxy-functionalized G7 dendrimer.
• Chemical Synthesis, Folding, and Structural Insights into O-Fucosylated Epidermal Growth Factor-like Repeat 12 of Mouse Notch-1 Receptor

  Kazumi Hiruma-Shimizu, Kensaku Hosoguchi, Yan Liu, Naoki Fujitani, Takashi Ohta, Hiroshi Hinou, Takahiko Matsushita, Hiroki Shimizu, Ten Feizo, Shin-Ichiro Nishimura

  JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 132 42 14857 - 14865 2010年10月 [査読有り][通常論文]
   

  Notch receptors are cell surface glycoproteins that play key roles in a number of developmental cascades in metazoa. The extracellular domains of Notch-1 receptors are composed of 36 tandem epidermal growth factor (EGF)-like repeats, many of which are modified at highly conserved consensus sites by an unusual form of O-glycan, with O-fucose. The O-fucose residues on certain EGF repeats may be elongated. In mammalian cells this can be a tetrasaccharide, Sia alpha 2,3Gal beta 1,4GlcNAc beta 1,3Fuc alpha 1 ->. This elongation process is initiated by the action of O-fucose-specific beta 1,3 N-acetylglucosaminyltransferases of the Fringe family. There is evidence that the addition of GlcNAc by Fringe serves as an essential modulator of the interaction of Notch with its ligands and the triggering of activation. Here we describe the efficient synthesis, folding, and structural characterization of EGF repeat 12 (EGF 12) of a mouse Notch-1 receptor bearing different O-fucose glycan chains. We demonstrate that the three disulfide bonds, Cys(456)-Cys(467) (C1-C3), Cys(461)-Cys(476) (C2-C4), and Cys(478)-Cys(487) (C5-C6) were correctly formed in the nonglycosylated as well as the O-fucosylated forms of EGF 12. Three-dimensional structural studies by NMR reveal that the methyl group of fucose is in close contact with ILe(475), Met(477), Pro(478) residues and this stabilizes the conformation of the antiparallel beta-sheet of EGF 12. The addition of the GlcNAc residue on O-fucosylated EGF 12 induces a significant conformational change in the adjacent tripeptide sequence, Gln(462)Asn(463)Asp(464), which is a motif involved in the natural, enzymatic O-fucosylation at the conserved site (Cys(461)X(4)Ser/ThrCys(467)).
• A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence

  Sebastiao T. Carvalho, Mauro Sola-Penna, Isadora A. Oliveira, Samuel Pita, Arlan S. Goncalves, Bianca C. Neves, Francisco R. Sousa, Leonardo Freire-de-Lima, Masaki Kurogochi, Hiroshi Hinou, Shin-Ichiro Nishimura, Lucia Mendonca-Previato, Jose O. Previato, Adriane R. Todeschini

  GLYCOBIOLOGY 20 8 1034 - 1045 2010年08月 [査読有り][通常論文]
   

  One of the most interesting aspects of Trypanosoma cruzi is its adaptation to obtain sialic acid from its host, fulfilling this need exclusively through the reaction catalyzed by enzymatically active trans-sialidase (aTS), thought to play an important role in the pathogenesis of Chagas' disease. Herein, we report that 2-difluoromethyl-4-nitrophenyl-3,5-dideoxy-d-glycero-alpha-d-galacto-2-nonulopyranosid acid (NeuNAcFNP) inactivates aTS time- and dose-dependently, and this inhibition was not relieved removing the inhibitor. Also, NeuNAcFNP causes a decrease in infection of mammalian cells. Characterization of labeled aTS by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry revealed that inactivation of the enzyme occurs through formation of a covalent bond between Arg245 and Asp247 and the inhibitor aglycone. Participation of Asp247 in the catalytic mechanism was proved by constructing a TSD247A mutant, which presents only residual activity. Molecular dynamic simulations indicate that the D247A mutation results in a more open catalytic cleft. In summary, NeuNAcFNP is the first reported mechanism-based inhibitor of aTS, representing a new template for drug design and opening new possibilities for chemotherapy of Chagas' disease, as well as for the elucidation of aTS function in T. cruzi pathogenesis and biology.
• An Efficient Approach to the Discovery of Potent Inhibitors against Glycosyltransferases

  Kensaku Hosoguchi, Takahiro Maeda, Jun-ichi Furukawa, Yasuro Shinohara, Hiroshi Hinou, Mitsuaki Sekiguchi, Hiroko Togame, Hiroshi Takemoto, Hirosato Kondo, Shin-Ichiro Nishimura

  JOURNAL OF MEDICINAL CHEMISTRY 53 15 5607 - 5619 2010年08月 [査読有り][通常論文]
   

  We describe a standardized approach for searching potent and selective inhibitors of glycosyltransferases by high throughput quantitative MALDI-TOFMS-based screening of focused compound libraries constructed by 1,3-dipolar cycloaddition of the desired azidosugar nucleotides with various alkynes. An aminooxy-functionalized reagent with a stable isotope was conjugated with oligosaccharides to afford glycopeptides as acceptor substrates with improved ion sensitivity. Enhanced ionization potency of new substrates allowed for MALDI-TOFMS-based facile and quantitative analysis of enzymatic glycosylation in the presence of glycosyl donor substrates. A non-natural synthetic sugar nucleotide was identified to be the first highly specific inhibitor for rat recombinant alpha 2,3-(N)-sialyltransferase (alpha 2,3ST, IC(50) = 8.2 mu M), while this compound was proved to become a favorable substrate for rat recombinant alpha 2,6-(N)-sialyltransferase (alpha 2,6ST, K(m) = 125 mu M). Versatility of this strategy was demonstrated by identification of two selective inhibitors for human recombinant alpha 1,3-fucosyltransferase V (alpha 1,3-FucT, K(i) = 293 nM) and alpha 1,6-fucosyltransferase VIII (alpha 1,6-FucT, K(i) = 13.8 mu M).
• Unexpected Tolerance of Glycosylation by UDP-GalNAc:Polypeptide alpha-N-Acetylgalactosaminyltransferase Revealed by Electron Capture Dissociation Mass Spectrometry: Carbohydrate as Potential Protective Groups

  Yayoi Yoshimura, Takahiko Matsushita, Naoki Fujitani, Yasuhiro Takegawa, Haruhiko Fujihira, Kentarou Naruchi, Xiao-Dong Gao, Naomi Manri, Takeshi Sakamoto, Kentaro Kato, Hiroshi Hinou, Shin-Ichiro Nishimura

  BIOCHEMISTRY 49 28 5929 - 5941 2010年07月 [査読有り][通常論文]
   

  UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases (ppGalNAcTs, EC 2.4.1.41), a family of key enzymes that initiate posttranslational modification with O-glycans in mucin synthesis by introduction of alpha-GalNAc residues, are structurally composed of a catalytic domain and a lectin domain. It has been known that multiple Ser/Thr residues are assigned in common mucin glycoproteins as potential O-glycosylation sites and more than 20 distinct isoforms of this enzyme family contribute to produce densely O-glycosylated mucin glycoproteins. However, it seems that the functional role of the lectin domain of ppGalNAcTs remains unclear. We considered that electron capture dissociation mass spectrometry (ECD-MS), a promising method for highly selective fragmentation at peptide linkages of glycopeptides to generate unique c and z series of ions, should allow for precise structural characterization to uncover the mechanism in O-glycosylation of mucin peptides by ppGalNAcTs. In the present study, it was demonstrated that a system composed of an electrospray source, a linear RFQ ion trap that isolates precursor ions, the ECD device, and a TOF mass spectrometer is a nice tool to identify the preferential O-glycosylation sites without any decomposition of the carbohydrate moiety. It should be noted that electrons used for ECD are accelerated within a range from 1.75 to 9.75 eV depending on the structures of glycopeptides of interest. We revealed for the first time that additional installation of a alpha-GalNAc residue at potential glycosylation sites by ppGalNAcT2 proceeds smoothly in various unnatural glycopeptides having alpha-Man, alpha-Fuc, and beta-Gal residues as well as alpha-GalNAc residues. The results may suggest that ppGalNAcT2 did not differentiate totally presubstituted sugar residues in terms of configuration of functional groups, D-, L-configuration, and even alpha-, beta-stereochemistry at an anomeric carbon atom when relatively short synthetic peptides were employed for the acceptor substrates. Unexpected characteristics of ppGalNAcT2 motivated us to challenge site-directed installation of alpha-GalNAc residues at desired position(s) by protecting some hydroxyl groups of Thr/Ser residues with selectively removable sugars, notably a novel concept as "carbohydrate as protective groups", toward a goal of the systematic chemical and enzymatic synthesis of biologically important mucin glycopeptides.
• Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase

  Shingo Arioka, Masahiro Sakagami, Rie Uematsu, Hiroto Yamaguchi, Hiroko Togame, Hiroshi Takemoto, Hiroshi Hinou, Shin-ichiro Nishimura

  BIOORGANIC & MEDICINAL CHEMISTRY 18 4 1633 - 1640 2010年02月 [査読有り][通常論文]
   

  The protozoan Trypanosoma cruzi, the causative agent of Chagas' disease, can infect the heart, causing cardiac arrest frequently followed by death. To treat this disease, a potential molecular drug target is T. cruzi trans-sialidase (TcTS). However, inhibitors found to date are not strong enough to serve as a lead scaffold; most inhibitors reported thus far are derivatives of the substrate sialic acid or a transition state analogue known as 2,3-dehydro-3-deoxy-N-acetylneuraminic acid (DANA) with an IC(50) value of more than hundreds of micromolar. Since natural products are highly stereodiversified and often provide highly specific biological activity, we screened a natural product library for inhibitors of TcTS and identified promising flavonoid and anthraquinone derivatives. A structure-activity relationship (SAR) analysis of the flavonoids revealed that apigenin had the minimal and sufficient structure for inhibition. Intriguingly, the compound has been reported to possess trypanocidal activity. An SAR analysis of anthraquinones showed that 6-chloro-9,10-dihydro-4,5,7-trihydroxy-9,10-dioxo-2-anthracenecarboxylic acid had the strongest inhibitory activity ever found against TcTS. Moreover, its inhibitory activity appeared to be specific to TcTS. These compounds may serve as potent lead chemotherapeutic scaffolds against Chagas' disease. (C) 2010 Elsevier Ltd. All rights reserved.
• An Efficient Strategy for the Exploration of Specific Inhibitors of Sialyltransferases

  Hiroshi Hinou

  Molecular Imaging for Integrated Medical Therapy and Drug Development 2010年
• An Essential Epitope of Anti-MUC1 Monoclonal Antibody KL-6 Revealed by Focused Glycopeptide Library

  Naoki Ohyabu, Hiroshi Hinou, Takahiko Matsushita, Ryukou Izumi, Hiroki Shimizu, Keiko Kawamoto, Yoshito Numata, Hiroko Togame, Hiroshi Takemoto, Hirosato Kondo, Shin-Ichiro Nishimura

  JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 131 47 17102 - 17109 2009年12月 [査読有り][通常論文]
   

  Human serum Krebs von den Lungen-6 (KL-6) antigen, a high-molecular-weight glycoprotein classified as a polymorphic epithelial mucin (MUC1), is a biomarker of diseases such as interstitial pneumonia, lung adenocarcinoma, breast cancer, colorectal adenocarcinoma, and hepatocellular carcinoma. Anti-KL-6 monoclonal antibody (anti-KL-6 MAb) is therefore a potential diagnostic and therapeutic reagent. Although glycosylation at Thr/Ser residues of the tandem-repeating MUC1 peptides appears to determine the disease-associated antigenic structures of KL-6, an essential epitope structure recognized by anti-KL-6 MAb remains unclear. In the present study, a novel compound library of synthetic MUC1 glycopeptides allowed the first rapid and precise evaluation of the specific epitope structure of anti-KL-6 MAb by combined use of a tailored glycopeptides library and common ELISA protocol. We demonstrated that the minimal antigenic structure, an essential epitope, recognized by anti-KL-6 MAb is a heptapeptide sequence Pro-Asp-Thr-Arg-Pro-Ala-Pro (PDTRPAP), in which the Thr residue is modified by Neu5Ac alpha 2,3Gal beta 1,3GalNAc alpha (2,3-sialyl T antigen, core 1-type O-glycan). Anti-KL-6 MAb did not bind with other tumor-relevant antigens, such as GalNA alpha(Tn), Neu5Ac alpha 2,6GalNAc alpha(STn), and Gal beta 1,3GalNAc alpha (T), except for Neu5Ac alpha 2,3Gal beta 1,3(Neu5Ac alpha 2,6) GalNAc alpha(2,3/2,6-disialyl T). However, anti-KL-6 MAb could not differentiate the above minimal antigenic glycopepticle from some core 2-based glycopeptides involving this crucial epitope structure and showed a similar binding affinity toward these compounds, indicating that branching at the O-6 position of GalNAc residue does not influence the interaction of anti-KL-6 MAb with some MUC1 glycoproteins involving an essential epitope. Actually, anti-KL-6 MAb reacts with 2,3/2,6-disialyl T having a 2,3-sialyl T component. This is why anti-KL-6 MAb often reacts with various kinds of tumor-derived MUC1 glycoproteins as well as a clinically important MUC1 glycoprotein biomarker of interstitial pneumonia, namely KL-6, originally discovered as a circulating pulmonary adenocarcinoma-associated antigen. In other words, combined use of anti-KL-6 MAb and some probes that can differentiate the sugars substituted at the O-6 position of the GalNAc residue in MUC1 glycopeptides including the PDTRPAP sequence might be a promising diagnostic protocol for individual disease-specific biomarkers. It was also revealed that glycosylation at neighboring Thr/Ser residues outside the immunodominant PDTRPAP motif strongly influences the interaction between anti-KL-6 MAb and MUC1 glycopeptides involving the identified epitope. Our novel strategy will greatly facilitate the processes for the identification of the tumor-specific and strong epitopes of various known anti-MUC1 MAbs and allow for their practical application in the generation of improved antibody immunotherapeutics, diagnostics, and MUC1-based cancer vaccines.
• Microwave Effect for Glycosylation Promoted by Solid Super Acid in Supercritical Carbon Dioxide

  Hiroshi Hinou, Naohiro Saito, Masato Ogawa, Takahiko Maeda, Shin-Ichiro Nishimura

  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 10 12 5285 - 5295 2009年12月 [査読有り][招待有り]
   

  The effects of microwave irradiation (2.45 GHz, 200 W) on glycosylation promoted by a solid super acid in supercritical carbon dioxide was investigated with particular attention paid to the structure of the acceptor substrate. Because of the symmetrical structure and high diffusive property of supercritical carbon dioxide, microwave irradiation did not alter the temperature of the reaction solution, but enhanced reaction yield when aliphatic acceptors are employed. Interestingly, the use of a phenolic acceptor under the same reaction conditions did not show these promoting effects due to microwave irradiation. In the case of aliphatic diol acceptors, the yield seemed to be dependent on the symmetrical properties of the acceptors. The results suggest that microwave irradiation do not affect the reactivity of the donor nor promoter independently. We conclude that the effect of acceptor structure on glycosylation yield is due to electric delocalization of hydroxyl group and dielectrically symmetric structure of whole molecule.
• Functional Neoglycopeptides: Synthesis and Characterization of a New Class of MUC1 Glycoprotein Models Having Core 2-Based O-Glycan and Complex-Type N-Glycan Chains

  Takahiko Matsushita, Reiko Sadamoto, Naoki Ohyabu, Hideki Nakata, Masataka Fumoto, Naoki Fujitani, Yasuhiro Takegawa, Takeshi Sakamoto, Masaki Kurogochi, Hiroshi Hinou, Hiroki Shimizu, Takaomi Ito, Kentarou Naruchi, Hiroko Togame, Hiroshi Takemoto, Hirosato Kondo, Shin-Ichiro Nishimura

  BIOCHEMISTRY 48 46 11117 - 11133 2009年11月 [査読有り][通常論文]
   

  An efficient protocol for the construction of MUC1-related glycopeptide analogues having complex O-glycan and N-glycan chains was established by integrating chemical and enzymatic approaches on the functional polymer platforms. We demonstrated the feasibility of sortase A-mediated ligation between two glycopeptide segments by tagging with signal peptides, LPKTGLR and GG, at each C- or N-terminal position. Structural analysis of the macromolecular N,O-glycopeptides was performed by means of ESI-TOFMS (MS/MS) equipped with an electron-captured dissociation device. Immunological assay using MUC1 glycopeptides synthesized in this study revealed that N-glycosylation near the antigenic O-glycosylated PDTR motif did not disturb the interaction between the anti-MUC1 monoclonal antibody and this crucial O-glycopeptide moiety. NMR study indicated that the N-terminal immunodominant region [Ala-ProAsp-Thr(O-glycan)-Arg] forms an inverse gamma-turn-like structure, while the C-terminal region composed of N-glycopeptide and linker SrtA-peptide was proved to be an independently random structure. These results indicate that the bulky O- and N-glycan chains can function independently as disease-relevant epitopes and ligands for carbohydrate-binding proteins, when both are combined by an artificial intervening peptide having a possible effect of separating N- and C-terminal regions. The present strategy will greatly facilitate rapid synthesis of multiply functionalized complex neoglycopeptides as new types of convenient tools or models for the investigation of the structure-function relationship of various glycoproteins and development of novel class glycopeptide-based biopharmaceuticals, drug delivery systems, and biomedical materials.
• One-pot synthesis of cyclic antifreeze glycopeptides

  Masakazu Hachisu, Hiroshi Hinou, Manabu Takamichi, Sakae Tsuda, Shuhei Koshidaa, Shin-Ichiro Nishimura

  CHEMICAL COMMUNICATIONS 13 1641 - 1643 2009年 [査読有り][通常論文]
   

  The first cyclic glycopeptides exhibiting significant antifreeze activity by forming hexagonal-bipyramidal ice crystals, denoted cyclic antifreeze glycopeptides (cyclic AFGPs), were constructed by a one-pot synthesis based on the controlled cyclization reaction of pre-formed small linear glycopeptides.
• An Efficient Strategy for the Explortion of Specific Inhibitors of Sialyltransferases

  Kensku Hosoghchi, Hiroshi Hinou, Shin-Ichiro Nishimura

  Proceeding of Molecular Imaging for Integrated Medical Therapy and Drug Development 294 - 301 2009年 [査読無し][招待有り]
  
• A new glycosylation method part 3: study of microwave effects at low temperatures to control reaction pathways and reduce byproducts

  Hiroki Shimizu, Yayoyi Yoshimura, Hiroshi Hinou, Shin-Ichiro Nishimura

  TETRAHEDRON 64 43 10091 - 10096 2008年10月 [査読有り][通常論文]
   

  The efficiency of microwave irradiation at low temperature for glycosylations is described. Although oligosaccharide synthesis usually requires reactive donors for glycosylations, which have leaving groups on the another positions, i.e., trichloroacetoimidates, halogenates, thioalkyl glycosides, etc., the suitable donors in our microwave supported synthesis of Lewis X oligosaccharide were very stable acetate derivatives. Regarding glycosylation with a fucosyl acetate donor and a glucosamine acceptor, microwave irradiation with simultaneous cooling improved yields. Moreover, further synthesis to Lewis X derivatives was achieved only with microwave irradiation at low temperatures. Without microwave irradiation, we could only obtain byproducts and none of the designed product at any reaction temperature. (C) 2008 Elsevier Ltd. All rights reserved.
• One-pot solid-phase glycoblotting and probing by transoximization for high-throughput glycomics and glycoproteomics

  Hideyuki Shimaoka, Hiromitsu Kuramoto, Jun-ichi Furukawa, Yoshiaki Miura, Masaki Kurogochi, Yoko Kita, Hiroshi Hinou, Yasuro Shinohara, Shin-Ichiro Nishimura

  CHEMISTRY-A EUROPEAN JOURNAL 13 6 1664 - 1673 2007年 [査読有り][通常論文]
   

  The development of rapid and efficient methods for high-throughput protein glycomics is of growing importance because the glycoform-focused reverse proteomics/genomics strategy will greatly contribute to the discovery of novel biomarkers closely related to cellular development, differentiation, growth, and aging as well as a variety of diseases such as cancers and vital infection. Recently, we communicated that rapid and efficient purification of carbohydrates can be achieved by employing sugar-specific chemical ligation with aminooxy-functionalized polymers, which we termed "glycoblotting" (see SA. Nishimura et al., Angew. Chem. 2005, 117, 93-98; Angew. Chem. Int. Ed. 2005, 44, 9196). The chemoselective blotting of oligosaccharides present in crude biological materials onto synthetic polymers relies on the unique oxime-bond formation between aminooxy group displayed on the supporting materials and aldehyde/ketone group at the reducing terminal of all oligosaccharides, thus enabling highly selective and rapid oligoosaccharide purification. Aiming to improve the detection sensitivity of the released oligosaccharides, we introduce here a novel strategy for one-pot solid-phase glycoblotting and probing by transoximization. We found that oligosaccharides captured by the polymer supports via the oxime bond can be released in the presence of excess O-substituted aminooxy derivatives in a weakly acidic condition. The released oligosaccharides could be recovered as newly formed oxime derivatives of the O-substituted aminooxy compound added, thus demonstrating the simultaneous releasing and probing. In addition, we synthesized a novel aminooxy-functionalized monomer, N-[2-[2-(2tert-butoxycarbonylaminooxyacetylami-no-ethoxy)ethoxy]ethyl]-2-methacrylamide, which allows for the large-scale preparation of a versatile polymer characterized by its high stability, high blotting capacity, and easy use. The one-pot protocol allowed to profile 23 kinds of N-glycan chains of human serum glycoproteins. This concept was further applied for the glycopeptides analysis in a crude mixture followed by galactose oxidase treatment to generate free aldehyde group at the non-reducing terminal of oligosaccharide moiety of glycopeptides. Our technique may be implemented in existing bio-chemistry and molecular diagnostics laboratories because enriched oligosaccharides and glycopeptides by solid-phase transoximization with high-sensitive labeling reagents are widely applicable in a variety of common analytical methods using two-dimensional HPLC, LC/MS, and capillary electrophoresis as well as modern mass spectrometry.
• Structural analysis of O-glycopeptides employing negative- and positive-ion multi-stage mass spectra obtained by collision-induced and electron-capture dissociations in linear ion trap time-of-flight mass spectrometry

  Kisaburo Deguchi, Hiroki Ito, Takashi Baba, Atsumu Hirabayashi, Hiroaki Nakagawa, Masataka Fumoto, Hiroshi Hinou, Shin-Ichiro Nishimura

  RAPID COMMUNICATIONS IN MASS SPECTROMETRY 21 5 691 - 698 2007年 [査読有り][通常論文]
   

  Structural analyses of various glycans attached to proteins and peptides are highly desirable for elucidating their biological roles. An approach based on mass spectrometry (MS) combining both collision-induced dissociation (CID) and electron-capture dissociation (ECD) in the positive- and negative-ion modes has been proposed as a simple and direct method of assigning an O-glycan without releasing it from the peptide and of determining the amino acid sequence of the peptide and glycosylation site. The instrument used is an electrospray ionization (ESI) linear ion trap (LIT) time-of-flight (TOF) mass spectrometer with tandem LITs for CID by He gas and ECD. The proposed approach was tested with two synthetic O-glycopeptides binding a sialyl Lewis x (sLe(x)) oligosaccharide and a 3'-sialyl N-acetyllactosamine (3'-SLN) on a serine (S) residue. In the negative-ion mode, the CID MS2 spectra of O-glycopeptides showed a relatively abundant glycoside-bond cleavage between the core N-acetylglucosamine (GlcNAc) and serine (S) that yields deprotonated C-3-type fragment ions of O-glycan and deprotonated Z(0)-type peptide ions. The structure of the sLe(x) (3'-SLN) oligosaccharide was simply assigned by comparing the CID MS3 spectrum derived from the C-3-type fragment ion with the CID MS2 spectra of the sLe(x) and sLe(a) (3'- and 6'-SLN) standards (i.e., negative-ion MSn spectral matching). The amino acid sequence of the peptide including the glycosylation site was determined from the ECD MS2 spectrum in the positive-ion mode. Copyright (c) 2007 John Wiley & Sons, Ltd.
• Highly efficient and versatile synthesis of proteoglycan core structures from 1,6-anhydro-beta-lactose as a key starting material

  Ken Shimawaki, Yoshinori Fujisawa, Fumihiro Sato, Naoki Fujitani, Masaki Kurogochi, Hiroko Hoshi, Hiroshi Hinou, Shin-Ichiro Nishiinura

  ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 46 17 3074 - 3079 2007年 [査読有り][通常論文]
  
• Construction and structural characterization of versatile lactosaminoglycan-related compound library for the synthesis of complex glycopeptides and glycosphingolipids

  Kentarou Naruchi, Tomoki Hamamoto, Masaki Kurogochi, Hiroshi Hinou, Hiroki Shimizu, Takahiko Matsushita, Naoki Fujitani, Hirosato Kondo, Shin-Ichiro Nishimura

  JOURNAL OF ORGANIC CHEMISTRY 71 26 9609 - 9621 2006年12月 [査読有り][通常論文]
   

  We have established a facile and efficient protocol for the preparative-scale synthesis of various compound libraries related to lactosaminoglycans: cell surface oligosaccharides composed of N-acetyllactosamine as a repeating disaccharide unit, based on chemical and enzymatic approaches. Substrate specificity and feasibility of a bacterial glycosyltransferase, Neisseria meningitidis beta 1,3-N-acetylglucosaminyltransferase (LgtA), were investigated in order to synthesize various key intermediates suited for the construction of mammalian O-glycopeptides and glycosphingolipids containing poly-N-acetyllactosamine structures. Recombinant LgtA exhibited the highest glycosyltransferase activity with strongly basic conditions (pH = 10, glycine-NaOH buffer) and a broad range of optimal temperatures from 20 to 30 C. Interestingly, it was found that LgtA discriminates L-serine and L-threonine and functions both as a core-1 beta 1,3-N-acetylglucosaminyltransferase and core-2 beta 1,3-N-acetylglucosaminyltransferase toward Fmoc-Ser derivatives, while LgtA showed only core-2 beta 1,3-N-acetylglucosaminyltransferase activity in the presence of Fmoc-Thr derivatives. Combined use of LgtA with human beta 1,4-galactosyltransferase allowed for controlled sugar extension reactions from synthetic sugar amino acids and gave synthetic lactosaminoglycans, such as a decasaccharide derivative, Gal,(1 -> 4) GlcNAc beta(1 -> 3) Gal beta(1 -> 4) GlcNAc beta( 1 -> 3) Gal beta(1 -> 4) GlcNAc beta(1 -> 3) Ga beta(1 -> 4) GlcNAc beta(1 -> 6)[Gal beta(1 -> 3)] GalNAc alpha 1 f Fmoc-Ser-OH (6), and a dodecasaccharide derivative, Gal beta( 1 f 4) GlcNAc beta(1 -> 3) Gal beta( 1 -> 4) GlcNAc beta(1 -> 3) Gal beta(1 -> 4)GlcNAc beta(1 -> 6)[Gal beta(1 -> 4) GlcNAc beta(1 -> 3) Gal beta(1 -> 4) GlcNAc beta(1 -> 3) Gal beta(1 -> 3)] GalNAc alpha 1 f Fmoc-Ser-OH(9). A partially protected pentasaccharide intermediate, GlcNAc beta(1 -> 3) Gal beta(1 -> 4)GlcNAc,(1 -> 6)[Gal beta(1 -> 3)] GalNAc alpha 1 -> Fmoc-Thr-OH (11), was applied for the microwave-assisted solid-phase synthesis of a MUC1-related glycopeptide 19 (MW = 2610.1). The findings suggest that this sugar extension strategy can be employed for the modification of lactosyl ceramide mimetic polymers to afford convenient precursors for the synthesis of various glycosphingolipids.
• Construction of MUC1 related compound library

  Naoki Ohyabu, Takahiko Matsushita, Hiroshi Hinou, Ryuko Izumi, Hiroki Shimizu, Hirosato Kondo, Shin-Ichiro Nishimura

  GLYCOBIOLOGY 16 11 1152 - 1152 2006年11月 [査読有り][通常論文]
  
• Structural analysis of O-glycopeptides employing negative- and positive-ion MSn spectra acquired by nanoHPLC/ESI-linear ion trap time-of-flight mass spectrometer

  Hiroki Ito, Kisaburo Deguchi, Kuriko Yamada, Shinji Nagai, Masataka Fumoto, Hiroshi Hinou, Hiroaki Nakagawa, Yasuro Shinohara, Shin-Ichiro Nishimura

  GLYCOBIOLOGY 16 11 1136 - 1136 2006年11月 [査読有り][通常論文]
  
• Construction of highly glycosylated mucin-type glycopeptides based on microwave-assisted solid-phase syntheses and enzymatic modifications

  T Matsushita, H Hinou, M Fumoto, M Kurogochi, N Fujitani, H Shimizu, SI Nishimura

  JOURNAL OF ORGANIC CHEMISTRY 71 8 3051 - 3063 2006年04月 [査読有り][通常論文]
   

  A MUCI-related glycopeptide having five core-2 hexasaccharide branches C330H527N46O207, MW = 8450.9) was synthesized by a new strategy using a combination of microwave-assisted solid-phase synthesis (MA-SPGS) and enzymatic sugar elongation. Synthesis of a key glycopeptide intermediate was best achieved in a combination of PEGA [poly(ethylene glycol)-poly-(NN-dimethylacrylamide) copolymer] resin and MA-SPGS using glycosylated amino acid building blocks with high speed and high purity. Deprotection of the glycopeptide intermediate and subsequent glycosyltransferase-catalyzed sugar elongations were performed for generation of the additional diversities with the sugar moieties of glycopeptides using beta 1,4-galactosyltransferase (beta 1,4-GaIT) and two kinds of alpha 2,3-sialyltransferases [ST3Gal III; alpha 2,3-(N)-SiaT and ST3Gal II; alpha 2,3-(O)-SiaT]. These reactions proceeded successfully in the presence of 0.2% Triton X-100 to convert the chemically synthesized trisaccharide glycans to disialylated hexasaccharide.
• Glycosidation promoted by a reusable solid superacid in supercritical carbon dioxide

  Xue-Bing Li, Masato Ogawa, Toshiki Monden, Takahiro Maeda, Eri Yamashita, Mariko Naka, Masao Matsuda, Hiroshi Hinou, Shin-Ichiro Nishimura

  ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 45 34 5652 - 5655 2006年 [査読有り][通常論文]
  
• Mechanism-based inhibitors to probe transitional states of glycoside hydrolases

  Hiroshi Hinou, Masaki Kurogochi, Shin-Ichiro Nishimura

  GLYCOBIOLOGY 415 202 - + 2006年 [査読有り][通常論文]
   

  Recent structural and kinetic studies indicate that glycosidases (glycoside hydrolases) change the peripheral structure of their catalytic sites dynamically to trim glycan structures. Inhibitors that label specific.amino acid residues in the active site of these enzymes based on its mechanism of action are powerful tools to probe such a hidden transitional state. This chapter describes methods of mechanism-based irreversible inhibitors having fluorescence tags, including synthesis, inhibitory assay, rapid separation of the peptides containing labeled residues using antibody column, and proteomic analysis of key amino acid residues using matrix-assisted laser desorption/ionization-time-of-flight (TOF)/TOF mass spectrometry.
• Characterization of Vibrio cholerae neuraminidase by a novel mechanism-based fluorescent labeling reagent

  H Hinou, M Kurogochi, H Shimizu, SI Nishimura

  BIOCHEMISTRY 44 35 11669 - 11675 2005年09月 [査読有り][通常論文]
   

  Vibrio cholerae neuraminidase (VCNA) plays a significant role in the pathogenesis of cholera by removing sialic acid residues from higher-order gangliosides to an unmasked GM1, the essential receptor for cholera toxin. Here we report that a novel mechanism-based fluorescent labeling reagent, 5-acetamido2-(4-N-5-dimethylaminonaphthalene-1-sulfonyl-2-difluoroi-nethylphenyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosonic acid (1), becomes a unique irreversible inhibitor of VCNA. Characterization of an inactivated VCNA by MALDI-TOF/TOFMS analysis revealed that the Asp-576 and Arg-577 residues, which are located within the (DRFF571)-D-576 sequence, were specifically labeled with this suicide-type fluorescent substrate. Neither Asp-576 nor Arg-577 has ever been known to contribute to a specific residue in the rigid and highly conserved active site of VCNA investigated by crystallographic analysis, suggesting that a flexible beta-turn structure containing this sequence may have a crucial role in the dynamic nature of substrate recognition and catalytic action by VCNA.
• Combinatorial synthesis of MUC1 glycopeptides: Polymer blotting facilitates chemical and enzymatic synthesis of highly complicated mucin glycopeptides

  M Fumoto, H Hinou, T Ohta, T Ito, K Yamada, A Takimoto, H Kondo, H Shimizu, T Inazu, Y Nakahara, SI Nishimura

  JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 127 33 11804 - 11818 2005年08月 [査読有り][通常論文]
   

  The chemoselective polymer blotting method allows for rapid and efficient synthesis of glycopeptides based on a "catch and release" strategy between solid-phase and water-soluble polymer supports. We have developed a heterobifunctional linker sensitive to glutamic acid specific protease (BLase). The general procedure consists of five steps, namely (i) the solid-phase synthesis of glycopeptide containing BLase sensitive linker, (ii) subsequent deprotections and the release of the glycopeptide from the resin, (iii) chemoselective blotting of the glycopeptide intermediates in the presence of water-soluble polymers with oxylamino functional groups, (iv) sugar elongations using glycosyltransferases, and (v) the release of target glycopeptides from the polymer platform by selective BLase promoted hydrolysis. The combined use of the solid-phase chemical syntheses of peptides and the enzymatic syntheses of carbohydrates on water-soluble polymers would greatly contribute to the production of complicated glycopeptide libraries, thereby enhancing applicative research. We report here a high-throughput synthetic system for the various types of MUC1 glycopeptides exhibiting a variety of sugar moieties. It is our belief that this concept will become part of the entrenched repertoire for the synthesis of biologically important glycopeptides on the basis of glycosyltransferase reactions in automated and combinatorial syntheses.
• A novel glycosylation concept; microwave-assisted acetal-exchange type glycosylations from methyl glycosides as donors

  Y Yoshimura, H Shimizu, H Hinou, SI Nishimura

  TETRAHEDRON LETTERS 46 28 4701 - 4705 2005年07月 [査読有り][通常論文]
   

  Efficient microwave-assisted glycosylations from methyl glucopyranosides are described. We have discussed the effects of microwave irradiation on this unique glycoside exchanging reaction from view points such as amount of Lewis acid promoters and acceptors, hydroxyl protecting groups of methyl glucopyranosides donors for reactivity, and neighboring effect. (c) 2005 Published by Elsevier Ltd.
• Rapid microwave-assisted solid-phase glycopeptide synthesis

  T Matsushita, H Hinou, M Kurogochi, H Shimizu, SI Nishimura

  ORGANIC LETTERS 7 5 877 - 880 2005年03月 [査読有り][通常論文]
   

  Coupling of glycosylated Fmoc-Thr or Fmoc-Ser with N-terminal amino acids on a resin proceeded smoothly under microwave irradiation for 20 min with much higher efficiency (98% yield per coupling) than found in more general conditions. Compared with a conventional protocol, the present method greatly reduces the time required for solid-phase glycopeptide synthesis from 4 days to 7 h, as is the case with the synthesis of Muc-1-related 20-residue glycopeptide carrying five core-2 trisaccharide chains.
• High-throughput protein glycomics: Combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectrometry

  SI Nishimura, K Niikura, M Kurogochi, T Matsushita, M Fumoto, H Hinou, R Kamitani, H Nakagawa, K Deguchi, N Miura, K Monde, H Kondo

  ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 44 1 91 - 96 2005年 [査読有り][通常論文]
  
• Molecular transporter between polymer platforms: Highly efficient chemoenzymatic glycopeptide synthesis by the combined use of solid-phase and water-soluble polymer supports

  M Fumoto, H Hinou, T Matsushita, M Kurogochi, T Ohta, T Ito, K Yamada, A Takimoto, H Kondo, T Inazu, SI Nishimura

  ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 44 17 2534 - 2537 2005年 [査読有り][通常論文]
  
• Systematic syntheses and inhibitory activities of bisubstrate-type inhibitors of sialyltransferases

  H Hinou, XL Sun, Y Ito

  JOURNAL OF ORGANIC CHEMISTRY 68 14 5602 - 5613 2003年07月 [査読有り][通常論文]
   

  Bisubstrate-type sialyltransferase inhibitors 1/2a-e, having CMP-NeuAc and N-acetyllactosamine (or lactose) moieties connected by an alkanedithiol linker, were synthesized systematically. A uniform synthetic strategy was adopted that consists of consecutive couplings of three components (N-acetyllactosamine or lactose, sialic acid, and CMP), followed by oxidation. Due to the sensitivity of the compounds under alkaline conditions, final deprotection required careful monitoring by H-1 NMR. The inhibitory activities of 1/2a-e toward ST6N and ST3N indicated that both the structure of the acceptor moiety and the distance between donor and acceptor moieties were important.
• Efficient strategy for convergent synthesis of trans-fused polycyclic ethers based on an intramolecular SmI2-promoted cyclization of iodo ester

  K Kawamura, H Hinou, G Matsuo, T Nakata

  TETRAHEDRON LETTERS 44 28 5259 - 5261 2003年07月 [査読有り][通常論文]
   

  An efficient convergent strategy for the construction of a trans-fused 6-6-6-6-membered tetracyclic ether ring system was developed. The key steps involve coupling of two cyclic ethers by esterification, SmI2-promoted intramolecular reductive cyclization of iodo ester to hemiacetal, dehydration to dihydropyran, hydroboration, oxidation, intramolecular acetalization, and Lewis-acid catalyzed silane reduction. (C) 2003 Elsevier Science Ltd. All rights reserved.
• Glyco-silicon functional materials. Part 6. Synthesis of a useful anomeric thioacetate of an N-acetyllactosamine derivative and its application

  K Matsuoka, T Ohtawa, H Hinou, T Koyama, Y Esumi, SI Nishimura, K Hatano, D Terunuma

  TETRAHEDRON LETTERS 44 18 3617 - 3620 2003年04月 [査読有り][通常論文]
   

  A novel anomeric beta-thioacetate of an N-acetyllactosamine derivative was efficiently synthesized in high yield from the known 2-azido glycosyl chloride using thioacetic acid as a convenient reagent. The synthesis involved not only an S,2 replacement of the chloride by a carbothiolate anion but also a reductive acetamidation of the azide group. Applications of the thioacetate for glycosidation were demonstrated to provide both O- and S-glycosides in high yields. Furthermore, both intermediates gave a new class of glycoclusters that included thioglycosidic linkages. (C) 2003 Elsevier Science Ltd. All rights reserved.
• Bisubstrate-type inhibitor of sialyltransferases

  H Hinou, XL Sun, Y Ito

  TETRAHEDRON LETTERS 43 50 9147 - 9150 2002年12月 [査読有り][通常論文]
   

  A convergent strategy for the construction of bisubstrate-type sialyltransferase inhibitor (1) was developed. It consists of consecutive coupling of three components (N-acetyllactosamine, sialic acid, and CMP), followed by oxidation and deprotection. As expected, compound I showed potent inhibitory activities toward both 2,3-(N)- and 2,6-(N)-sialyltransferase. (C) 2002 Elsevier Science Ltd. All rights reserved.
• Disaccharides as starting materials for the synthesis of valuable compounds

  H Hinou

  TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY 12 65 185 - 190 2000年05月 [査読無し][招待有り]
   

  Hinou, H, 2000, '二糖類を出発物とした有用化合物の合成研究', vol. 12, no. 65, pp. 185-190.
• Efficient convergent synthesis of a trans-fused 6-6-6-6-membered tetracyclic ether ring system

  G Matsuo, H Hinou, H Koshino, T Suenaga, T Nakata

  TETRAHEDRON LETTERS 41 6 903 - 906 2000年02月 [査読有り][通常論文]
   

  A very efficient convergent strategy for the construction of the trans-fused 6-6-6-6-membered tetracyclic ether ring system was developed based on the acetylide-triflate coupling of two tetrahydropyrans, oxidation of the alkyne group to an alpha-diketone, double cyclization to 6,6,6,6-membered tetracyclic diacetal, and stereoselective reduction of the diacetal with Et3SiH-TMSOTf. (C) 2000 Elsevier Science Ltd. All rights reserved.
• Synthesis of amphiphilic chitopentaose and chitoheptaose derivatives using a common disaccharidic synthon as the chain elongation unit

  H Hinou, A Umino, K Matsuoka, D Terunuma, S Takahashi, Y Esumi, H Kuzuhara

  BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 73 1 163 - 171 2000年01月 [査読有り][通常論文]
   

  With interest in clustering bioactive chitooligosaccharides, a pair of amphiphilic derivatives of around DP (degree of polymerization) 6, which has been considered to be the minimum molecular length for some kinds of bioactivity, was synthesized. Homologous derivatives of chitopentaose and chitoheptaose carrying tetradecanoyl and tetradecyloxy groups at the NH and C-1 of the reducing ends, respectively, were actually obtained using a 1,6-anhydro-2-azido-2-deoxy-beta-D-glucopyranose derivative as the terminal precursor and a chitobiose derivative as the elongation unit. Micelle formation of both derivatives was assumed from the results obtained by dye solubilization tests.
• Novel synthesis of L-iduronic acid using trehalose as the disaccharidic starting material

  Hiroshi Hinou, Hidehiro Kurosawa, Koji Matsuoka, Daiyo Terunuma, Hiroyoshi Kuzuhara

  Tetrahedron Letters 40 8 1501 - 1504 1999年02月19日 [査読有り][通常論文]
   

  For the preparation of L-iduronic acid, trehalose was converted into a derivative of a novel disaccharide, β-L-idopyranosyl β-L-idopyranoside, through diastereoselective hydroboration of the 5,5'-di-eno intermediate. The 6- and 6'-hydroxy groups were then oxidized in two steps to give a disaccharide composed of 2 units of L-iduronate moieties, which underwent acidic cleavage of the glycosidic bond to give the target compound.
• Synthetic conversion of cellobiose into the glycal-type monomers and their polymerization

  Y Ogawa, H Hinou, K Matsuoka, D Terunuma, H Kuzuhara

  TETRAHEDRON LETTERS 39 32 5789 - 5792 1998年08月 [査読有り][通常論文]
   

  A pair of disaccharidic glycals thoroughly O-benzylated except the 4'- or the 6'-hydroxyl groups were prepared as the monomers for iodonium ion-promoted polymerization, which proceeded under dark conditions to give polysaccharides of more than DP 12 (24 saccharide). Reductive removal of the iodine atom and subsequent deprotection gave polysaccharides alternatively composed of beta-D-glucopyranosyl and 2-deoxy-alpha, beta-D-glucopyranosyl residues. (C) 1998 Elsevier Science Ltd. All rights reserved.
• Efficient conversion of a 1,6-anhydro chitobiose derivative into the corresponding tetradecyl β-glycoside derivative by means of participation of a neighboring tetradecanamide group

  Atsushi Umino, Hiroshi Hinou, Koji Matsuoka, Daiyo Terunuma, Shunya Takahashi, Hiroyoshi Kuzuhara

  Journal of Carbohydrate Chemistry 17 2 231 - 239 1998年 [査読有り][通常論文]
   

  In the course of our studies on the synthesis of amphiphilic chitoheptaose derivatives carrying binary long hydrocarbon chains at the reducing sugar, tetradecyl 4-O-(2-amino-2-deoxy-β-D-glucopyranosyl)-2-deoxy-2-tetradecanamido-β- D-glucopyranoside was prepared as a model. For general applicability, the 1,6-anhydro-2-deoxy-2-tetradecanamido-β-D-glucopyranosyl moiety was employed as a precursor of the reducing end. Acetolysis of the 1,6-anhydro ring using triethylsilyl triflate gave an oxazoline intermediate as a major product, accompanied by α-glycosyl acetate as a by-product. Immediate treatment of the mixture with 1-tetradecanol and protic acid followed by a separation work-up efficiently led to tetradecyl β-glycoside derivative.
• Synthesis of Amphiphilic Chitoheptaose Derivative

  Hiroshi Hinou, Atsushi Umino, Koji Matsuoka, Daiyo Terunuma, Shunya Takahashi, Yasuaki Esumi, Hiroyoshi Kuzuhara

  Tetrahedron Letters 38 46 8041 - 8044 1997年11月 [査読有り]
  

MISC

• MALDI MSによる簡便・迅速な糖タンパク質糖鎖解析

  浦上彰吾, 比能洋 化学系学協会北海道支部冬季研究発表会(Web) 2022 2022年
• MALDI-TOF MSによるO抗原迅速同定法の開発

  浦上彰吾, 比能洋 質量分析総合討論会講演要旨集 70th 2022年
• シアリル化糖鎖・複合糖質の直接MALDI-TOFMS解析法

  比能洋 日本糖質学会年会要旨集 38th 2019年
• がん細胞の動的糖鎖修飾の解析によるバイオマーカーの探索

  高山理沙, GEBREHIWOT Abrha Gebreselema, 加藤芳規, MARTIN Fayna Maria Garcia, 比能洋, 西村紳一郎 日本化学会春季年会講演予稿集(CD-ROM) 97th 2017年
• Glycoblotting型糖ペプチドマイクロアレイを用いた構造活性相関研究

  比能洋, 比能洋 日本糖質学会年会要旨集 36th 2017年
• グライコブロッティング法に基づくリポソーム及びリポたんぱく質中酸化脂質の迅速解析

  古川貴之, 比能洋, 武田晴治, 千葉仁志, 西村紳一郎, HUI Shu-Ping JSBMS Letters 42 (Supplement) 2017年
• グライコブロッティング法によるリポタンパク質中の脂質アルデヒド分析

  古川貴之, 比能洋, 武田晴治, 千葉仁志, 西村紳一郎, 惠淑萍 臨床化学 46 2017年
• Glycoblotting型マイクロアレイによる合成糖ペプチドの相互作用解析

  比能洋, 比能洋 高分子学会予稿集(CD-ROM) 65 (2) 2016年
• 脂質アルデヒド類の新規分析法-グライコブロッティング法によるアプローチ:合成標品からリポソームまで

  古川貴之, 惠淑萍, 比能洋, 西村紳一郎, 千葉仁志 臨床化学 45 2016年
• O-mannosylated glycan induced conformational alteration of alpha-dystroglycan fragment

  Hiroshi Hinou, Shin-Ichiro Nishimura ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 249 2015年03月 [査読無し][通常論文]
  
• Structural insight into glycosylated human Notch1 EGF12 analogs

  Shun Hayakawa, Hiroshi Hinou, Shin-Ichiro Nishimura ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 249 2015年03月 [査読無し][通常論文]
  
• Intracellular traffic of cell surface mimetic quantum dots-anchored glycopeptides

  Shin-Ichiro Nishimura, Roger Tan, Kentaro Naruchi, Maho Amano, Hiroshi Hinou ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 249 2015年03月 [査読無し][通常論文]
  
• 糖尿病モデルマウスの比較糖鎖解析

  坂西裕介, 比能洋, 天野麻穂, 幸田敏明, 上村佳子, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 49th 2015年
• アルコールを用いたペプチド環化反応のpKa依存性について

  酒井隆史, 比能洋, 西村紳一郎 高分子学会予稿集(CD-ROM) 64 (1) 2015年
• ブロッティング技術に基づく脂質アルデヒド類の網羅的定量解析

  古川貴之, 惠淑萍, 比能洋, 西村紳一郎, 千葉仁志 日本未病システム学会学術総会抄録集 22nd 2015年
• Glycoblotting法を用いた牛乳中遊離オリゴ糖の網羅的定量解析

  山本祐輔, 古川貴之, 惠淑萍, 比能洋, 西村紳一郎, 千葉仁志 日本未病システム学会学術総会抄録集 22nd 2015年
• グライコブロッティング法を用いた脂質アルデヒドの定量測定法の開発

  古川貴之, 惠淑萍, 比能洋, 西村紳一郎, 千葉仁志 臨床化学 44 2015年
• タウタンパクフラグメントの合成および立体構造解析

  横井康広, 早川瞬, 比能洋, 西村紳一郎 高分子学会予稿集(CD-ROM) 64 (1) 2015年
• CMPアジド化シアル酸の合成と糖タンパク質末端の改変

  飯田優香, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 49th 2015年
• MRM法によるヒトIgG糖ペプチドフラグメントのキャラクタリゼーション

  半村和基, 三好利尚, 成地健太郎, 比能洋, 西村紳一郎 高分子学会予稿集(CD-ROM) 64 (1) 2015年
• 糖鎖固定化電界効果トランジスタによるインフルエンザウイルスから分離したヘマグルチニンの検出

  南部谷俊介, 前川達洋, 秀島翔, 比能洋, 西村紳一郎, 迫田義博, 黒岩繁樹, 中西卓也, 逢坂哲彌 電気化学会大会講演要旨集(CD-ROM) 82nd (Supplement A) 2015年
• 糖鎖修飾の多様性に着目した糖ペプチドライブラリ構築技術の開発と機能解析・利用

  比能 洋 PEPTIDE NEWSLETTER JAPAN 98 2 -5 2015年 [査読無し][招待有り]
  
• 量子ドットに提示したCMPシアル酸のライブセルイメージング

  平根望巳, 比能洋, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 48th 2014年
• O-Mannose型糖鎖を有する糖ペプチドライブラリの構築及び機能解析に関する研究

  菊地星矢, 松下隆彦, 比能洋, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 48th 2014年
• ヒトIgG1抗体に存在するBisect型N-Glycanの効率合成と糖ペプチド合成への応用

  石川明香里, RAVI KUMAR H.V., 比能洋, 比能洋, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 48th 2014年
• Highly efficient synthesis of hyperbranched N-glycans from locust bean gum

  H. V. Ravi Kuma, Kentaro Naruchi, Risho Miyoshi, Hiroshi Hinou, Shin-Ichiro Nishimura ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 246 2013年09月 [査読無し][通常論文]
  
• High-Throughput Antigen Profiling for MUC1 Glycoprotein Antibody

  F. Garcia-Martin, T. Matsushita, H. Hinou, S-I Nishimura BIOPOLYMERS 100 (3) 269 -269 2013年05月 [査読無し][通常論文]
  
• ケイ素保護基を用いた糖ペプチドの迅速固相合成法

  藤井宏圭, 松下隆彦, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 47th 2013年
• 糖残基を有するヒトNotch-1EGF-12ドメインの合成と配座解析

  脇本行彦, 松下隆彦, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 47th 2013年
• O-Mannose型糖鎖を有するαジストログリカン糖ペプチドライブラリの合成と相互作用解析

  菊地星矢, 比能洋, 西村紳一郎 日本化学会講演予稿集 93rd (3) 2013年
• O-マンノース含有ジストログリカン関連糖ペプチドの合成と相互作用解析

  比能洋, 比能洋, 菊地星矢, 松下隆彦, 西村紳一郎, 西村紳一郎 高分子学会予稿集(CD-ROM) 62 (1) 2013年
• ムチン型糖タンパク質におけるTTXモチーフのNMR構造解析

  早川瞬, 松下隆彦, GARCIA-MARTIN Fayna, 成地健太郎, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 47th 2013年
• O-Mannose型糖鎖を有するαジストログリカン糖ペプチドライブラリの合成と相互作用解析

  菊地星矢, 比能洋, 比能洋, 松下隆彦, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 47th 2013年
• Autoantibodies to cancer-associated MUC1 fragments in healthy human sera discovered by high performance glycopeptide microarray platform

  Hiroshi Hinou Abstracts of Papers of the American Chemical Society 246 2013年 [査読有り][通常論文]
  
• Rapid Discovery of MUC1 Epitopes by Glycopeptide Combinatorial Chemistry

  GARCIA-MARTIN Fayna, MATSUSHITA Takahiko, HINOU Hiroshi, NISHIMURA Shin-Ichiro Peptide science : proceedings of the ... Japanese Peptide Symposium 2011 67 -68 2012年03月01日
• 糖鎖捕捉反応を用いた新規糖脂質ライブラリの構築と溶液中における構造解析

  石田純也, 比能洋, 西村紳一郎 日本薬学会年会要旨集 132nd (2) 2012年
• ¹C₄配座を有する新奇グルクロン酸糖供与体に関する研究

  古川貴之, 比能洋, 西村紳一郎 日本薬学会年会要旨集 132nd (2) 2012年
• ムチン型糖ペプチドにおけるTTXモチーフのNMR構造解析

  早川瞬, 松下隆彦, 比能洋, 西村紳一郎 日本薬学会年会要旨集 132nd (2) 2012年
• グライコブロッティング法を用いた異なる種類のヒアルロン酸分解酵素生成ヒアルロン酸断片の同定

  荒井みさき, 古川貴之, ガルシア ファイナ, 比能洋, 天野麻穂, 西村紳一郎 日本薬学会年会要旨集 132nd (3) 2012年
• An efficient protocol for the solid-phase synthesis of glycopeptides under microwave irradiation

  Fayna Garcia-Martin, Hiroshi Hinou, Takahiko Matsushita, Shun Hayakawa, Shin-Ichiro Nishimura ORGANIC & BIOMOLECULAR CHEMISTRY 10 (8) 1612 -1617 2012年 [査読無し][通常論文]
   

  A standardized and smooth protocol for solid-phase glycopeptides synthesis under microwave irradiation was developed. Double activation system was proved to allow for highly efficient coupling of Tn-Ser/Thr and bulky core 2-Ser/Thr derivatives. Versatility and robustness of the present strategy was demonstrated by constructing a Mucine-1 (MUC1) fragment and glycosylated fragments of tau protein. The success of this approach relies on the combination of microwave energy, a resin consisting totally of polyethylene glycol, a low excess of sugar amino acid and the "double activation" method.
• Exploration of Disease-Specific Epitopes by using MUC1 Glycopeptide Microarray

  Wataru Takada, Takahiko Matsushita, Hiroshi Hinou, Shin-Ichiro Nishimura GLYCOBIOLOGY 21 (11) 1509 -1510 2011年11月 [査読無し][通常論文]
  
• Importance of Sialic Acid Residues Illuminated by Live Animal Imaging Using Phosphorylcholine Self-Assembled Monolayer-Coated Quantum Dots

  Tatsuya Ohyanagi, Noriko Nagahori, Ken Shimawaki, Hiroshi Hinou, Tadashi Yamashita, Akira Sasaki, Takashi Jin, Toshihiko Iwanaga, Masataka Kinjo, Shin-Ichiro Nishimura JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 133 (32) 12507 -12517 2011年08月 [査読無し][通常論文]
   

  Glycans are expected to be one of the potential signal molecules for controlling drug targeting/delivery or long-term circulation of biopharmaceuticals. However, the effect of the carbohydrates of artificially glycosylated derivatives on in vivo dynamic distribution profiles after intravenous injection of model animals remains unclear due to the lack of standardized methodology and a suitable platform. We report herein an efficient and versatile method for the preparation of multifunctional quantum dots (QDs) displaying common synthetic glycosides with excellent solubility and long-term stability in aqueous solution without loss of quantum yields. Combined use of an aminooxy-terminated thiol derivative, 11,11'-dithio bis[undec-11-yl 12-(aminooxyacetyl)amino hexa(ethyleneglycol)], and a phosphorylcholine derivative, 11-mercaptoundecylphosphorylcholine, provided QDs with novel functions for the chemical ligation of ketone-functionalized compounds and the prevention of nonspecific protein adsorption concurrently. In vivo near-infrared (NIR) fluorescence imaging of phosphorylcholine self-assembled monolayer (SAM)-coated QDs displaying various simple sugars (glyco-PC-QDs) after administration into the tail vein of the mouse revealed that distinct long-term delocalization over 2 h can be achieved in cases of QDs modified with alpha-sialic acid residue (Neu5Ac-PC-QDs) and control PC-QDs, while QDs bearing other common sugars, such as alpha-glucose (Glc-PC-QDs), alpha-mannose (Man-PC-QDs), alpha-fucose (Fuc-PC-QDs), lactose (Lac-PC-QDs), beta-glucuronic acid (GlcA-PC-QDs), N-acetyl-beta-D-glucosamine (GlcNAc-PC-QDs), and N-acetyl-beta-D-galactosamine (GalNAc-PC-QDs) residues, accumulated rapidly (5-10 min) in the liver. Sequential enzymatic modifications of GlcNAc-PC-QDs gave Gal beta 1,4GlcNAc-PC-QDs (LacNAc-PC-QDs), Gal beta 1,4(Fuc alpha 1,3)GlcNAc-PC-QDs (Le(x)-PC-QDs), Neu5Ac alpha 2,3Gal beta 1,4GlcNAc-PC-QDs (sialyl LacNAc-PC-QDs), and Neu5Ac alpha 2,3Gal beta 1,4(Fuc alpha 1,3)GlcNAc-PC-QDs (sialyl Le(x)-PC-QDs) in quantitative yield as monitored by direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry analyses. Live animal imaging uncovered for the first time that Le(x)-PC-QDs also distributed rapidly in the liver after intravenous injection and almost quenched over 1 h in similar profiles to those of LacNAc-PC-QDs and Lac-PC-QDs. On the other hand, sialyl LacNAc-PC-QDs and sialyl Le(x)-PC-QDs were still retained stably in the whole body after 2 h, while they showed significantly different in vivo dynamics in the tissue distribution, suggesting that structure/sequence of the neighboring sugar residues in the individual sialyl oligosaccharides might influence the final organ-specific distribution. The present results clearly visualize the evidence of an essential role of the terminal sialic acid residue(s) for achieving prolonged in vivo lifetime and biodistribution of various glyco-PC-QDs as a novel class of functional platforms for nanomaterial-based drug targeting/delivery. A standardized protocol using multifunctional PC-QDs should facilitate live animal imaging of ligand-displayed QDs using versatile NIR fluorescence photometry without influence of size-dependent accumulation/excretion pathway for nanoparticles (e.g., viruses) >10 nm in hydrodynamic diameter by the liver.
• Novel Coupling Method for the Incorporation of 'Complex' Amino acid

  GARCIA-MARTIN Fayna, HINOU Hiroshi, MATSUSHITA Takahiko, NISHIMURA Shin-Ichiro Peptide science : proceedings of the ... Japanese Peptide Symposium 2010 204 -204 2011年03月01日
• 新規糖脂質ライブラリの構築と構造解析

  石田純也, 比能洋, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 45th 2011年
• シアリダーゼ阻害剤の探索技術に関する研究

  三好利尚, 甲斐宏一, 高須康明, 比能洋, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 45th 2011年
• 新規糖脂質類縁体ライブラリの構築と構造解析

  石田純也, 比能洋, 西村紳一郎 日本化学会講演予稿集 91st (3) 2011年
• 環状構造を有する新奇シアリダーゼ自殺基質型阻害剤の開発

  甲斐宏一, 比能洋, 西村紳一郎 日本化学会講演予稿集 91st (3) 2011年
• 配座変換を鍵戦略とした新規グルクロン酸及びイズロン酸糖供与体の開発

  古川貴之, 比能洋, 西村紳一郎 日本化学会講演予稿集 91st (4) 2011年
• 疾患特異的エピトープ探索を指向したMUC1糖ペプチドマイクロアレイの開発

  松下隆彦, 高田渉, 比能洋, 西村紳一郎 日本糖質学会年会要旨集 30th 2011年
• Chemo-enzymatic synthesis of mucin-type glycopeptides using sugar-protective groups and ppGalNAcT-2

  Yayoi Yoshimura, Takahiko Matsushita, Naoki Fujitani, Fujihira Haruhiko, Yasuhiro Takegawa, Naomi Manri, Akihito Kaneko, Takeshi Sakamoto, Xiao-Dong Gao, Hiroshi Hinou, Shin-Ichiro Nishimura ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 239 2010年03月 [査読無し][通常論文]
  
• 新奇シアリダーゼ自殺基質型阻害剤の開発

  甲斐宏一, 比能洋, 西村紳一郎 日本化学会講演予稿集 90th (3) 2010年
• 高反応性かつ高立体選択性を有する新規グルクロン酸供与体の開発

  古川貴之, 比能洋, 西村紳一郎 日本化学会講演予稿集 90th (4) 2010年
• ppGalNAcT阻害剤に関する研究

  阿部皓基, 比能洋, 比能洋, 古川潤一, 前田哲宏, 細口健作, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 43rd 2009年
• シアリダーゼ阻害剤の新規骨格の探索

  佐藤公法, 比能洋, 比能洋, 高須康明, 黒河内政樹, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 43rd 2009年
• ヒトシアリダーゼの発現と機能解析

  奥山力, 高暁冬, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 43rd 2009年
• 環境調和型グリコシル化反応~固体超強酸プロモーターの改質~

  齋藤直裕, 前田哲宏, 松田匡雄, 比能洋, 西村紳一郎 日本化学会講演予稿集 89th (1) 2009年
• 新規骨格をベースとしたシアリダーゼ阻害剤の開発研究

  佐藤公法, 比能洋, 高須康明, 黒河内政樹, 西村紳一郎 日本化学会講演予稿集 89th (2) 2009年
• ppGalNAcT阻害剤に関する研究

  阿部皓基, 比能洋, 古川潤一, 前田哲宏, 細口健作, 西村紳一郎 日本化学会講演予稿集 89th (2) 2009年
• グライコミミックを用いた糖鎖生合成機構の制御

  日向寺慧, 羽藤愛美, 天野麻穂, FENG Fei, 三浦嘉晃, 篠原康郎, 比能洋, 西村紳一郎 日本化学会講演予稿集 89th (2) 2009年
• ケイ素保護基を用いた糖ペプチドの固相合成研究

  川崎慶, 嶋脇健, 松下隆彦, 比能洋, 西村紳一郎 日本化学会講演予稿集 89th (2) 2009年
• 糖ペプチドチップを用いた糖ペプチド-タンパク質間相互作用の解析

  松下隆彦, 越智里香, 五十嵐幸太, 比能洋, 西村紳一郎 繊維学会予稿集 64 (1) 2009年
• 新規自殺基質を用いた蛋白質のラベル化

  古川貴之, 比能洋, FENG Fei, 西村紳一郎 日本化学会講演予稿集 89th (2) 2009年
• Notch-1受容体EGF12のフォールディング構造における糖修飾の影響について

  細口健作, 蛭間(清水)和美, 藤谷直樹, 比能洋, 西村紳一郎 日本化学会講演予稿集 89th (2) 2009年
• α-ジストログリカン糖ペプチドの効率的合成および機能解析

  越智里香, 比能洋, 五十嵐幸太, 松下隆彦, 西村紳一郎 日本薬学会年会要旨集 129th (2) 2009年
• ケイ素保護体アミノ酸ビルディングブロックを用いた糖ペプチド固相合成

  川崎慶, 嶋脇健, 比能洋, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 43rd 2009年
• O-マンノース型糖ペプチドの効率的合成および機能解析

  越智里香, 比能洋, 五十嵐幸太, 松下隆彦, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 43rd 2009年
• ペプチド型プローブの迅速探索法

  古川貴之, 比能洋, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 43rd 2009年
• 環状不凍糖タンパク質の合成および不凍活性

  八須匡和, 高道学, 比能洋, 清水弘樹, 津田栄, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 43rd 2009年
• 癌関連糖ペプチドライブラリーの構築と抗体エピトープマッピングへの応用

  松下隆彦, 比能洋, 泉龍孝, 西村紳一郎, 大藪巨樹, 川本敬子, 沼田義人, 十亀弘子, 武本浩, 近藤裕郷 メディシナルケミストリーシンポジウム講演要旨集 28th 2009年
• NMRによるリニア不凍糖タンパク質(AFGP)のコンフォメーション解析

  泉龍孝, 藤谷直樹, 松下隆彦, 比能洋, 高道学, 西宮佳志, 津田栄, 西村紳一郎 日本糖質学会年会要旨集 29th 2009年
• 新規不凍糖タンパク質誘導体の合成と性質

  八須匡和, 比能洋, 高道学, 三浦信明, 清水弘樹, 津田栄, 西村紳一郎, 西村紳一郎 日本糖質学会年会要旨集 29th 2009年
• Mechanism-based probing, characterization, and inhibitor design of glycosidases and glycosyltransferases

  Hiroshi Hinou, Shin-Ichiro Nishimura Current Topics in Medicinal Chemistry 9 (1) 106 -116 2009年 [査読有り][通常論文]
   

  Recent structural and kinetic studies indicated that enzymes shift their peripheral structures of the catalytic sites dynamically to modify the substrate structures. Molecules which disturb such mechanism of specific enzymes may become potent candidates for therapeutic reagent. This article describes a versatile strategy to synthesize new class of mechanism-based inhibitors for glycosyltransferases and glycoside hydrolases. Combination of irreversible tagging and proteomic analysis of crucial amino acid residues using MALDI-TOF/TOF mass spectrometry allowed a promising method to probe such invisible transitional state in the enzymatic reactions. Feasibility of the fluorescence energy resonance transfer (FRET) is also documented as novel protocol for the real-time and continuous monitoring of glycosyltransferase catalyzed reactions. It was demonstrated that FRET method greatly facilitates discovery research of selective inhibitors in combination with click chemistry. © 2009 Bentham Science Publishers Ltd.
• シアリダーゼ自殺基質におけるアグリコンフォーカスドライブラリーの作製と評価

  甲斐宏一, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 42nd 2008年
• 多糖類誘導体の整形外科領域での高次利用

  比能洋, 西村紳一郎, 岩崎倫政, 三浪明男 繊維学会予稿集 63 (1/2) 2008年
• 酵素の動的構造に着目したシアリダーゼ阻害剤の開発研究

  高須康明, 黒河内政樹, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 42nd 2008年
• フォーカスドライブラリを用いた特異的シアル酸転移酵素阻害剤の探索

  細口健作, 古川潤一, 前田哲宏, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 42nd 2008年
• 大規模高速糖鎖構造解析法の開発と応用

  天野麻穂, 比能洋, 古川潤一, 篠原康郎, 西村紳一郎 日本化学会講演予稿集 88th (2) 2008年
• O-マンノース型糖ペプチドの効率的合成および機能解析に関する研究

  越智里香, 比能洋, 五十嵐幸太, 西村紳一郎 日本化学会講演予稿集 88th (2) 2008年
• 腫瘍マーカーに対する糖鎖修飾が誘導する立体構造変化

  藤谷直樹, 黒河内政樹, GAO Xiao-Dong, 松下隆彦, 比能洋, 篠原康郎, 西村紳一郎 Abstracts. Annual Meeting of the NMR Society of Japan 46th 2007年
• ポリラクトサミン含有複合糖質のライブラリー構築と構造解析

  成地健太郎, 浜本智樹, 黒河内政樹, 松下隆彦, 藤谷直樹, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎 高分子学会北海道支部研究発表会講演要旨集 41st 2007年
• Construction of tumor - Related gkycpeptided library

  Shin Ichiro Nishimura, Hiroshi Hinou, Hiroki Shimizu, Takahiko Matsushita, Naoki Oyabu, Masataka Fumoto, Hirosato Kondo Polymer Preprints, Japan 55 5508 2006年12月01日 [査読無し][通常論文]
   

  Combined use of a solid-phase chemical synthesis of peptide and enzymatic synthesis of carbohydrate on water soluble polymer allowed for the construction of complicated glycopeptide library which contributes to functional analysis of the glycopeptides. This study was supported by NEDO.
• Efficient syntheses and characterizations of MUC1 related high-molecular weight glycopeptides

  Takahiko Matsushita, Toshiki Ohyabu, Toshiki Ohyabu, Hiroshi Hinou, Hiroki Shimizu, Shin Ichiro Nishimura, Shin Ichiro Nishimura Polymer Preprints, Japan 55 1857 2006年10月19日 [査読無し][通常論文]
   

  The mucin-type glycoprotein MUC1 is known to be aberrant glycosylated in various cancer cells. We report the efficient method for the syntheses of MUC1-related glycopeptides having different sugar chains based on core2-type trisaccharide structure by combination of microwave-assisted solid-phase syntheses and enzymatic sugar elongation. Characterizations by MUC1 antibody assay will also be discussed.
• CARB 63-One-pot solid phase glycoblotting and labeling by trans-oximization for high-throughput glycomics and glycoproteomics

  Hideyuki Shimaoka, Jun-ichi Furukawa, Yoshiaki Miura, Masaki Kurogochi, Hiroshi Hinou, Yasuro Shinohara, Kisaburo Deguchi, Shin-Ichiro Nishimura ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 232 2006年09月 [査読無し][通常論文]
  
• ダイナミックな作用機序に基づく糖転移酵素阻害剤の分子設計法

  西村紳一郎, 西村紳一郎, 高谷健二, 前田哲宏, 細口健作, 古川潤一, 比能洋 日本糖質学会年会要旨集 26th 2006年
• 癌関連糖ペプチドライブラリの構築

  西村紳一郎, 比能洋, 清水弘樹, 松下隆彦, 大藪巨樹, 麓昌高, 近藤裕郷 高分子学会予稿集(CD-ROM) 55 (2 Disk1) 2006年
• MUC1関連高分子糖ペプチドの効率的合成と機能評価

  松下隆彦, 大藪巨樹, 大藪巨樹, 比能洋, 清水弘樹, 西村紳一郎, 西村紳一郎 高分子学会予稿集(CD-ROM) 55 (1 Disk1) 2006年
• 酵素連続反応による糖鎖自動合成法 糖鎖自動合成装置Golgiの開発

  西村紳一郎, 清水弘樹, 比能洋 産総研TODAY 6 (2) 2006年
• 自殺基質によるシアリダーゼ解析

  比能洋, 黒河内政樹, 秋場聡, 武川泰啓, 西村紳一郎 日本糖質学会年会要旨集 26th 2006年
• 糖鎖自動合成装置"Golgi"の開発と糖ペプチド合成システムへの展開 (第23回 バイオテクノロジー シンポジウム 予稿集) -- (講演会の部)

  比能 洋 バイオテクノロジ-シンポジウム予稿集 23 15 -18 2005年11月22日
• 糖ペプチド合成用プライマーの開発と糖ペプチドライブラリーへの応用 (第23回 バイオテクノロジー シンポジウム 予稿集) -- (ポスターセッションの部 糖鎖エンジニアリングプロジェクト/糖鎖構造解析技術開発)

  麓 昌高, 比能 洋, 清水 弘樹 バイオテクノロジ-シンポジウム予稿集 23 164 -166 2005年11月22日
• 糖ペプチド合成用プライマーの開発と糖ペプチドライブラリーへの応用

  麓昌高, 麓昌高, 比能洋, 比能洋, 清水弘樹, 太田尚志, 太田尚志, 松下隆彦, 岩田一道, 山田久里子, 山田久里子, 伊藤孝臣, 大藪巨樹, 大藪巨樹, 瀧本明生, 近藤裕郷, 稲津敏行, 中原義昭, 西村紳一郎, 西村紳一郎 バイオテクノロジーシンポジウム予稿集 23rd 2005年
• 糖鎖自動合成装置“Golgi”用糖転移酵素の開発と利用

  岩田一道, 太田尚志, 太田尚志, 山田久里子, 山田久里子, 戸田篤志, 戸田篤志, 比能洋, 西村紳一郎, 西村紳一郎 バイオテクノロジーシンポジウム予稿集 23rd 2005年
• 糖転移酵素Och1pの機能解析に関する研究

  清水弘樹, 坂本雅博, 坂本雅博, 千葉靖典, 喜多島敏彦, 地神芳文, 比能洋, 西村紳一郎, 西村紳一郎 日本農芸化学会大会講演要旨集 2005 2005年
• 糖ペプチド合成用高分子プライマーの開発とその応用

  麓昌高, 比能洋, 太田尚志, 伊藤孝臣, 瀧本明生, 近藤裕郷, 稲津敏行, 中原義昭, 西村紳一郎 日本化学会講演予稿集 85th (2) 2005年
• 非可逆的阻害機構を有するノイラミニダーゼプローブの開発

  比能洋, 黒河内政樹, 長堀紀子, 西村紳一郎 日本化学会講演予稿集 85th (2) 2005年
• マイクロ波照射下における糖ペプチド固相合成

  松下隆彦, 比能洋, 清水弘樹, 西村紳一郎 日本化学会講演予稿集 85th (2) 2005年
• 光学活性スルホキシドを用いる不斉Favorskii転位反応を利用した光学活性化合物の合成

  三浦基文, 鳥山正晴, 比能洋, 浅見覚, 鈴木孝, 佐藤毅, 本橋重康 日本薬学会年会要旨集 125th (4) 2005年
• 糖鎖自動合成装置“Golgi”の開発

  山田久里子, 山田久里子, 太田尚志, 太田尚志, 岩田一道, 麓昌高, 麓昌高, 大藪巨樹, 大藪巨樹, 比能洋, 清水弘樹, 西村紳一郎 バイオテクノロジーシンポジウム予稿集 23rd 2005年
• 糖鎖化学の最先端技術

  シーエムシー出版 -HH003053 2005年 [査読無し][招待有り]
  
• 糖鎖自動合成装置“Golgi”にむけた糖ペプチド合成用プライマーの開発

  岩田一道, 麓昌高, 比能洋, 太田尚志, 松下隆彦, 山田久里子, 伊藤孝臣, 瀧本明生, 稲津敏行 バイオテクノロジーシンポジウム予稿集 22nd 2004年
• 不斉Favorskii転位反応を用いた光学活性アミンの合成

  大東彩子, 比能洋, 浅見覚, 鳥山正晴, 鈴木孝, 本橋重康 日本薬学会年会要旨集 124th (2) 2004年
• 糖鎖自動合成装置“Golgi”による複合糖質の合成

  山田久里子, 戸田篤志, 西口進, 岩田一道, 麓昌高, 比能洋, 西村紳一郎 バイオテクノロジーシンポジウム予稿集 22nd 2004年
• 糖鎖自動合成技術の開発研究および,糖ペプチドライブラリー合成への展開

  比能洋, 太田尚志, 山田久里子, 西口進, 戸田篤志, 岩田一道, 地神芳文, 松下隆彦, 新間陽一 高分子学会予稿集(CD-ROM) 53 (2 Disk1) 2004年
• 糖鎖自動合成法に関する基礎研究(X)

  西口進, 戸田篤志, 山田久里子, 太田尚志, 比能洋, 新間陽一, 地神芳文, 西村紳一郎 高分子学会予稿集(CD-ROM) 53 (2 Disk1) 2004年
• PTPase阻害薬を用いた小児悪性腫ようへの応用

  宮本智子, 浅見覚, 堀川あすか, 大東彩子, 比能洋, 鳥山正晴, 本橋重康, 鈴木孝 日本薬学会年会要旨集 124th (4) 2004年
• 糖鎖自動合成装置“Golgi”用固定化糖転移酵素の開発

  戸田篤志, 山田久里子, 比能洋, 西村紳一郎 バイオテクノロジーシンポジウム予稿集 22nd 2004年
• 二基質型シアル酸転移酵素阻害剤の系統的合成

  比能洋, 本橋重康, 伊藤幸成 日本薬学会年会要旨集 123rd (2) 2003年
• 二基質型シアル酸転移酵素阻害剤の合成研究

  比能洋, 孫学龍, 本橋重康, 伊藤幸成 次世代を担う有機化学シンポジウム講演要旨集 1st 2003年
• 不斉Favorskii転位反応を用いた光学活性カルボン酸の合成

  吉原久美子, 比能洋, 鳥山正晴, 本橋重康 日本薬学会年会要旨集 123rd (2) 2003年
• 二基質結合型シアル酸転移酵素阻害剤の合成研究 (4)

  比能洋, 伊藤幸成 日本化学会講演予稿集 81st (2) 2002年
• 二基質結合型シアル酸転移酵素阻害剤の合成研究

  比能洋, SUN X-L, 伊藤幸成 日本糖質学会年会要旨集 23rd 2002年
• 二基質結合型シアル酸転移酵素阻害剤の合成研究

  比能洋, SUN X-L, 伊藤幸成 日本化学会講演予稿集 79th (2) 2001年
• 二基質結合型シアル酸転移酵素阻害剤の合成研究 (2)

  比能洋, SUN X L, 伊藤幸成 日本糖質学会年会要旨集 22nd 2001年
• 多環状エーテルの収束的構築法の開発

  松尾剛, 上田剛, 比能洋, 越野広雪, 中田忠 日本化学会講演予稿集 79th (2) 2001年
• 2基質結合型シアル酸転移酵素阻害剤の合成

  比能洋 生体分子の化学講演要旨集 5th 2001年
• トランス縮環四環性ポリエーテルの短段階収束的合成

  松尾剛, 比能洋, 越野広雪, 末永俊朗, 中田忠 日本化学会講演予稿集 78th (2) 2000年
• 多環状エーテルの高効率的合成法の開発

  中田忠, 松尾剛, 堀伸行, 松倉弘子, 比能洋 反応と合成の進歩シンポジウム講演要旨集 26th 2000年
• 2糖トレハロースを出発物としたL-イズロン酸の新規合成法

  比能洋, 黒沢英弘, 松岡浩司, 照沼大陽, 葛原弘美 日本化学会講演予稿集 76th (2) 1999年
• トレハロースのL-イドース含有2糖への変換反応

  比能洋, 黒沢英弘, 松岡浩司, 照沼大陽, 葛原弘美 日本化学会講演予稿集 74th (2) 1998年
• 両親媒性キトヘプタオース誘導体の合成

  比能洋, 海野篤, 松岡浩司, 照沼大陽, 葛原弘美 糖質シンポジウム講演要旨集 19th 1997年
• 両親媒性キトオリゴ糖誘導体の合成 I 長鎖アシルアミノ基を活用したグリコシル化反応

  海野篤, 比能洋, 松岡浩司, 照沼大陽, 葛原弘美 日本化学会講演予稿集 72nd (2) 1997年
• 両親媒性キトオリゴ糖誘導体の合成 II 2本の疎水性長鎖を結合した3糖,5糖,7糖の合成

  比能洋, 海野篤, 松岡浩司, 照沼大陽, 葛原弘美 日本化学会講演予稿集 72nd (2) 1997年
• 分子集合能を持つキトビオース誘導体の合成

  比能洋, 海野篤, 松岡浩司, 照沼大陽, 葛原弘美 キチン・キトサン研究 3 (2) 1997年
• キトオリゴ糖ミセルの合成研究

  比能洋, 海野篤, 松岡浩司, 照沼大陽, 葛原弘美 日本化学会講演予稿集 70th (2) 1996年

書籍等出版物

• 天然2糖を出発物とした有用化合物の合成研究

  比能 洋 
  比能洋 2000年

講演・口頭発表等

• Glycotyping: Old and New Concept of Glycoscience  [招待講演]

  Hiroshi Hinou

  108th Indian Science Congress 2023年01月 口頭発表（基調）
• MALDI Glycotyping of Glycoproteins, Biofluids, and Bacterial O-antigens  [招待講演]

  Hiroshi Hinou

  International Congress on Pure and Applied Chemistry (ICPAC) Kota Kinabalu 2022 2022年11月 口頭発表（招待・特別）
• 糖鎖選択的イオン化技術（質量分析）、糖鎖機能探索技術（マイクロアレイ）  [通常講演]

  比能洋

  イノベーション・ジャパン2021 2021年08月 シンポジウム・ワークショップパネル（公募）
• MALDI-TOFMSによる糖質解析 ～前処理工程をどれだけ簡素化できるか～  [招待講演]

  比能 洋

  質量分析学会第29回北海道談話会 2021年02月 口頭発表（招待・特別）
• 化学者から見た糖鎖研究  [招待講演]

  比能 洋

  異分野meetup week2020☆研究者コミュニティサロン☆“糖鎖研究について語ろう！ 2020年12月 シンポジウム・ワークショップパネル（指名）
• マイクロアレイおよび質量分析による糖鎖・複合糖質の機能及び構造解析  [招待講演]

  比能 洋

  畜産とキチンキトサン勉強会 2020年11月 口頭発表（招待・特別）
• Chemical Glycobiology (Starting from Glycoconjugate Syntheses)  [招待講演]

  Hiroshi Hinou

  107th Indian Science Congress 2020年01月 口頭発表（招待・特別）
• 糖ペプチドの迅速合成・品質管理・利用に関する基盤技術の構築  [招待講演]

  比能 洋

  糖化学フォーラム 2019年10月 口頭発表（招待・特別）
• 糖を介して見る生命の世界  [通常講演]

  比能 洋

  北大道新アカデミー 2019年10月 公開講演，セミナー，チュートリアル，講習，講義等
• Novel matrix system for reflectron mode MALDI-TOF and TOF/TOF MS analysis of unmodified sialylated oligosaccharides and glycopeptides  [招待講演]

  Hiroshi Hinou

  Japanese-American Symposium on Applied & Translational Glycosciences, ACS Fall 2019 National Meeting 2019年08月 口頭発表（招待・特別）
• ペプチド環化と水素結合とpKa  [通常講演]

  比能洋

  第51回若手ペプチド夏の勉強会 2019年08月 口頭発表（一般）
• シアリル化糖鎖・複合糖質の直接MALDI-TOFMS解析法  [通常講演]

  比能洋

  第38回日本糖質学会年会 2019年08月 口頭発表（一般）
• Microarray and NMR Study of Core M1 Glycan Modified α-Dystroglycan Fragments  [招待講演]

  Hiroshi Hinou

  International Congress on Pure and Applied Chemistry 2018 2018年03月 口頭発表（招待・特別）
• グライコブロッティング法によるリポタンパク質中の脂質アルデヒド分析  [通常講演]

  古川貴之, 比能洋, 武田晴治, 千葉仁志, 西村紳一郎, 惠淑萍

  臨床化学 2017年09月
• グライコブロッティング法に基づくリポソーム及びリポたんぱく質中酸化脂質の迅速解析  [通常講演]

  古川貴之, 比能洋, 武田晴治, 千葉仁志, 西村紳一郎, HUI Shu‐Ping

  JSBMS Letters 2017年08月
• Glycoblotting型糖ペプチドマイクロアレイを用いた構造活性相関研究  [通常講演]

  比能洋, 比能洋

  日本糖質学会年会要旨集 2017年07月
• がん細胞の動的糖鎖修飾の解析によるバイオマーカーの探索  [通常講演]

  高山理沙, GEBREHIWOT Abrha Gebreselema, 加藤芳規, MARTIN Fayna, Maria Garcia, 比能洋, 西村紳一郎

  日本化学会春季年会講演予稿集(CD-ROM) 2017年03月
• Glycoblotting型マイクロアレイによる合成糖ペプチドの相互作用解析  [招待講演]

  比能洋, 比能洋

  高分子学会予稿集(CD-ROM) 2016年08月 口頭発表（招待・特別）
• グライコブロッティング法を用いた脂質アルデヒドの定量測定法の開発  [通常講演]

  古川貴之, 惠淑萍, 比能洋, 西村紳一郎, 千葉仁志

  臨床化学 2015年10月
• Glycoblotting法を用いた牛乳中遊離オリゴ糖の網羅的定量解析  [通常講演]

  山本祐輔, 古川貴之, 惠淑萍, 比能洋, 西村紳一郎, 千葉仁志

  日本未病システム学会学術総会抄録集 2015年09月
• ブロッティング技術に基づく脂質アルデヒド類の網羅的定量解析  [通常講演]

  古川貴之, 惠淑萍, 比能洋, 西村紳一郎, 千葉仁志

  日本未病システム学会学術総会抄録集 2015年09月
• MRM法によるヒトIgG糖ペプチドフラグメントのキャラクタリゼーション  [通常講演]

  半村和基, 三好利尚, 成地健太郎, 比能洋, 西村紳一郎

  高分子学会予稿集(CD-ROM) 2015年05月
• タウタンパクフラグメントの合成および立体構造解析  [通常講演]

  横井康広, 早川瞬, 比能洋, 西村紳一郎

  高分子学会予稿集(CD-ROM) 2015年05月
• アルコールを用いたペプチド環化反応のpKa依存性について  [通常講演]

  酒井隆史, 比能洋, 西村紳一郎

  高分子学会予稿集(CD-ROM) 2015年05月
• 糖鎖固定化電界効果トランジスタによるインフルエンザウイルスから分離したヘマグルチニンの検出  [通常講演]

  南部谷俊介, 前川達洋, 秀島翔, 比能洋, 西村紳一郎, 迫田義博, 黒岩繁樹, 中西卓也, 逢坂哲彌

  Chem Sens 2015年03月
• 糖鎖固定化電界効果トランジスタによるインフルエンザウイルスから分離したヘマグルチニンの検出  [通常講演]

  南部谷俊介, 前川達洋, 秀島翔, 比能洋, 西村紳一郎, 迫田義博, 黒岩繁樹, 中西卓也, 逢坂哲彌

  電気化学会大会講演要旨集(CD-ROM) 2015年03月
• CMPアジド化シアル酸の合成と糖タンパク質末端の改変  [通常講演]

  飯田優香, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2015年
• Synthesis and Application of Bicyclic Carbohydrates  [招待講演]

  Hiroshi Hinou

  International Symposium on Chemical Biology-Drug Discovery 2014年01月 口頭発表（招待・特別）
• ヒトIgG1抗体に存在するBisect型N‐Glycanの効率合成と糖ペプチド合成への応用  [通常講演]

  石川明香里, RAVI KUMAR H.V, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2014年
• O‐Mannose型糖鎖を有する糖ペプチドライブラリの構築及び機能解析に関する研究  [通常講演]

  菊地星矢, 松下隆彦, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2014年
• 量子ドットに提示したCMPシアル酸のライブセルイメージング  [通常講演]

  平根望巳, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2014年
• New Strategy for Peptide Cyclization H-bonding effect of fluorinated alcohol  [招待講演]

  Hiroshi Hinou

  Special Seminar;at Chemistry Department of Wane;State University 2013年09月 公開講演，セミナー，チュートリアル，講習，講義等
• O‐マンノース含有ジストログリカン関連糖ペプチドの合成と相互作用解析  [招待講演]

  比能洋, 菊地星矢, 松下隆彦, 西村紳一郎

  高分子学会予稿集(CD-ROM) 2013年05月 口頭発表（招待・特別）
• O‐Mannose型糖鎖を有するαジストログリカン糖ペプチドライブラリの合成と相互作用解析  [通常講演]

  菊地星矢, 比能洋, 西村紳一郎

  日本化学会講演予稿集 2013年03月 口頭発表（一般）
• 糖残基を有するヒトNotch‐1EGF‐12ドメインの合成と配座解析  [通常講演]

  脇本行彦, 松下隆彦, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2013年
• O‐Mannose型糖鎖を有するαジストログリカン糖ペプチドライブラリの合成と相互作用解析  [通常講演]

  菊地星矢, 比能洋, 松下隆彦, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2013年 口頭発表（一般）
• ムチン型糖タンパク質におけるTTXモチーフのNMR構造解析  [通常講演]

  早川瞬, 松下隆彦, GARCIA‐MARTIN Fayna, 成地健太郎, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2013年 口頭発表（一般）
• ケイ素保護基を用いた糖ペプチドの迅速固相合成法  [通常講演]

  藤井宏圭, 松下隆彦, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2013年
• リバースグライコブロッティング法を利用した腎癌糖タンパク質マーカーの探索(Exploration of novel diagnosis markers of renal cancer utilized by reverse glycoblotting method)  [通常講演]

  天野 麻穂, 畠山 真吾, 三好 利尚, 比能 洋, 大山 力, 西村 紳一郎

  日本癌学会総会記事 2012年08月
• ¹C₄配座を有する新奇グルクロン酸糖供与体に関する研究  [通常講演]

  古川貴之, 比能洋, 西村紳一郎

  日本薬学会年会要旨集 2012年03月
• 糖鎖捕捉反応を用いた新規糖脂質ライブラリの構築と溶液中における構造解析  [通常講演]

  石田純也, 比能洋, 西村紳一郎

  日本薬学会年会要旨集 2012年03月
• グライコブロッティング法を用いた異なる種類のヒアルロン酸分解酵素生成ヒアルロン酸断片の同定  [通常講演]

  荒井みさき, 古川貴之, ガルシア ファイナ, 比能洋, 天野麻穂, 西村紳一郎

  日本薬学会年会要旨集 2012年03月
• ムチン型糖ペプチドにおけるTTXモチーフのNMR構造解析  [通常講演]

  早川瞬, 松下隆彦, 比能洋, 西村紳一郎

  日本薬学会年会要旨集 2012年03月
• Rapid Discovery of MUC1 Epitopes by Glycopeptide Combinatorial Chemistry  [通常講演]

  GARCIA-MARTIN Fayna, MATSUSHITA Takahiko, HINOU Hiroshi, NISHIMURA Shin-Ichiro

  Peptide science : proceedings of the ... Japanese Peptide Symposium 2012年03月
• 疾患特異的エピトープ探索を指向したMUC1糖ペプチドマイクロアレイの開発  [通常講演]

  松下隆彦, 高田渉, 比能洋, 西村紳一郎

  日本糖質学会年会要旨集 2011年06月
• 環状構造を有する新奇シアリダーゼ自殺基質型阻害剤の開発  [通常講演]

  甲斐宏一, 比能洋, 西村紳一郎

  日本化学会講演予稿集 2011年03月
• 配座変換を鍵戦略とした新規グルクロン酸及びイズロン酸糖供与体の開発  [通常講演]

  古川貴之, 比能洋, 西村紳一郎

  日本化学会講演予稿集 2011年03月
• 新規糖脂質類縁体ライブラリの構築と構造解析  [通常講演]

  石田純也, 比能洋, 西村紳一郎

  日本化学会講演予稿集 2011年03月
• Novel Coupling Method for the Incorporation of 'Complex' Amino acid  [通常講演]

  GARCIA-MARTIN Fayna, HINOU Hiroshi, MATSUSHITA Takahiko, NISHIMURA Shin-Ichiro

  Peptide science : proceedings of the ... Japanese Peptide Symposium 2011年03月
• シアリダーゼ阻害剤の探索技術に関する研究  [通常講演]

  三好利尚, 甲斐宏一, 高須康明, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2011年02月
• 新規糖脂質ライブラリの構築と構造解析  [通常講演]

  石田純也, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2011年02月
• Peptide Cyclization in Fluorinated Alcohol: Toward Cyclic AFGP  [招待講演]

  Hiroshi Hinou

  Seminario Excepcional de Grupo-Chemistry and Molecular Pharmacology Programme 2010年09月 公開講演，セミナー，チュートリアル，講習，講義等
• Novel Strategies for Neuraminidase Inhibitors using Suicide Substrates  [招待講演]

  Hiroshi Hinou

  Barcelona Biomed Seminer-Chemistry and Molecular Pharmacology Programme 2010年09月 公開講演，セミナー，チュートリアル，講習，講義等
• 新奇シアリダーゼ自殺基質型阻害剤の開発  [通常講演]

  甲斐宏一, 比能洋, 西村紳一郎

  日本化学会講演予稿集 2010年03月
• 高反応性かつ高立体選択性を有する新規グルクロン酸供与体の開発  [通常講演]

  古川貴之, 比能洋, 西村紳一郎

  日本化学会講演予稿集 2010年03月
• 癌関連糖ペプチドライブラリーの構築と抗体エピトープマッピングへの応用  [通常講演]

  松下隆彦, 比能洋, 泉龍孝, 西村紳一郎, 大藪巨樹, 川本敬子, 沼田義人, 十亀弘子, 武本浩, 近藤裕郷

  メディシナルケミストリーシンポジウム講演要旨集 2009年11月
• 新規不凍糖タンパク質誘導体の合成と性質  [通常講演]

  八須匡和, 比能洋, 高道学, 三浦信明, 清水弘樹, 津田栄, 西村紳一郎, 西村紳一郎

  日本糖質学会年会要旨集 2009年08月
• NMRによるリニア不凍糖タンパク質(AFGP)のコンフォメーション解析  [通常講演]

  泉龍孝, 藤谷直樹, 松下隆彦, 比能洋, 高道学, 西宮佳志, 津田栄, 西村紳一郎

  日本糖質学会年会要旨集 2009年08月
• 糖ペプチドチップを用いた糖ペプチド‐タンパク質間相互作用の解析  [通常講演]

  松下隆彦, 越智里香, 五十嵐幸太, 比能洋, 西村紳一郎

  繊維学会予稿集 2009年06月
• グライコミミックを用いた糖鎖生合成機構の制御  [通常講演]

  日向寺慧, 羽藤愛美, 天野麻穂, FENG Fei, 三浦嘉晃, 篠原康郎, 比能洋, 西村紳一郎

  日本化学会講演予稿集 2009年03月
• 新規骨格をベースとしたシアリダーゼ阻害剤の開発研究  [通常講演]

  佐藤公法, 比能洋, 高須康明, 黒河内政樹, 西村紳一郎

  日本化学会講演予稿集 2009年03月
• Notch‐1受容体EGF12のフォールディング構造における糖修飾の影響について  [通常講演]

  細口健作, 蛭間(清水)和美, 藤谷直樹, 比能洋, 西村紳一郎

  日本化学会講演予稿集 2009年03月
• 新規自殺基質を用いた蛋白質のラベル化  [通常講演]

  古川貴之, 比能洋, FENG Fei, 西村紳一郎

  日本化学会講演予稿集 2009年03月
• 環境調和型グリコシル化反応~固体超強酸プロモーターの改質~  [通常講演]

  齋藤直裕, 前田哲宏, 松田匡雄, 比能洋, 西村紳一郎

  日本化学会講演予稿集 2009年03月
• ケイ素保護基を用いた糖ペプチドの固相合成研究  [通常講演]

  川崎慶, 嶋脇健, 松下隆彦, 比能洋, 西村紳一郎

  日本化学会講演予稿集 2009年03月
• ppGalNAcT阻害剤に関する研究  [通常講演]

  阿部皓基, 比能洋, 古川潤一, 前田哲宏, 細口健作, 西村紳一郎

  日本化学会講演予稿集 2009年03月
• α‐ジストログリカン糖ペプチドの効率的合成および機能解析  [通常講演]

  越智里香, 比能洋, 五十嵐幸太, 松下隆彦, 西村紳一郎

  日本薬学会年会要旨集 2009年03月
• 環状不凍糖タンパク質の合成および不凍活性  [通常講演]

  八須匡和, 高道学, 比能洋, 清水弘樹, 津田栄, 西村紳一郎, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2009年02月
• ペプチド型プローブの迅速探索法  [通常講演]

  古川貴之, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2009年02月
• ヒトシアリダーゼの発現と機能解析  [通常講演]

  奥山力, 高暁冬, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2009年02月
• O‐マンノース型糖ペプチドの効率的合成および機能解析  [通常講演]

  越智里香, 比能洋, 五十嵐幸太, 松下隆彦, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2009年02月
• ケイ素保護体アミノ酸ビルディングブロックを用いた糖ペプチド固相合成  [通常講演]

  川崎慶, 嶋脇健, 比能洋, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2009年02月
• シアリダーゼ阻害剤の新規骨格の探索  [通常講演]

  佐藤公法, 比能洋, 比能洋, 高須康明, 黒河内政樹, 西村紳一郎, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2009年02月
• ppGalNAcT阻害剤に関する研究  [通常講演]

  阿部皓基, 比能洋, 比能洋, 古川潤一, 前田哲宏, 細口健作, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2009年02月
• 多糖類誘導体の整形外科領域での高次利用  [通常講演]

  比能洋, 西村紳一郎, 岩崎倫政, 三浪明男

  繊維学会予稿集 2008年06月
• O‐マンノース型糖ペプチドの効率的合成および機能解析に関する研究  [通常講演]

  越智里香, 比能洋, 五十嵐幸太, 西村紳一郎

  日本化学会講演予稿集 2008年03月
• 大規模高速糖鎖構造解析法の開発と応用  [通常講演]

  天野麻穂, 比能洋, 古川潤一, 篠原康郎, 西村紳一郎

  日本化学会講演予稿集 2008年03月
• フォーカスドライブラリを用いた特異的シアル酸転移酵素阻害剤の探索  [通常講演]

  細口健作, 古川潤一, 前田哲宏, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2008年01月
• 酵素の動的構造に着目したシアリダーゼ阻害剤の開発研究  [通常講演]

  高須康明, 黒河内政樹, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2008年01月
• シアリダーゼ自殺基質におけるアグリコンフォーカスドライブラリーの作製と評価  [通常講演]

  甲斐宏一, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2008年01月
• 腫瘍マーカーに対する糖鎖修飾が誘導する立体構造変化  [通常講演]

  藤谷直樹, 黒河内政樹, GAO Xiao‐Dong, 松下隆彦, 比能洋, 篠原康郎, 西村紳一郎

  Abstr Annu Meet NMR Soc Jpn 2007年09月
• ポリラクトサミン含有複合糖質のライブラリー構築と構造解析  [通常講演]

  成地健太郎, 浜本智樹, 黒河内政樹, 松下隆彦, 藤谷直樹, 比能洋, 比能洋, 西村紳一郎, 西村紳一郎

  高分子学会北海道支部研究発表会講演要旨集 2007年02月
• Construction of tumor - Related gkycpeptided library  [通常講演]

  Shin Ichiro Nishimura, Hiroshi Hinou, Hiroki Shimizu, Takahiko Matsushita, Naoki Oyabu, Masataka Fumoto, Hirosato Kondo

  Polymer Preprints, Japan 2006年12月 

  Combined use of a solid-phase chemical synthesis of peptide and enzymatic synthesis of carbohydrate on water soluble polymer allowed for the construction of complicated glycopeptide library which contributes to functional analysis of the glycopeptides. This study was supported by NEDO.
• Efficient syntheses and characterizations of MUC1 related high-molecular weight glycopeptides  [通常講演]

  Takahiko Matsushita, Toshiki Ohyabu, Toshiki Ohyabu, Hiroshi Hinou, Hiroki Shimizu, Shin Ichiro Nishimura, Shin Ichiro Nishimura

  Polymer Preprints, Japan 2006年10月 

  The mucin-type glycoprotein MUC1 is known to be aberrant glycosylated in various cancer cells. We report the efficient method for the syntheses of MUC1-related glycopeptides having different sugar chains based on core2-type trisaccharide structure by combination of microwave-assisted solid-phase syntheses and enzymatic sugar elongation. Characterizations by MUC1 antibody assay will also be discussed.
• 癌関連糖ペプチドライブラリの構築  [通常講演]

  西村紳一郎, 比能洋, 清水弘樹, 松下隆彦, 大藪巨樹, 麓昌高, 近藤裕郷

  高分子学会予稿集(CD-ROM) 2006年09月
• 自殺基質によるシアリダーゼ解析  [通常講演]

  比能洋, 黒河内政樹, 秋場聡, 武川泰啓, 西村紳一郎

  日本糖質学会年会要旨集 2006年07月
• ダイナミックな作用機序に基づく糖転移酵素阻害剤の分子設計法  [通常講演]

  西村紳一郎, 西村紳一郎, 高谷健二, 前田哲宏, 細口健作, 古川潤一, 比能洋

  日本糖質学会年会要旨集 2006年07月
• MUC1関連高分子糖ペプチドの効率的合成と機能評価  [通常講演]

  松下隆彦, 大藪巨樹, 大藪巨樹, 比能洋, 清水弘樹, 西村紳一郎, 西村紳一郎

  高分子学会予稿集(CD-ROM) 2006年05月
• 糖鎖自動合成装置“Golgi”用糖転移酵素の開発と利用  [通常講演]

  岩田一道, 太田尚志, 太田尚志, 山田久里子, 山田久里子, 戸田篤志, 戸田篤志, 比能洋, 西村紳一郎, 西村紳一郎

  バイオテクノロジーシンポジウム予稿集 2005年11月
• 糖ペプチド合成用プライマーの開発と糖ペプチドライブラリーへの応用  [通常講演]

  麓昌高, 麓昌高, 比能洋, 比能洋, 清水弘樹, 太田尚志, 太田尚志, 松下隆彦, 岩田一道, 山田久里子, 山田久里子, 伊藤孝臣, 大藪巨樹, 大藪巨樹, 瀧本明生, 近藤裕郷, 稲津敏行, 中原義昭, 西村紳一郎, 西村紳一郎

  バイオテクノロジーシンポジウム予稿集 2005年11月
• 糖鎖自動合成装置“Golgi”の開発  [通常講演]

  山田久里子, 山田久里子, 太田尚志, 太田尚志, 岩田一道, 麓昌高, 麓昌高, 大藪巨樹, 大藪巨樹, 比能洋, 清水弘樹, 西村紳一郎

  バイオテクノロジーシンポジウム予稿集 2005年11月
• 糖ペプチド合成用プライマーの開発と糖ペプチドライブラリーへの応用 (第23回 バイオテクノロジー シンポジウム 予稿集) -- (ポスターセッションの部 糖鎖エンジニアリングプロジェクト/糖鎖構造解析技術開発)  [通常講演]

  麓 昌高, 比能 洋, 清水 弘樹

  バイオテクノロジ-シンポジウム予稿集 2005年11月
• 糖鎖自動合成装置"Golgi"の開発と糖ペプチド合成システムへの展開 (第23回 バイオテクノロジー シンポジウム 予稿集) -- (講演会の部)  [招待講演]

  比能 洋

  バイオテクノロジ-シンポジウム予稿集 2005年11月
• マイクロ波照射下における糖ペプチド固相合成  [通常講演]

  松下隆彦, 比能洋, 清水弘樹, 西村紳一郎

  日本化学会講演予稿集 2005年03月
• 非可逆的阻害機構を有するノイラミニダーゼプローブの開発  [通常講演]

  比能洋, 黒河内政樹, 長堀紀子, 西村紳一郎

  日本化学会講演予稿集 2005年03月
• 糖ペプチド合成用高分子プライマーの開発とその応用  [通常講演]

  麓昌高, 比能洋, 太田尚志, 伊藤孝臣, 瀧本明生, 近藤裕郷, 稲津敏行, 中原義昭, 西村紳一郎

  日本化学会講演予稿集 2005年03月
• 光学活性スルホキシドを用いる不斉Favorskii転位反応を利用した光学活性化合物の合成  [通常講演]

  三浦基文, 鳥山正晴, 比能洋, 浅見覚, 鈴木孝, 佐藤毅, 本橋重康

  日本薬学会年会要旨集 2005年03月
• 糖転移酵素Och1pの機能解析に関する研究  [通常講演]

  清水弘樹, 坂本雅博, 坂本雅博, 千葉靖典, 喜多島敏彦, 地神芳文, 比能洋, 西村紳一郎, 西村紳一郎

  日本農芸化学会大会講演要旨集 2005年03月
• 糖鎖自動合成装置“Golgi”用固定化糖転移酵素の開発  [通常講演]

  戸田篤志, 山田久里子, 比能洋, 西村紳一郎

  バイオテクノロジーシンポジウム予稿集 2004年11月
• 糖鎖自動合成装置“Golgi”による複合糖質の合成  [通常講演]

  山田久里子, 戸田篤志, 西口進, 岩田一道, 麓昌高, 比能洋, 西村紳一郎

  バイオテクノロジーシンポジウム予稿集 2004年11月
• 糖鎖自動合成装置“Golgi”にむけた糖ペプチド合成用プライマーの開発  [通常講演]

  岩田一道, 麓昌高, 比能洋, 太田尚志, 松下隆彦, 山田久里子, 伊藤孝臣, 瀧本明生, 稲津敏行

  バイオテクノロジーシンポジウム予稿集 2004年11月
• 糖鎖自動合成装置"Golgi"にむけた糖ペプチド合成用プライマーの開発 (第22回バイオテクノロジーシンポジウム予稿集) -- (ポスターセッションの部 糖鎖エンジニアリングプロジェクト/糖鎖構造解析技術開発)  [通常講演]

  岩田 一道, 麓 昌高, 比能 洋

  バイオテクノロジ-シンポジウム予稿集 2004年11月
• 糖鎖自動合成法に関する基礎研究(X)  [通常講演]

  西口進, 戸田篤志, 山田久里子, 太田尚志, 比能洋, 新間陽一, 地神芳文, 西村紳一郎

  高分子学会予稿集(CD-ROM) 2004年09月
• 糖鎖自動合成技術の開発研究および,糖ペプチドライブラリー合成への展開  [招待講演]

  比能洋, 太田尚志, 山田久里子, 西口進, 戸田篤志, 岩田一道, 地神芳文, 松下隆彦, 新間陽一

  高分子学会予稿集(CD-ROM) 2004年09月 口頭発表（招待・特別）
• PTPase阻害薬を用いた小児悪性腫ようへの応用  [通常講演]

  宮本智子, 浅見覚, 堀川あすか, 大東彩子, 比能洋, 鳥山正晴, 本橋重康, 鈴木孝

  日本薬学会年会要旨集 2004年03月
• 不斉Favorskii転位反応を用いた光学活性アミンの合成  [通常講演]

  大東彩子, 比能洋, 浅見覚, 鳥山正晴, 鈴木孝, 本橋重康

  日本薬学会年会要旨集 2004年03月
• PTPase阻害薬を用いた小児悪性腫瘍への応用  [通常講演]

  宮本 智子, 浅見 覚, 堀川 あすか, 大東 彩子, 比能 洋, 鳥山 正晴, 本橋 重康, 鈴木 孝

  日本薬学会年会要旨集 2004年03月
• PTPase阻害剤による小児悪性腫瘍への応用  [通常講演]

  浅見 覚, 宮本 智子, 伊藤 リエ, 堀川 あすか, 鶴見 洋子, 三宅 宗晴, 大東 彩子, 比能 洋, 鳥山 正晴, 木村 由美子, 秋久 俊博, 佐藤 毅, 本橋 重康, 陳 基明, 麦島 秀雄, 鈴木 孝

  小児がん 2003年11月
• 糖鎖エンジニアリングプロジェクト/糖鎖構造解析技術開発 糖鎖自動合成装置のさらなる改良に向けて  [招待講演]

  西村紳一郎, 比能洋

  バイオテクノロジーシンポジウム予稿集 2003年11月 口頭発表（招待・特別）
• 二基質型シアル酸転移酵素阻害剤の合成研究  [招待講演]

  比能洋, 孫学龍, 本橋重康, 伊藤幸成

  次世代を担う有機化学シンポジウム講演要旨集 2003年05月 口頭発表（招待・特別）
• 二基質型シアル酸転移酵素阻害剤の系統的合成  [通常講演]

  比能洋, 本橋重康, 伊藤幸成

  日本薬学会年会要旨集 2003年03月
• 不斉Favorskii転位反応を用いた光学活性カルボン酸の合成  [通常講演]

  吉原久美子, 比能洋, 鳥山正晴, 本橋重康

  日本薬学会年会要旨集 2003年03月
• 二基質結合型シアル酸転移酵素阻害剤の合成研究  [通常講演]

  比能洋, SUN X‐L, 伊藤幸成

  日本糖質学会年会要旨集 2002年07月
• 二基質結合型シアル酸転移酵素阻害剤の合成研究 (4)  [通常講演]

  比能洋, 伊藤幸成

  日本化学会講演予稿集 2002年03月
• 2基質結合型シアル酸転移酵素阻害剤の合成  [招待講演]

  比能洋

  生体分子の化学講演要旨集 2001年11月 口頭発表（招待・特別）
• 二基質結合型シアル酸転移酵素阻害剤の合成研究 (2)  [通常講演]

  比能洋, SUN X L, 伊藤幸成

  日本糖質学会年会要旨集 2001年07月
• 二基質結合型シアル酸転移酵素阻害剤の合成研究  [通常講演]

  比能洋, SUN X‐L, 伊藤幸成

  日本化学会講演予稿集 2001年03月
• 多環状エーテルの収束的構築法の開発  [通常講演]

  松尾剛, 上田剛, 比能洋, 越野広雪, 中田忠

  日本化学会講演予稿集 2001年03月
• 多環状エーテルの高効率的合成法の開発  [通常講演]

  中田忠, 松尾剛, 堀伸行, 松倉弘子, 比能洋

  反応と合成の進歩シンポジウム講演要旨集 2000年10月
• トランス縮環四環性ポリエーテルの短段階収束的合成  [通常講演]

  松尾剛, 比能洋, 越野広雪, 末永俊朗, 中田忠

  日本化学会講演予稿集 2000年03月
• 2糖トレハロースを出発物としたL‐イズロン酸の新規合成法  [通常講演]

  比能洋, 黒沢英弘, 松岡浩司, 照沼大陽, 葛原弘美

  日本化学会講演予稿集 1999年03月
• トレハロースのL‐イドース含有2糖への変換反応  [通常講演]

  比能洋, 黒沢英弘, 松岡浩司, 照沼大陽, 葛原弘美

  日本化学会講演予稿集 1998年03月
• 両親媒性キトヘプタオース誘導体の合成  [通常講演]

  比能洋, 海野篤, 松岡浩司, 照沼大陽, 葛原弘美

  糖質シンポジウム講演要旨集 1997年07月
• 分子集合能を持つキトビオース誘導体の合成  [通常講演]

  比能洋, 海野篤, 松岡浩司, 照沼大陽, 葛原弘美

  キチン・キトサン研究 1997年05月
• 両親媒性キトオリゴ糖誘導体の合成 II 2本の疎水性長鎖を結合した3糖,5糖,7糖の合成  [通常講演]

  比能洋, 海野篤, 松岡浩司, 照沼大陽, 葛原弘美

  日本化学会講演予稿集 1997年03月
• 両親媒性キトオリゴ糖誘導体の合成 I 長鎖アシルアミノ基を活用したグリコシル化反応  [通常講演]

  海野篤, 比能洋, 松岡浩司, 照沼大陽, 葛原弘美

  日本化学会講演予稿集 1997年03月
• キトオリゴ糖ミセルの合成研究  [通常講演]

  比能洋, 海野篤, 松岡浩司, 照沼大陽, 葛原弘美

  日本化学会講演予稿集 1996年03月

担当経験のある科目（授業）

科学・技術の世界（生命科学の最前線）北海道大学
科学・技術の世界（はじめての生命科学II-研究の最前線-）北海道大学
実験生物科学北海道大学
有機化学実験東京理科大学
化学実験日本大学
糖鎖生物学北海道大学
生体高分子学基礎実験北海道大学
生体高分子学実験北海道大学
有機化学演習北海道大学
応用生物有機化学北海道大学
生物系のための有機化学北海道大学
基礎有機化学北海道大学
生命融合科学概論/ソフトマター科学概論北海道大学
環境と人間(生命科学の最前線)北海道大学
科学・技術の世界（はじめての生命科学から「医」への展開）北海道大学

所属学協会

• 日本質量分析学会   高分子学会   日本薬学会   日本糖質学会   日本化学会   GFRGプロジェクト   

共同研究・競争的資金等の研究課題

• 広範な生体サンプル糖鎖を標的としたMALDIバイオタイピング技術の開発

  日本学術振興会：科学研究費助成事業 基盤研究(B)

  研究期間 : 2022年04月 -2026年03月 

  代表者 : 比能 洋, 小林 純子
• 黄体の機能制御に重要な糖鎖の探索～alpha2,6シアル酸修飾に注目して

  日本学術振興会：科学研究費助成事業 基盤研究(C)

  研究期間 : 2021年04月 -2024年03月 

  代表者 : 小林 純子, 工藤 正尊, 比能 洋

   

  黄体は妊娠の成立と維持に必須なプロゲステロンを産生する内分泌組織で、排卵後の卵胞壁細胞より形成される。妊娠が成立しない場合、ヒトでは、黄体は1週間ほど機能したのち、自発的に退行する。一方、妊娠が成立すると、胎盤より産生されるヒト絨毛性ゴナドトロピン（hCG）の作用により、黄体は退行を免れ妊娠黄体となって妊娠初期の数か月間機能を維持する。マウスやウシなどの動物では、子宮由来の因子が黄体の退行を誘導するが、ヒトでは子宮由来の因子は卵巣周期に影響を与えない。ヒトでは、黄体内で産生される因子が自発的に黄体の退行を制御すると考えられるがそのメカニズムは不明な点が多く残されている。 我々は、ヒト黄体では、beta-galactosideを認識するガレクチンのうち、galectin-1が機能黄体に、galectin-3が退行黄体に発現しており、ガレクチンと糖鎖との相互作用が機能制御に重要な役割を果たすことを報告してきた。ガレクチンと糖鎖との結合を阻害するalpha2,6シアル酸修飾は退行黄体で増加することから、ヒト黄体の機能制御に重要な役割を果たすと考えられるが、alpha2,6シアル酸修飾された糖鎖をもつタンパク質やその機能の詳細は明らかでない。 本研究では、ヒト黄体細胞において、退行時にalpha2,6シアル酸修飾をうける糖タンパク質を同定し、その機能を明らかにするとともに、質量分析イメージング装置を用いた切片上で糖鎖を検出できる技術の確立を目指し、黄体の機能制御に重要な糖鎖を探索することを目的とする。
• タンパク質の翻訳後糖鎖修飾により生成する動的エピトープを標的とする抗体医薬の開発

  日本学術振興会：科学研究費助成事業 基盤研究(A)

  研究期間 : 2019年04月 -2023年03月 

  代表者 : 西村 紳一郎, 田中 良和, 比能 洋, 尾瀬 農之

   

  申請者らの独創的なアイデアおよび開発戦略によって作製されたED抗体（epitope-defined antibody）を用いて、がん領域におけるアンメットメディカルニーズに応え得る新たながん治療薬の開発を目的として本研究課題を設定した。2019年度（初年度）は多くのがん細胞表面に高発現してがんの増殖や転移を促進することが広く知られるMUC1の細胞外ドメインに生成する多様な動的エピトープを標的とするED抗体である抗MUC1モノクローナル抗体（SN-101, SN-121, およびSN-131）に関して以下の各項目に進展があった。（１）SN-101の作製、特性、構造および機能に関する基礎的研究の成果について論文を発表した（H. Wakui, et al., A straightforward approach to antibodies recognizing cancer specific glycopeptidic neoepitopes, Chemical Science, 2020, in press）。本論文は水溶液中でユニークなコンフォメーションを示す糖ペプチドエピトープの糖鎖とペプチド領域を同時に認識して結合する抗MUC1抗体として構造が示された世界初の事例であり、ED-抗体の概念と基本的な製法を記載した最初の論文としての意義が大きい。また、（２）SN-121およびSN-131についても同様の構造機能解析が進んでおり、SN-131の結晶構造解析を完了した。これらの抗体の高付加価値化を目指してエピトープ認識領域での変異導入による機能改変の試みが開始されている。さらに、（３）SN-131に新たな機能（がん細胞障害活性）を付与するため遺伝子工学的手法により新たな二重特異性抗体の作製を行い、MUC1発現がん細胞を標的として特異的な細胞障害活性を示す新規SN-131キメラ抗体の開発に成功した。以上のように本年度はED-抗体開発戦略の有効性とdynamic epitope理論に基づく新しい抗体デザインに関する基本原理である「抗原構造形成における新たな分子機構」の普遍性を証明する様々な研究が極めて順調に進行している。
• D-マンノ－ス骨格を持つ糖鎖による免疫・炎症反応制御とその分子基盤の解析

  日本学術振興会：科学研究費助成事業 基盤研究(B)

  研究期間 : 2019年04月 -2022年03月 

  代表者 : 戸田 雅子, 佐分利 亘, 比能 洋, 新谷 尚弘

   

  真菌類や植物には結合様式の異なる様々なα型とβ型のマンナン（D-マンノ－スを含む多糖類）が含まれる。マンナンは「免疫系に対する機能を持つ食品成分」と注目され、その機能性の科学的解析が求められている。本研究はマンノ－ス骨格を持つ分子の免疫学的な意義を明らかすることを目的とする。また、日本の国菌と言われる「麹菌」を用いてマンノシル化アレルゲンを発現する麹菌を構築し、抗アレルギ－作用を持つマンナン分子の作製を目指す。本年度はまずβ型マンノオリゴ糖の調製を行い、その免疫機能性を解析した。その結果、β-Man-(1→4)-Manやβ-Man-(1→4)-Glc骨格を持つオリゴ糖の中で、β-1,4-マンノビオースがマウス骨髄樹状細胞を高レベルで活性化することが明らかになった。また、α型マンナンをβ-1,4-マンノビオースや他の多糖類と共に樹状細胞を刺激すると、樹状細胞による抗炎症サイトカイン産生が増強されることを見いだした。αマンノオリゴ糖に関しては、α-1,2およびα-1,6結合への伸長方向が任意に制御可能な保護基の組み合わせによるαマンノオリゴ糖の合成ルート構築を実施した。この目的を満たす共通中間体の最適化を行い、中間体を使用することによりそれぞれのα-1,2およびα-1,6結合型の直鎖オリゴ糖をベンジルグリコシド体として調製するルート構築に成功した。マンノシル化アレルゲンを発現する麹菌に関しては、オボアルブミン（OVA：モデルアレルゲン）の cDNAを麹菌グルコアミラーゼglaAの触媒ドメインをコードするDNAの下流に連結し、GlaA-OVA融合タンパク質として麹菌で発現させた。2日間液体培養した培養上清500 µL分をSDS-PAGEに供し、Coomassie Brilliant Blue R-250染色したところ、OVAの発現が確認できたが発現量は低かった。
• 感染症に伴う免疫応答と抗原糖鎖修飾の相関解析技術

  科学技術振興機構(JST)：研究成果最適展開支援プログラム(A-STEP) トライアウト ｗｉｔｈ／ｐｏｓｔコロナにおける社会変革への寄与が期待される研究開発課題

  研究期間 : 2021年04月 -2022年03月 

  代表者 : Hiroshi Hinou
• 質量管理によるキトサンオリゴ糖の製造・加工技術の革新

  科学技術振興機構(JST)：研究成果最適展開支援プログラム(A-STEP) トライアウト

  研究期間 : 2020年11月 -2022年03月 

  代表者 : 比能洋
• 糖ペプチド―レクチン相互作用の精密解析：ペプチド配列に潜む糖鎖コードの解明

  日本学術振興会：科学研究費助成事業 基盤研究(C)

  研究期間 : 2017年04月 -2020年03月 

  代表者 : 比能 洋

   

  前年度揃えた化合物ライブラリとビオチンラベル化ガレクチン類との相互作用解析を実施した。ビオチン化ガレクチン類は複数のビオチン結合サイトを有しており、相互作用は蛍光ラベル化ストレプトアビジンを使用し、全反射マイクロアレイ観察系を用いて観察を行った。マイクロアレイスポッターの不調により、スポット再現性の取得に苦労したが、観察系において別途開発中の小型化装置を用い、特に、スポッターを設置しているクリーンルームに持ち込むことも容易であることから、従来カメラで一点ずつ目視でのスポットの品質管理を強いられていたことに対し、全スポット完了後、明視野、散乱光、および蛍光を用いてスポットの品質管理ができる体制の構築に成功した。 さらに、品質管理の一環として合成糖ペプチドのシアル酸を切断することなく効率的にイオン化可能なマトリックス支援レーザー脱離イオン化法解析用のマトリックス系の開発に成功した。特に、シアリル化糖鎖解析の定石とされつつあるシアル酸のカルボン酸の修飾を必要としない高感度、高分解能解析を実現し、微量かつ多検体の品質管理を必要とする化合物マイクロアレイ研究を信頼できるレベルで遂行する上で必須の基盤構築に成功した。 上述の通り本年度は品質管理技術の向上にかなりの労力を費やしたが、ガレクチンのようなはがれやすく弱い相互作用を比較解析するためにはアレイに使用する化合物群の品質管理技術が極めて重要である。本年度は信頼性向上に時間を要したため標的となるガレクチンとの相互作用解析にリソースをあてられなかったが、信頼性の高い相互作用解析実施に必要な基礎技術群を整備することに成功しており、研究は確実に進捗しているといえる。
• 網羅的糖鎖解析による新規癌マーカーの探索と診断技術の開発

  日本学術振興会：科学研究費助成事業 基盤研究(S)

  研究期間 : 2013年05月 -2018年03月 

  代表者 : 西村 紳一郎, 能祖 一裕, 比能 洋, 大山 力, 神山 俊哉, 天野 麻穂

   

  世界初の「疾患糖鎖構造データベースの構築」を目標として、医師を含む臨床チームとの強力な連携により３５００件を超える患者検体を用いた大規模網羅的糖鎖解析による新規バイオマーカーの探索を進めた。特に消化器癌と泌尿器癌に焦点を絞りバイオマーカーとして有望な糖鎖構造情報を獲得するため、独創的な「全自動糖鎖解析装置」による大規模糖鎖解析からの疾患糖鎖データベースの構築に挑戦した。具体的には膵臓癌、膵炎、肝細胞癌、肝炎、潰瘍性大腸炎、大腸癌、自己免疫性膵炎等の消化器疾患領域、および腎細胞癌、腎炎、前立腺癌等の泌尿器疾患領域を中心に疾患糖鎖情報を収集して世界初の疾患関連糖鎖データベースの構築が実現した。
• ２糖資源を活用した２糖アミノ酸調製法

  科学技術振興機構(JST)：A-STEP機能検証フェーズ（旧・地域産学バリュープログラム）(A-STEP機能検証フェーズ)

  研究期間 : 2015年06月 -2016年03月 

  代表者 : 比能洋
• グライコブロッティング法を用いた多糖構造解析に基づく膜ファウリング制御技術の開発

  日本学術振興会：科学研究費助成事業 基盤研究(B)

  研究期間 : 2012年04月 -2015年03月 

  代表者 : 木村 克輝, 比能 洋, 相沢 智康

   

  多糖中に含まれるアルデヒド基とアミノオキシ基間の特異的結合を利用したグライコブロッティング法の適用により、高解像度のMALDI-TOF/MS分析を行うことでMBRにおける膜ファウリング多糖の構造と起源について検討した。本研究の結果、抽出ファウリング多糖と上澄み液中の多糖には共通する多糖構造が必ずしも多くないことが示された。MBRの膜ファウリング発生には、莢膜多糖（CPS）あるいはリポ多糖（LPS）が重要な関与をしている可能性が本研究により得られたMALDI-TOF/MSスペクトルの検討および質量数ピークの微生物多糖データベースとの照合により示された。
• 環状不凍糖ペプチドの迅速合成と不凍化分子機構の解明

  日本学術振興会：科学研究費助成事業 基盤研究(B)

  研究期間 : 2011年04月 -2014年03月 

  代表者 : 比能 洋

   

  環状不凍糖ペプチドは天然型の直鎖状不凍糖ペプチドが有する活性型配座を取れないことから異なる不凍化機構の存在が予想されていたが、従来の合成法では高純度の標品を得ることが困難であった。本研究ではフッ素化アルコールの水素結合能に着目したを新規ペプチド環化法の開発に成功し、この環状不凍糖ペプチドの高純度標品の迅速調整に成功し、さらに従来のペプチド環化に多用されてきた方法ではC-末端アミノ酸のラセミ化が生じることにより生成物の複雑化が生じていることを解明した。さらに、糖鎖不可前後の環状ペプチド骨格の結晶構造および溶液中の構造を解明し、１対の逆並行βシート型構造の配列が糖付加により変化することを見出した。
• 新奇構造を有する機能選択的タンパク質迅速検出・標識・分離解析システムの構築

  日本学術振興会：科学研究費助成事業 若手研究(A)

  研究期間 : 2007年 -2009年 

  代表者 : 比能 洋

   

  シアリダーゼをモデルタンパク質とし、酵素の機能選択的に共有結合を形成可能な自殺基質によるラベル化情報を用いた新規阻害剤の開発を行った。構造変化が予測されたループ構造と相互作用できるようFocused libraryを設計し、その阻害能を評価した結果、特異的かつ強力な阻害剤が見出された。さらに、既知の非特異的阻害剤と本研究で見出された特異的阻害剤の構造を組み合わせた結果、最強(Ki=73nM)の阻害剤を得ることに成功した。
• 環状化合物の合成、制御、利用

  研究期間 : 2008年
• 金属微粒子を用いた選択的レーザー脱離イオン化TOF-MSによる複合糖質の機能探索

  日本学術振興会：科学研究費助成事業 基盤研究(A)

  研究期間 : 2005年 -2007年 

  代表者 : 西村 紳一郎, 長堀 紀子, 比能 洋, 篠原 康郎

   

  本研究では"糖鎖提示ナノ微粒子および質量分析計"を用いることで、複合糖質の分子レベでの機能解明すなわち「相互作用相手分子を効率的に探索し、同定する新規方法論」を開発することを目的とした。 〈非特異吸着抑制型水溶性糖鎖提示ナノ微粒子の作製〉 本研究では、金属表面とチオール基との親和性を利用して金属ナノ微粒子表面修飾を行った。金属ナノ微粒子表面には糖鎖を〜数百分子程度提示できるため、相互作用相手分子との強い結合力が得られる(糖鎖クラスター効果)。また、アミノオキシ基と糖鎖還元末端との化学選択的反応を利用することであらゆる糖鎖を提示可能なシステムを構築した。これを利用し、糖鎖提示ナノ懲粒子のライブラリー化を行った。標的タンパク質を共有結合で捕捉可能な自殺基質型の糖鎖誘導体を微粒子表面に簡便に提示する方法の開発も合わせて行った。金属-チオール結合がレーザーによって切断されることを利用し、ナノ微粒子表面への糖鎖の提示をMALDI-TOF MSによって評価した。ナノ微粒子への非特異吸着を低減するために、双性イオン型チオール化合物を合成し、これを用いた。作製したすべてのナノ微粒子は高い水溶性および安定性を示した。 〈糖鎖相互作用分子の探索および同定方法の確立〉 本研究で作製したナノ微粒子は水溶性であるため、相互作用相手分子を捕捉後そのまま各種生化学的アッセイおよびMALDI-TOF MS測定に供することができる。生体試料からの相互作用相手分子(タンパク質)の捕捉においては、ナノ微粒子と試料溶液をインキュベートし洗浄後そのままSDS-PAGEにアプライし、目的のバンドを切り出してプロテオミクスの常法に従ってタンパク質の同定が可能であった。このように、競合糖鎖による溶出が必要なアフィニティークロマトグラフィー等の従来法と比較して、サンプルロスが少ないことによる高感度化、および作業工程の簡素化による大幅な效率化を達成した。
• 糖鎖・糖ペプチド自動合成システムを活用した創薬シーズの探索研究

  研究期間 : 2006年
• 酵素阻害剤の開発

  研究期間 : 2000年
• 天然有機資源の有効活用

  研究期間 : 1994年

産業財産権

• 特願PCT/JP2020/002624:未修飾シアリル化複合糖質および糖ペプチドのリフレクトロンモードＭＡＬＤＩ－ＴＯＦおよびＴＯＦ／ＴＯＦ質量分析のためのアニリン誘導体またはアミノオキシ基含有芳香族誘導体／ＤＨＢ／アルカリ金属マトリックス組成物  2020年01月

  比能 洋
• 特願2019-011457:未修飾シアリル化複合糖質および糖ペプチドのリフレクトロンモードＭＡＬＤＩ－ＴＯＦおよびＴＯＦ／ＴＯＦ質量分析のためのアニリン誘導体／ＤＨＢ／アルカリ金属マトリックス組成物  2019年01月25日

  比能 洋  北海道大学
• 特許第6019944号:糖化合物固定化半導体センシングデバイス及び生物学的物質の検出方法  2016年10月14日

  逢坂 哲彌, 秀島 翔, 黒岩 繁樹, 西村 紳一郎, 比能 洋  逢坂 哲彌  201603006914839016
• 特許第5773352号:抗MUC1抗体  2015年07月10日

  西村 紳一郎, 比能 洋, 沼田 義人, 小野田 順二, 内藤 正一, 大藪 巨樹  塩野義製薬株式会社, 国立大学法人北海道大学  201503005608873550
• 特開2013-152211:糖化合物固定化半導体センシングデバイス及び生物学的物質の検出方法  2013年08月08日

  逢坂 哲彌, 秀島 翔, 黒岩 繁樹, 西村 紳一郎, 比能 洋  学校法人早稲田大学  201303031273044877
• 特許第4942014号:O−結合型糖アミノ酸  2012年03月09日

  西村 紳一郎, 比能 洋, 西口 進, 浜本 智樹  独立行政法人産業技術総合研究所, 国立大学法人北海道大学  201303039837534498
• WO2010-050528:抗MUC1抗体  2010年05月06日

  西村 紳一郎, 比能 洋, 沼田 義人, 小野田 順二, 内藤 正一, 大藪 巨樹  塩野義製薬株式会社, 国立大学法人北海道大学  201203074594144478
• 特開2009-215207:O−マンノース型糖鎖結合アミノ酸及びそれを用いた糖ペプチドの製造方法  2009年09月24日

  西村 紳一郎, 比能 洋  国立大学法人 北海道大学  200903095867572860
• WO2009-004899:シアリダーゼ阻害剤  2009年01月08日

  西村 紳一郎, 比能 洋  国立大学法人北海道大学, 塩野義製薬株式会社  201003067533838050
• 特開2008-285448:シアリダーゼ阻害剤  2008年11月27日

  西村 紳一郎, 比能 洋  国立大学法人 北海道大学  200903075477968851
• WO2006-126504:銀被覆粒子およびその用途  2006年11月30日

  岩田 一道, 比能 洋, 西村 紳一郎  独立行政法人産業技術総合研究所  200903067315142698
• WO2006-064914:ノイラミニダーゼ阻害剤  2006年06月22日

  西村 紳一郎, 比能 洋, 近藤 裕郷, 藤原 一彦  独立行政法人産業技術総合研究所, 国立大学法人 北海道大学, 塩野義製薬株式会社, 住友ベークライト株式会社  200903022388768940
• 特開2006-111618:O−結合型糖アミノ酸  2006年04月27日

  西村 紳一郎, 比能 洋, 西口 進, 浜本 智樹  独立行政法人産業技術総合研究所, 国立大学法人 北海道大学, 東洋紡績株式会社, ヤマサ醤油株式会社  200903084311417074
• WO2006-030840:ムチン型ペプチドの合成法とMUC1関連糖ペプチド  2006年03月23日

  西村 紳一郎, 比能 洋, 麓 昌高  独立行政法人産業技術総合研究所, 塩野義製薬株式会社  200903006544391902
• 特開2006-063055:O−アセチル化糖アミノ酸  2006年03月09日

  西村 紳一郎, 比能 洋  独立行政法人産業技術総合研究所  200903025121684320
• 特開2006-028141:糖ペプチドの製造方法  2006年02月02日

  西村 紳一郎, 比能 洋, 松下 隆彦  独立行政法人産業技術総合研究所  200903000287255557